
<html lang="en"     class="pb-page"  data-request-id="9d531341-d919-428f-afb8-a75501849e43"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";issue:issue:10.1021/jmcmar.2020.63.issue-24;requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;article:article:10.1021/acs.jmedchem.0c01531;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Cyclic Phosphopantothenic Acid Prodrugs for Treatment of Pantothenate Kinase-Associated Neurodegeneration" /></meta><meta name="dc.Creator" content="Giulio  Auciello" /></meta><meta name="dc.Creator" content="Annalise  Di Marco" /></meta><meta name="dc.Creator" content="Odalys  Gonzalez Paz" /></meta><meta name="dc.Creator" content="Savina  Malancona" /></meta><meta name="dc.Creator" content="Steven  Harper" /></meta><meta name="dc.Creator" content="Maria  Beconi" /></meta><meta name="dc.Creator" content="Ilaria  Rossetti" /></meta><meta name="dc.Creator" content="Alina  Ciammaichella" /></meta><meta name="dc.Creator" content="Paola  Fezzardi" /></meta><meta name="dc.Creator" content="Andrea  Vecchi" /></meta><meta name="dc.Creator" content="Elena  Bracacel" /></meta><meta name="dc.Creator" content="Daniel  Cicero" /></meta><meta name="dc.Creator" content="Edith  Monteagudo" /></meta><meta name="dc.Creator" content="Daniel  Elbaum" /></meta><meta name="dc.Description" content="Mutations in the human PANK2 gene are implicated in neurodegenerative diseases such as pantothenate kinase-associated neurodegeneration (PKAN) and result in low levels of coenzyme-A (CoA) in the CN..." /></meta><meta name="Description" content="Mutations in the human PANK2 gene are implicated in neurodegenerative diseases such as pantothenate kinase-associated neurodegeneration (PKAN) and result in low levels of coenzyme-A (CoA) in the CN..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="December 15, 2020" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.0c01531" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2020 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.0c01531" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.0c01531" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.0c01531" /></link>
        
    
    

<title>Cyclic Phosphopantothenic Acid Prodrugs for Treatment of Pantothenate Kinase-Associated Neurodegeneration | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.0c01531" /></meta><meta property="og:title" content="Cyclic Phosphopantothenic Acid Prodrugs for Treatment of Pantothenate Kinase-Associated Neurodegeneration" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01531/20201218/images/large/jm0c01531_0015.jpeg" /></meta><meta property="og:description" content="Mutations in the human PANK2 gene are implicated in neurodegenerative diseases such as pantothenate kinase-associated neurodegeneration (PKAN) and result in low levels of coenzyme-A (CoA) in the CNS due to impaired production of phosphopantothenic acid (PPA) from vitamin B5. Restoration of central PPA levels by delivery of exogenous PPA is a recent strategy to reactivate CoA biosynthesis in PKAN patients. Fosmetpantotenate is an oral PPA prodrug. We report here the development of a new PANk2–/– knockout model that allows CoA regeneration in brain cells to be evaluated and describe two new series of cyclic phosphate prodrugs of PPA capable of regenerating excellent levels of CoA in this system. A proof-of-concept study in mouse demonstrates the potential of this new class of prodrugs to deliver PPA to the brain following oral administration and confirms incorporation of the prodrug-derived PPA into CoA." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.0c01531"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c01531">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.0c01531&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.0c01531&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.0c01531&amp;href=/doi/10.1021/acs.jmedchem.0c01531" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2020</span><span class="cit-fg-volume">, 63</span><span class="cit-fg-issue">, 24</span><span class="cit-fg-pageRange">, 15785-15801</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/63/24" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.0c01528" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.0c01535" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Cyclic Phosphopantothenic Acid Prodrugs for Treatment of Pantothenate Kinase-Associated Neurodegeneration</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Giulio Auciello</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Giulio Auciello</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Departments of Chemistry and Biology, IRBM Science Park, Via Pontina km 30,600, 00071 Pomezia, Rome, Italy</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Giulio++Auciello">Giulio Auciello</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Annalise Di Marco</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Annalise Di Marco</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Departments of Chemistry and Biology, IRBM Science Park, Via Pontina km 30,600, 00071 Pomezia, Rome, Italy</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Annalise++Di+Marco">Annalise Di Marco</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Odalys Gonzalez Paz</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Odalys Gonzalez Paz</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Departments of Chemistry and Biology, IRBM Science Park, Via Pontina km 30,600, 00071 Pomezia, Rome, Italy</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Odalys++Gonzalez+Paz">Odalys Gonzalez Paz</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Savina Malancona</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Savina Malancona</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Departments of Chemistry and Biology, IRBM Science Park, Via Pontina km 30,600, 00071 Pomezia, Rome, Italy</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Savina++Malancona">Savina Malancona</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-5388-6533" title="Orcid link">http://orcid.org/0000-0002-5388-6533</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Steven Harper</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Steven Harper</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Departments of Chemistry and Biology, IRBM Science Park, Via Pontina km 30,600, 00071 Pomezia, Rome, Italy</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Steven++Harper">Steven Harper</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Maria Beconi</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Maria Beconi</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Travere, 3721 Valley Centre Drive, San Diego, California 92130, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Maria++Beconi">Maria Beconi</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Ilaria Rossetti</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Ilaria Rossetti</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Departments of Chemistry and Biology, IRBM Science Park, Via Pontina km 30,600, 00071 Pomezia, Rome, Italy</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Ilaria++Rossetti">Ilaria Rossetti</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Alina Ciammaichella</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Alina Ciammaichella</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Departments of Chemistry and Biology, IRBM Science Park, Via Pontina km 30,600, 00071 Pomezia, Rome, Italy</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Alina++Ciammaichella">Alina Ciammaichella</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Paola Fezzardi</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Paola Fezzardi</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Departments of Chemistry and Biology, IRBM Science Park, Via Pontina km 30,600, 00071 Pomezia, Rome, Italy</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Paola++Fezzardi">Paola Fezzardi</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Andrea Vecchi</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Andrea Vecchi</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Departments of Chemistry and Biology, IRBM Science Park, Via Pontina km 30,600, 00071 Pomezia, Rome, Italy</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Andrea++Vecchi">Andrea Vecchi</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Elena Bracacel</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Elena Bracacel</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Departments of Chemistry and Biology, IRBM Science Park, Via Pontina km 30,600, 00071 Pomezia, Rome, Italy</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Elena++Bracacel">Elena Bracacel</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Daniel Cicero</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Daniel Cicero</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Departments of Chemistry and Biology, IRBM Science Park, Via Pontina km 30,600, 00071 Pomezia, Rome, Italy</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Daniel++Cicero">Daniel Cicero</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Edith Monteagudo</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Edith Monteagudo</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Departments of Chemistry and Biology, IRBM Science Park, Via Pontina km 30,600, 00071 Pomezia, Rome, Italy</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Edith++Monteagudo">Edith Monteagudo</a></span></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">Daniel Elbaum</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Daniel Elbaum</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Travere, 3721 Valley Centre Drive, San Diego, California 92130, United States</div></div><span class="conrtib-corresp"><strong>*</strong>Email: <a href="/cdn-cgi/l/email-protection#224646474e4043574f62454f434b4e0c414d4f"><span class="__cf_email__" data-cfemail="adc9c9c8c1cfccd8c0edcac0ccc4c183cec2c0">[email protected]</span></a></span><span class="conrtib-corresp"></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Daniel++Elbaum">Daniel Elbaum</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-6012-7965" title="Orcid link">http://orcid.org/0000-0002-6012-7965</a></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.0c01531&amp;href=/doi/10.1021%2Facs.jmedchem.0c01531" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2020</span></span><span class="cit-volume">, 63</span><span class="cit-issue">, 24</span><span class="cit-pageRange">, 15785–15801</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">December 15, 2020</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>1 September 2020</li><li><span class="item_label"><b>Published</b> online</span>15 December 2020</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 24 December 2020</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.0c01531" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01531</a></div><div class="article_header-article-copyright"><strong>Copyright © 2020 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D15785%26pageCount%3D17%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DGiulio%2BAuciello%252C%2BAnnalise%2BDi%2BMarco%252C%2BOdalys%2BGonzalez%2BPaz%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D63%26issueNum%3D24%26contentID%3Dacs.jmedchem.0c01531%26title%3DCyclic%2BPhosphopantothenic%2BAcid%2BProdrugs%2Bfor%2BTreatment%2Bof%2BPantothenate%2BKinase-Associated%2BNeurodegeneration%26numPages%3D17%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D15801%26publicationDate%3DDecember%2B2020">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.0c01531"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">752</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val">-</div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.0c01531" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Cyclic Phosphopantothenic Acid Prodrugs for Treatment of Pantothenate Kinase-Associated Neurodegeneration&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Giulio&quot;,&quot;last_name&quot;:&quot;Auciello&quot;},{&quot;first_name&quot;:&quot;Annalise&quot;,&quot;last_name&quot;:&quot;Di Marco&quot;},{&quot;first_name&quot;:&quot;Odalys&quot;,&quot;last_name&quot;:&quot;Gonzalez Paz&quot;},{&quot;first_name&quot;:&quot;Savina&quot;,&quot;last_name&quot;:&quot;Malancona&quot;},{&quot;first_name&quot;:&quot;Steven&quot;,&quot;last_name&quot;:&quot;Harper&quot;},{&quot;first_name&quot;:&quot;Maria&quot;,&quot;last_name&quot;:&quot;Beconi&quot;},{&quot;first_name&quot;:&quot;Ilaria&quot;,&quot;last_name&quot;:&quot;Rossetti&quot;},{&quot;first_name&quot;:&quot;Alina&quot;,&quot;last_name&quot;:&quot;Ciammaichella&quot;},{&quot;first_name&quot;:&quot;Paola&quot;,&quot;last_name&quot;:&quot;Fezzardi&quot;},{&quot;first_name&quot;:&quot;Andrea&quot;,&quot;last_name&quot;:&quot;Vecchi&quot;},{&quot;first_name&quot;:&quot;Elena&quot;,&quot;last_name&quot;:&quot;Bracacel&quot;},{&quot;first_name&quot;:&quot;Daniel&quot;,&quot;last_name&quot;:&quot;Cicero&quot;},{&quot;first_name&quot;:&quot;Edith&quot;,&quot;last_name&quot;:&quot;Monteagudo&quot;},{&quot;first_name&quot;:&quot;Daniel&quot;,&quot;last_name&quot;:&quot;Elbaum&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2020&quot;,&quot;month&quot;:&quot;12&quot;,&quot;day&quot;:&quot;15&quot;,&quot;issue&quot;:&quot;24&quot;,&quot;volume&quot;:&quot;63&quot;,&quot;pages&quot;:&quot;15785-15801&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.0c01531&quot;},&quot;abstract&quot;:&quot;Mutations in the human PANK2 gene are implicated in neurodegenerative diseases such as pantothenate kinase-associated neurodegeneration (PKAN) and result in low levels of coenzyme-A (CoA) in the CNS due to impaired production of phosphopantothenic acid (PPA) from vitamin B5. Restoration of central PPA levels by delivery of exogenous PPA is a recent strategy to reactivate CoA biosynthesis in PKAN patients. Fosmetpantotenate is an oral PPA prodrug. We report here the development of a new PANk2–/– knockout model that allows CoA regeneration in brain cells to be evaluated and describe two new series of cyclic phosphate prodrugs of PPA capable of regenerating excellent levels of CoA in this system. A proof-of-concept study in mouse demonstrates the potential of this new class of prodrugs to deliver PPA to the brain following oral administration and confirms incorporation of the prodrug-derived PPA into CoA.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.0c01531&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c01531" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.0c01531&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c01531" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.0c01531&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c01531" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.0c01531&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c01531&amp;href=/doi/10.1021/acs.jmedchem.0c01531" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.0c01531" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.0c01531" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (3 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01531&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.0c01531%26sid%3Dliteratum%253Aachs%26pmid%3D33320012%26genre%3Darticle%26aulast%3DAuciello%26date%3D2020%26atitle%3DCyclic%2BPhosphopantothenic%2BAcid%2BProdrugs%2Bfor%2BTreatment%2Bof%2BPantothenate%2BKinase-Associated%2BNeurodegeneration%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D63%26issue%3D24%26spage%3D15785%26epage%3D15801%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=290758" title="Anatomy">Anatomy</a>,</li><li><a href="/action/doSearch?ConceptID=292462" title="Central nervous system">Central nervous system</a>,</li><li><a href="/action/doSearch?ConceptID=292178" title="Organic compounds">Organic compounds</a>,</li><li><a href="/action/doSearch?ConceptID=291070" title="Pharmaceuticals">Pharmaceuticals</a>,</li><li><a href="/action/doSearch?ConceptID=291675" title="Stability">Stability</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/63/24" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/jmcmar.2020.63.issue-24/20201224/jmcmar.2020.63.issue-24.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01531/20201218/images/medium/jm0c01531_0015.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01531/20201218/images/large/jm0c01531_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01531&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Mutations in the human PANK2 gene are implicated in neurodegenerative diseases such as pantothenate kinase-associated neurodegeneration (PKAN) and result in low levels of coenzyme-A (CoA) in the CNS due to impaired production of phosphopantothenic acid (PPA) from vitamin B5. Restoration of central PPA levels by delivery of exogenous PPA is a recent strategy to reactivate CoA biosynthesis in PKAN patients. Fosmetpantotenate is an oral PPA prodrug. We report here the development of a new PANk2<sup>–/–</sup> knockout model that allows CoA regeneration in brain cells to be evaluated and describe two new series of cyclic phosphate prodrugs of PPA capable of regenerating excellent levels of CoA in this system. A proof-of-concept study in mouse demonstrates the potential of this new class of prodrugs to deliver PPA to the brain following oral administration and confirms incorporation of the prodrug-derived PPA into CoA.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_54312" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_54312" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Neurodegeneration with brain iron accumulation (NBIA) disorders comprise a group of neurological conditions of which the most common is pantothenate kinase-associated neurodegeneration (PKAN) with a prevalence of 1–3/1 000 000.<a onclick="showRef(event, 'ref1 ref2 ref3'); return false;" href="javascript:void(0);" class="ref ref1 ref2 ref3">(1−3)</a> Classic and atypical PKAN are autosomal recessive disorders with onset in childhood or early adolescence, respectively. Post-onset disease progression leads to a steady increase in muscle disorders, such as dystonia, rigidity, and dysphagia, and ultimately to movement disorders, cardiac and opthalmic complications, and death. The disease results in the accumulation of iron in the globus pallidus, which is seen as an “eye-of-the-tiger” pattern in the <i>T</i><sub>2</sub>-weighted magnetic resonance imaging (MRI).<a onclick="showRef(event, 'ref1 ref4'); return false;" href="javascript:void(0);" class="ref ref1 ref4">(1,4)</a> Although PKAN is rare, its high toll in terms of patient suffering and the current poor standard of care create a strong case for the development of new therapies.</div><div class="NLM_p">PKAN is caused by mutations in the human PANK2 gene that encodes pantothenate kinase-2 (PanK2), a key enzyme in coenzyme-A (CoA) biosynthesis.<a onclick="showRef(event, 'ref5 ref6'); return false;" href="javascript:void(0);" class="ref ref5 ref6">(5,6)</a> PanK2 is predominantly expressed in brain mitochondria, where it catalyzes the mono-phosphorylation of the primary hydroxyl group of pantothenic acid (vitamin B5, <a class="ref internalNav" href="#cht1" aria-label="Chart 1">Chart 1</a>) to generate 4′-phosphopantothenic acid (PPA). PPA is further processed to 4′-pantetheine by phosphopantothenoyl cysteine synthetase and phosphopantothenoyl cysteine decarboxylase and ultimately converted to CoA by phosphopantetheine adenylyltransferase and dephospho-CoA kinase.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> Loss of Pank2 function leads to a mitochondrial deficiency of CoA in PKAN patients. As CoA plays a vital role in a myriad of cellular processes, including metabolism of fatty acids and post-translational modification of proteins, its deficiency is believed to be a root cause of undesirable phenotypes seen in individuals suffering from PKAN.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a></div><figure id="cht1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Chart 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01531/20201218/images/medium/jm0c01531_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01531/20201218/images/large/jm0c01531_0002.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Chart 1. Biosynthetic Intermediates in CoA Synthesis and New PPA Prodrugs</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01531/20201218/images/large/jm0c01531_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01531&amp;id=cht1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Although the synthesis of PPA is defective in the CNS of PKAN patients, the subsequent processing steps to CoA are functional, and a potential therapy for PKAN might therefore stem from administration of either PPA itself, or one of its downstream products in the CoA biosynthetic pathway. While this approach is conceptually appealing, poor blood–brain barrier (BBB) penetration for these highly polar and acidic compounds poses a significant limitation. To circumvent this issue, approaches that mask the polar phosphoric acid and carboxylic acid moieties in PPA with biochemically labile functionality provide an attractive strategy toward brain penetrant prodrugs with the potential to function as PPA precursors.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> The biopharmaceutical company Travere, Inc. recently reported work in this direction, targeting compounds capable of delivering viable CoA precursors to the CNS of PKAN patients following oral administration.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> A first candidate from this “kinase-bypass” PPA prodrug approach is Fosmetpantotenate (<a class="ref internalNav" href="#cht1" aria-label="Chart 1">Chart 1</a>), a phosphoramidate prodrug of PPA that recently completed a clinical trial (NCT 03041116) (<a href="https://clinicaltrials.gov/ct2/show/NCT03041116" class="extLink">https://clinicaltrials.gov/ct2/show/NCT03041116</a>).<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> Unfortunately, this trial did not meet its primary endpoint. Other efforts in this area include work on 4′-phophopantetheine.<a onclick="showRef(event, 'ref12 ref13'); return false;" href="javascript:void(0);" class="ref ref12 ref13">(12,13)</a> In addition, another therapeutic strategy is to increase the activity of other PanK isoforms.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a></div><div class="NLM_p">In follow-up to Fosmetpantotenate, a backup program was initiated to develop new prodrugs of PPA for the treatment of PKAN. The program had three goals: (1) provide a crystalline compound. Fosmetpantotenate is a viscous oil, which greatly complicates handling; (2) provide a more stable compound. Fosmetpantotenate was prone to intramolecular cyclization in which the 2′ hydroxyl displaced the phenoxy, resulting in cyclic phoshoramidate, <b>1</b> in <a class="ref internalNav" href="#cht1" aria-label="Chart 1">Chart 1</a>; and (3) provide a more efficacious compound. Treatment with Fosmetpantotenate results in a modest 2–3-fold increase in CoA in our cellular models. While it was uncertain if this would be sufficient, the urgent unmet need dictated rapid progression to the clinic.</div><div class="NLM_p">As a starting point, we were intrigued by compounds based on a 1,3,2-dioxaphosphinane heterocyclic core <b>1</b> the cyclization product of Fosmetpantotenate. Cyclic compounds were also found as circulating metabolites following administration of Fosmetpantotenate to rodents (data not shown). PPA release from cyclic phosphoramidates like <b>1</b> is potentially possible following phosphoramidase-mediated cleavage of the P–N bond<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> (and esterase-mediated hydrolysis of the carboxylic ester) but replacing the exocyclic phosphoramidate with more biochemically labile groups ought to favor the release of PPA.</div><div class="NLM_p last">Several intramolecularly cyclized phosphate prodrugs have been reported in the nucleoside area,<a onclick="showRef(event, 'ref16 ref17 ref18 ref19'); return false;" href="javascript:void(0);" class="ref ref16 ref17 ref18 ref19">(16−19)</a> and application of the pivaloyloxymethyl (POM) as a prodrug moiety has been documented.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> Here, we report work on three sets of analogues. This work started with an exploration of the pivaloyloxymethyl (POM)<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> group as a means to trigger release of PPA from 1,3,2-dioxaphosphinane-based prodrugs, and that resulted in a series of compounds (<b>2</b>) with attractive properties as second-generation PPA prodrugs. In addition, a set of compounds in which the pantothenate ester was varied were also explored as a means to modulate absorption, distribution, metabolism, and excretion (ADME) properties. Finally, a series of simplified analogues in which an arylphosphate (<b>3</b>) serves to mask the phosphoric acid of a cyclic PPA carboxylic ester that also proved to be viable PPA prodrugs are described. These compounds proved to be effective at restoring CoA levels in a cellular model, and oral dosing of isotopically labeled <b>2a</b> led to incorporation of the labels in the CoA found in the CNS. This provides a proof of principle for the use of this compound class to restore CoA levels in the CNS of PKAN patients.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i4">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_15863" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_15863" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i5" class="anchor-spacer"></div><h3 class="article-section__title" id="_i5"> Synthesis</h3><div class="NLM_p">Synthesis of 1,3,2-dioxaphosphinane-based PPA prodrug <b>1</b> was readily achievable by cyclization of Fosmetpantotenate under basic conditions (triethylamine in CH<sub>2</sub>Cl<sub>2</sub>) in 50% yield. Alkoyl and aroyl-oxymethyl prodrugs from <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Tables <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a> and <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a> were prepared by direct alkylation of the cyclic-PPA analogue <b>6</b> (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>). Synthesis of compound <b>6</b> began with methyl pantothenate <b>4</b> with POCl<sub>3</sub> followed by <i>in situ</i> displacement of the chloride from the intermediate 2-chloro-1,3,2-dioxaphosphinane 2-oxide with benzyl alcohol to give intermediate <b>5</b> in 25% yield. Removal of the benzyl group proceeded in 96% yield by hydrogenolysis over Pd/C. Alkylation of <b>6</b> could be accomplished by treatment with a chlormethyl ester<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> with either diisopropylethylamine (DIEA) or Ag<sub>2</sub>O (in the case of <b>2o</b>) to provide the analogues <b>2a</b>, <b>2b</b>, <b>2d</b>, <b>2f</b>, <b>2i</b>, <b>2j</b>, and <b>2n</b> in unoptimized yields ranging from less than 10 to 39% as a mixture of cis and trans diastereoisomers in an approximately 1:1 ratio. An alternative route to the target prodrugs involved conversion of <b>6</b> to the chloride intermediate <b>7</b> using chloromethyl sulfurochloridate,<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> which proceeded in only 10% yield. Compound <b>7</b> was then treated with the required carboxylic acid in the presence of Cs<sub>2</sub>CO<sub>3</sub> to provide compounds <b>2c</b>, <b>2e</b>, <b>2g</b>, <b>2h</b>, <b>2k</b>–<b>m</b>, and <b>2p</b>–<b>s</b>, again in unoptimized yields ranging from less than 10% to higher than 30%. This approach generally favored the formation of the cis-diastereoisomer. Stable isotope labeled <b>2a</b> (+6 amu) was prepared by construction of methyl pantothenate <b>4</b> (+4 amu) by ring opening<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> of commercial (<i>R</i>)-pantolactone with β-alanine methyl ester (+4 amu) in 67% yield, followed by cyclization employing P<sup>18</sup>OCl<sub>3</sub><a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> (<a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>). The resulting intermediate <b>12</b> was converted to <b>2a</b> (+6 amu) using the same conditions to construct <b>2a</b> in yields of 99 and 33% for the two remaining steps.</div><figure id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01531/20201218/images/medium/jm0c01531_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01531/20201218/images/large/jm0c01531_0004.jpeg" id="gr1" class="inline-fig internalNav" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01531/20201218/images/large/jm0c01531_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01531&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) POCl<sub>3</sub>, triethylamine (TEA), tetrahydrofuran (THF), −78 to 20 °C, then BnOH, TEA, THF, −78 to 20 °C; (b) H<sub>2</sub>, Pd/C, EtOAc; (c) RC(O)OCH<sub>2</sub>Cl, DIEA, dimethylformamide (DMF), 0–80 °C; (d) RC(O)OCH<sub>2</sub>Cl, Ag<sub>2</sub>O, AcCN, 80 °C; (e) chloromethyl sulfurochloridate, <i>t</i>-Bu<sub>4</sub>NHSO<sub>4</sub>, NaHCO<sub>3</sub>, H<sub>2</sub>O, dichloromethane (DCM), 0–20 °C; (f) RCO<sub>2</sub>H, Cs<sub>2</sub>CO<sub>3</sub>, DMF.</p></p></figure><figure id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01531/20201218/images/medium/jm0c01531_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01531/20201218/images/large/jm0c01531_0005.jpeg" id="gr2" class="inline-fig internalNav" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01531/20201218/images/large/jm0c01531_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01531&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) SOCl<sub>2</sub>, MeOH, reflux, 2 h; (b) (<i>R</i>)-pantolactone, TEA, MeOH, reflux, on; (c) PO(18)Cl<sub>3</sub>, TEA, THF, −78 to 20 °C, then BnOH, TEA, THF, −78 to 20 °C; (d) H<sub>2</sub>, Pd/C, EtOAc; (e) RC(O)OCH<sub>2</sub>Cl, DIEA, DMF, 0–80 °C;</p></p></figure><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. CoA Regeneration in PanK2 Knockdown Cells Treated with 1,3,2-Dioxaphosphinane Heterocycles Based on Alkoxymethyl and Aryloxymethyl Side Chains</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01531/20201218/images/medium/jm0c01531_0008.gif" alt="" id="fx1" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01531/20201218/images/medium/jm0c01531_0009.gif" alt="" id="fx2" /></img><div></div></div><div class="NLM_p">Analogues <b>9c</b>–<b>g</b> were prepared by cyclization of (<i>R</i>)-pantothenic acid <i>tert</i>-butyl ester, <b>8</b>, generated from <i>tert</i>-butyl 3-amino-propionate and (3<i>R</i>)-4-dimethyl-3-oxindanyl-oxolane-2-one in 88% yield, as outlined in <a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>. Construction of the cyclic POM analogue from <b>8</b> (as previously described for compound <b>2a</b>) in 28% overall yield for the three steps, followed by trifluoroacetic acid (TFA)-mediated ester deprotection gave the advanced carboxylic acid intermediate <b>9a</b>, in 87% yield. Introduction of the pantothenic ester functionality in compounds <b>9c</b>–<b>g</b> was achieved by condensation of <b>9a</b> with the required alcohols using 2-(1<i>H</i>-benzotriazole-1-yl)-1,1,3,3-tetramethyluronium tetrafluoroborate (TBTU) as the coupling reagent, in 29–97% yield. Compounds <b>3</b> were accessible by one of the two methods (<a class="ref internalNav" href="#sch4" aria-label="Scheme 4">Scheme 4</a>). Treatment of methyl pantothenate with POCl<sub>3</sub> provided the chloro-1,3,2-dioxaphosphinane intermediate (99% yield), which was used without purification. The crude material was treated with a phenol and TEA. This approach led to a mixture of diastereoisomers that were separated using SiO<sub>2</sub> chromatography to provide compounds <b>3a</b> and <b>3b</b> in 14 and 5% yields, respectively. The remaining compounds in <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a></a> were prepared using an alternative approach, in which the phenol was first activated by reaction with POCl<sub>3</sub>, followed by trapping of the resulting dichlorophosphate with <b>4</b>. This approach consistently gave rise to a single diastereoisomer of compounds <b>3c</b>–<b>g</b> with cis-stereochemistry across the ring junction in yields ranging from 3 to 23%.</div><figure id="sch3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01531/20201218/images/medium/jm0c01531_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01531/20201218/images/large/jm0c01531_0006.jpeg" id="gr3" class="inline-fig internalNav" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01531/20201218/images/large/jm0c01531_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01531&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) (3<i>R</i>)-4,4-dimethyl-3-oxidanyl-oxolan-2-one, 85 °C; (b) POCl<sub>3</sub>, TEA, THF, −78 °C, then BnOH, NMI, THF, −78 °C; (c) H<sub>2</sub>, Pd/C; (d) chloromethyl-2,2-dimethylpropanoate, DIEA, 80 °C; (e) TFA, DCM; (f) R′OH, TBTU, AcCN.</p></p></figure><figure id="sch4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01531/20201218/images/medium/jm0c01531_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01531/20201218/images/large/jm0c01531_0007.jpeg" id="gr4" class="inline-fig internalNav" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01531/20201218/images/large/jm0c01531_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01531&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) POCl<sub>3</sub>, TEA, THF, −78 °C; (b) R-C6H4-OH, TEA, Et<sub>2</sub>O, 0 °C; (c) POCl<sub>3</sub>, TEA, Et<sub>2</sub>O, −78 to 20 °C; (d) <b>4</b>, TEA, THF, −78 to 20 °C.</p></p></figure><div class="NLM_p last">Compounds <b>2a</b>–<b>s</b>, <b>9a</b>–<b>g</b>, <b>3a</b>–<b>g</b>, as well as <b>2a</b> were purified on SiO<sub>2</sub> or by reversed-phase C<sub>18</sub> column chromatography or high-performance liquid chromatography (HPLC) prior to use. Reversed-phase HPLC was also used to access the individual trans-diastereomers of compounds <b>1</b> as well as <b>2m</b>, <b>2r</b>, and <b>2s</b> (<a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a></a>). Ring stereochemistry for individual stereoisomers was assessed by <sup>1</sup>H–<sup>1</sup>H rotating-frame nuclear Overhauser effect spectroscopy (ROESY) NMR experiments on early compounds in each chemical series and for key compounds, as well as by small-molecule crystallography for compound <i><b>trans</b></i><b>-2a</b> (see the <a href="/doi/suppl/10.1021/acs.jmedchem.0c01531/suppl_file/jm0c01531_si_002.pdf" class="ext-link">Supporting Information</a>). Assignment of stereochemistry was simplified by confirmation that the relative <sup>31</sup>P NMR shift for either the cis or trans-isomer was a direct predictor of ring stereochemistry.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> The <sup>31</sup>P resonance for the cis-isomer was in all cases found downfield with respect to the trans, providing a straightforward means to assign stereochemistry in cases where both isomers were available.</div></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i7" class="anchor-spacer"></div><h3 class="article-section__title" id="_i7"> Biological Activity</h3><div class="NLM_p">To support medicinal chemistry efforts, a suitable PanK2-deficient cell model amenable to medium throughput in which to assess the potential of prodrugs to generate CoA was developed.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> This stable cell line expressing a PANK2 gene-specific shRNA allowed for the screening and characterization of potential drug candidates able to restore CoA levels. The quantitation of CoA concentrations in neuroblastoma cells was performed by HPLC analysis using a method that allowed measurement of either free CoA or total CoA.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> For analysis of free CoA, cell lysate samples were dissolved in a moderately acidified medium (pH 5) to avoid oxidation of the CoA thiol group to disulfides. For total CoA (see the <a href="/doi/suppl/10.1021/acs.jmedchem.0c01531/suppl_file/jm0c01531_si_002.pdf" class="ext-link">Supporting Information</a>), conversion of acetyl CoA (CoASAc) and other endogenous acyl CoA’s (of which >250 species are known) into free CoA was accomplished by a fast alkaline hydrolysis of the cell pellet and subsequent acidification to pH 5. This approach avoided the need for complex separations or the availability of authentic/labeled standards for the various CoA analytes. As there was a clear trend between free CoA and total CoA response in our PANk2<sup>–/–</sup> assay (data not shown), free CoA levels were used as the standard primary efficacy readout. CoA levels in the knockdown cells were not restored when cells were treated with PPA (likely reflecting its poor cell permeability<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a>). In contrast, daily treatment of cells with Fosmetpantotenate restored free CoA levels supporting the hypothesis that a precursor capable of delivering PPA intracellularly following metabolism can indeed generate free CoA in the absence of functional pantothenate kinase. Compounds were initially screened for their ability to increase intracellular CoA levels in PANk2<sup>–/–</sup> neuroblastoma cells at a fixed concentration of 50 μM for 24 h. Secondary assays that were used to support the restoration of intracellular CoA levels included measurement of tubulin acetylation levels<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> and determination of the compounds’ effects on lipid accumulation.</div><div class="NLM_p">Our first goal was the generation of more efficacious compounds as assessed by increases in CoA in our PANk2<sup>–/–</sup> model. POM analogues of 1,3,2-dioxaphosphinane heterocycles were evaluated as a first approach based both on the expectation that they would more efficiently release PPA (by hydrolysis of their alkoyloxymethyl side chain) and because they offer improved chemical stability with respect to acyclic prodrugs that, as described above, are susceptible to intramolecular cyclization of the secondary alcohol of pantothenic acid onto phosphorus. Compound <b>2a</b> (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>) was initially isolated as an approximately 1:1 mixture of two diastereomers resulting from the presence of epimers at phosphorus together with a stereo-defined carbon center in the dioxaphosphinane ring derived from (<i>R</i>)-pantothenic acid. Compound <b>2a</b> proved chemically stable and was a remarkably effective precursor to CoA when tested in PANk2<sup>–/–</sup> neuroblastoma cells. At the standard test concentration of 50 μM, <b>2a</b> generated CoA levels around 180-fold higher than in control cells. Generation of such high levels of CoA had not been achieved using either linear or cyclic phosphoramidate derivatives of PPA (data not shown), and these data therefore generated considerable interest in the POM series as a potential starting point for backup candidates to Fosmetpantotenate. Consistent with release of CoA from compound <b>2a</b>, a reversal of some phenotypical characteristics of treated PANk2<sup>–/–</sup> cells was observed. Levels of tubulin and histone H3 acetylation were measured as we have previously described and were found to be increased (see the <a href="/doi/suppl/10.1021/acs.jmedchem.0c01531/suppl_file/jm0c01531_si_002.pdf" class="ext-link">Supporting Information</a>). Acetyl-CoA is also known to influence levels of neutral lipids, and it has been reported that PanK2-defective neurons derived from KO mice show accumulation of lipids in the cytoplasm.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> To assess lipid content in PANk2<sup>–/–</sup> cells, they were stained with 100 ng/mL of a fluorescent lipophilic dye (Nile Red) and imaged using an inverted axiovert microscope (Zeiss) at 60× magnification. <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a> shows that compound <b>2a</b> was capable of producing a statistically significant decrease in the content of lipid droplet in PANk2<sup>–/–</sup> cells following this 48 h treatment, in line with the effect on CoA levels. Separation of the individual diastereomers of <b>2a</b> generated <i><b>cis</b></i><b>-2a</b> and <i><b>trans</b></i><b>-2a</b> that have cis and trans-ring geometry, respectively. These compounds both proved effective precursors to CoA in the PANk2<sup>–/–</sup> assay, with the trans-isomer generating levels approximately 2-fold higher. This led to a strategy in which compounds were first tested as diastereomeric mixtures with follow-up to separate or synthesize the individual diastereomers for selected compounds. All phosphoramidate-based prodrugs explored during the discovery of Fosmetpantotenate were viscous oils, a physical property that complicates purification, handling, and drug development. Importantly, while the cis-isomer <i><b>cis</b></i><b>-2a</b> was also an oil, the trans-isomer <i><b>trans</b></i><b>-2a</b> was a well-behaved solid, thus providing the first PPA prodrug with the preferred physical state for drug development.</div><figure id="fig1" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01531/20201218/images/medium/jm0c01531_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01531/20201218/images/large/jm0c01531_0003.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Effect of compound <b>2a</b> on lipid droplet content in PANk2<sup>–/–</sup> cells. (A) Two representative images of wild-type (mock) and PANk2<sup>–/–</sup> cells (untreated and treated with compound <b>2a</b> at 10 μM for 48 h); cells were fixed and stained with 100 ng/mL Nile Red and imaged by an inverted axiovert microscope (Zeiss) at 60× magnification. (B) Fluorimetric quantification of lipid droplet content using a Tecan Safire microplate detection system. Results are reported as mean ± standard deviation (sd) (two biological replicates, each in duplicate) **<i>p</i> < 0.01, two-tailed paired Student’s <i>t</i>-test.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01531/20201218/images/large/jm0c01531_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01531&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">In an attempt to modulate the rate of ester hydrolysis,<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> and by extension the effects on CoA generation, changes in the pivaloyloxymethyl side chain on CoA generation in PANk2<sup>–/–</sup> cells were explored extensively. The remaining compounds shown in <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a> illustrate the broad trends uncovered in these investigations. Apolar lipophilic terminal ester functionality in the side chain favored the generation of CoA, with extremely high levels (compared to vehicle-treated cells) being seen for compounds such as <b>2b</b>. In contrast, compounds <b>2c</b> and <b>2d</b>, both of which are formally truncated in their side-chain ester group by two carbons with respect to <b>2b</b>, were 4–5-fold less efficient at producing CoA. Introduction of more polar functionality into the side-chain ester consistently attenuated the levels of CoA in the PANk2<sup>–/–</sup> neuroblastoma assay. For example, compound <b>2e</b> generated relatively moderate levels of CoA with respect to the original lead <b>2a</b>, and only 3–4-fold higher than Fosmetpantotenate. Similarly, while replacement of the pivaloyl group on the oxymethyl side chain with a simple benzoyl ester <b>2f</b> led to a substantial increase in CoA, the introduction of more polar hetereoaryl substituents such as pyridine <b>2g</b> or pyrazine <b>2h</b> led to prodrugs that were somewhat less efficient CoA precursors. A further change that was explored was the use of a carbonate group at the terminus of the prodrug side chain. The use of phosphonyloxycarbonate (POC) groups<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> as promoieties has been successfully applied as an approach to mask nucleoside phosphate groups in marketed antivirals such as Tenofovir isoproxil,<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> resulting in a large increase in the systemic exposure of the parent drug. In the context of a cyclic PPA methyl ester, the use of a POC group (compound <b>2i</b>) led to a large increase in CoA level in our cellular model, comparable to <b>2a</b>.</div><div class="NLM_p">While the specific sequence of (bio-catalytic) hydrolysis events that free the effective PPA precursor of CoA from compounds <b>2a</b>–<b>i</b> are not known, esterase-mediated hydrolysis of the alkoyl or aroyl-oxymethyl side chains in these compounds is believed to serve as the trigger for release of the free phosphate group. It remains a mystery as to why the trans isomer of <b>2a</b> is more efficacious than the cis. Paradoxically, it is possible that the trans isomer is the more stable one, and thus survives to enter the cell and provide PPA to the CoA synthetic machinery. This hypothesis is bolstered by two pieces of data. First, the crystal structure of <i><b>trans-</b></i><b>2a</b> shows the amide side chain in the equatorial position putting the phosphate side chain in the axial position, and thus, possibly stabilized by an anomeric effect of the ring oxygens. Second, the stability of members of this series in whole blood was generally better for the trans isomers (see below). This could indicate that substituents in the axial position are less accessible to esterases.</div><div class="NLM_p">Degradation of the alkoyl or aroyl-oxymethyl side chain ultimately releases one equivalent of formaldehyde, a potential alkylating agent of nucleic acids and proteins. Although we did not observe toxicity in our cellular assay at 50 μM or any untoward effects in our <i>in vivo</i> studies, we decided to explore the possibility of using a prodrug that would release acetaldehyde rather than formaldehyde. However, analogues such as <b>2j</b> that were designed to release acetaldehyde (a less effective alkylating agent than formaldehyde and a xenobiotic that is effectively detoxified in man<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a>) resulted in much poorer generation of CoA in the PANk2<sup>–/–</sup> model. Overall, the results in <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a> indicate a broad tolerance to changes at the terminal ester functionality, with compounds such as <b>2g</b> and <b>2h</b> suggesting scope to employ changes at this ester group for modulating the overall physicochemical properties of the prodrugs without completely abolishing their ability to restore CoA in cells.</div><div class="NLM_p">The successful use of a prodrug approach to increase CoA in the CNS requires a complex interplay between biodistribution and metabolism. Adequate delivery of the intact prodrug to the systemic circulation and distribution across the blood–brain barrier must ultimately be balanced by incorporation of sufficiently labile functionality that allows for PPA release in the target tissue. Compound <b>2a</b> (and indeed all compounds in <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>) showed rather short <i>in vitro</i> half-lives in both human whole blood and hepatocytes, with both diastereomers being more than 50% degraded at the first time point of the whole blood/hepatocyte bioassay (10 and 15 min, respectively). This set of compounds also illustrates the need to assess stability in multiple matrices. Our initial compound progression tree used a plasma stability assay, and many of the POM analogues are quite stable in this matrix, with half-lives >1 h (data not shown). It thus came as somewhat of a shock when the assay in whole blood demonstrated limited stability. Rapid turnover of <b>2a</b> (<i>T</i><sub>1/2</sub> < 15 min) was also measured in mouse plasma and hepatocytes.</div><div class="NLM_p">Compound <b>2a</b> showed levels of permeability close to the value of the positive control (propranolol) used in a porcine brain endothelial cell (PBEC) blood–brain barrier (BBB) model in which both active and passive permeability (as well as P-glycoprotein (P-gp) and multidrug resistance protein (MRP)-superfamily counter-transport) can be assessed. Despite the low stability in whole blood, these data indicate the potential of this compound class for CNS delivery. The high levels of CoA generated from <b>2a</b> and its excellent brain permeability allowed a stable isotope-labeled isomer of the compound to be used at a high dose in an <i>in vivo</i> proof-of-concept study. The goal of this investigation was to evaluate whether CoA that originated from <b>2a</b>-derived PPA could be detected in mouse brain following a single oral dose of the isotopically labeled <b>2a</b> (500 mg/kg). The use of compound <b>2a</b> labeled both on its β-alanine fragment (with three <sup>13</sup>C atoms and one <sup>15</sup>N atom) and on its phosphate (one P═<sup>18</sup>O group) allowed insight into the fate of the administered prodrug by mass spectrometry analysis of brain tissue samples. CoA incorporating a 6 atomic mass unit (amu) increase in molecular ion over endogenous unlabeled CoA ([M + H]<sup>+</sup> = 774.1344 <i>vs</i> 768.1230, respectively) must derive from PPA formed directly from the administered compound. In contrast, CoA that incorporates a +4 amu increase in molecular ion over unlabeled CoA ([M + H]<sup>+</sup> = 772.1301 <i>vs</i> 768.1230, respectively) may derive either from H<sub>2</sub>O-mediated <sup>18</sup>O to <sup>16</sup>O exchange in PPA or may reflect complete hydrolysis of the phosphate group and re-phosphorylation by wild-type PanK (a pathway that is viable in the wild-type animals used) to regenerate PPA. In both cases, the pantothenic acid moiety incorporated into CoA originated from the administered labeled <b>2a</b>. As the data in <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a> highlight, no CoA derived from the labeled phosphopantothenic acid in the prodrug was found in brain at the 1 h time point. However, 6 h post dose, both CoA +6 and CoA +4 amu were detected and together comprised 15% of the free brain CoA at 24 h. Though no effort was made to quantitate actual CoA concentrations or to follow the full pharmacokinetic and metabolic behavior of compound <b>2a</b>, the finding that ca. 5% of CoA (at 6 h) retains all labeled atoms from the administered prodrug was encouraging. These data demonstrate that compound <b>2a</b> is competent in supplying the brain PPA that can ultimately be transformed to CoA, providing a proof of principle that cyclic phosphate prodrugs can effectively deliver their payload to the CNS.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Percentage of Free CoA Detected in Mouse Brain Following Oral Administration of Isotopically Labeled Compound <b>2a</b> That Is (a) Derived from Endogenous Phosphopantothenic Acid (Unlabeled); (b) Resulting from Phosphopantothenic Acid Derived from Compound <b>2a</b> (+4 amu); (c) Derived from Phosphopantothenic Acid from Compound <b>2a</b> (+6 amu)</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="left" char="."> </th><th class="rowsep1 colsep0" colspan="3" align="center" char=".">free CoA (%)<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center" char=".">time (h)</th><th class="colsep0 rowsep0" align="center" char=".">unlabeled</th><th class="colsep0 rowsep0" align="center" char=".">+4 amu</th><th class="colsep0 rowsep0" align="center" char=".">+6 amu</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char=".">0</td><td class="colsep0 rowsep0" align="char" char=".">100</td><td class="colsep0 rowsep0" align="char" char=".">0</td><td class="colsep0 rowsep0" align="char" char=".">0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char=".">1</td><td class="colsep0 rowsep0" align="char" char=".">100</td><td class="colsep0 rowsep0" align="char" char=".">0</td><td class="colsep0 rowsep0" align="char" char=".">0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char=".">6</td><td class="colsep0 rowsep0" align="char" char=".">92</td><td class="colsep0 rowsep0" align="char" char=".">2.7</td><td class="colsep0 rowsep0" align="char" char=".">5.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char=".">24</td><td class="colsep0 rowsep0" align="char" char=".">85</td><td class="colsep0 rowsep0" align="char" char=".">12.9</td><td class="colsep0 rowsep0" align="char" char=".">2.1</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup><sup>a</sup></sup><p class="last">Values are corrected based on the known % of <sup>18</sup>O content of compound <b>2a</b> dosed.</p></div></div></div><div class="NLM_p">The demonstrated ability of prodrugs such as <b>2a</b> to regenerate high CoA levels in a PANk2<sup>–/–</sup> model and to deliver intact PPA to the brain following oral administration in mouse provided additional impetus for the optimization of this compound class. Although these compounds need to be labile enough to generate PPA/CoA, the very rapid turnover in the liver and blood seen for compounds in <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a> clearly needed to be addressed. The finding that the carboxylic acid derivative <b>9a</b> (<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>) showed good stability in human blood, but generated low amounts of CoA in the PANk2<sup>–/–</sup> assay, led to an exploration of changes at the pantothenate methyl ester. This allowed the lipophilic ester functionality in the alkoyloxymethyl side chain that had proved highly beneficial for CoA generation to be retained. These ester analogues were anticipated to be more resistant to esterase-mediated hydrolysis. A panel of structurally diverse ester modifications was investigated, and a subset of these are illustrated in <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>. As hypothesized, increasing the steric impact of the ester moiety increased blood stability (<i>e.g</i>., <i>T</i><sub>1/2</sub> between 1 and 4 h for the <i>tert</i>-butyl analogue <b>9b</b>). However, it also significantly attenuated the generation of CoA in the PANk2<sup>–/–</sup> cell model. The relationship between blood stability and CoA production is also apparent in results for the less sterically encumbered ethyl analogue <b>9c</b> that combines good CoA production in PANk2<sup>–/–</sup> neuroblastoma cells with marginally improved stability in human blood (<i>T</i><sub>1/2</sub> ∼ 15 min). Efforts to balance CoA production and blood stability by changing the stereochemical impact and physicochemical properties of the ester ultimately proved unsuccessful. Introduction of heterocyclic systems (<i>e.g</i>., <b>9d</b>, <b>9e</b>), basic amines (<i>e.g</i>., <b>9g</b>), or polar groups (<i>e.g</i>., sulfone <b>9f</b>) typically generated prodrugs that retained good CoA in the PANk2<sup>–/–</sup> assay, but disappointingly none of these compounds improved blood stability with respect to <b>2a</b>.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. CoA Regeneration in PanK2 Knockdown Cells and Human Blood Stability for 1,3,2-Dioxaphosphinane Heterocycles Containing a POM Side Chain and Structurally Diverse Pantothenate Ester Functionality</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01531/20201218/images/medium/jm0c01531_0010.gif" alt="" id="fx3" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01531/20201218/images/medium/jm0c01531_0011.gif" alt="" id="fx4" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup><sup>a</sup></sup><p class="last">Compound <b>9b</b> is a cis/trans mixture (5:95) of diastereoisomers. All other compounds are single diastereoisomers/enantiomers.</p></div><div class="footnote" id="t3fn2"><sup><sup>b</sup></sup><p class="last">Human plasma stability.</p></div></div><div></div></div><div class="NLM_p">With changes to the pantothenic acid ester functionality having proven unsuccessful as a strategy to simultaneously improve both CoA production in the PANk2<sup>–/–</sup> cell model with <i>in vitro</i> drug metabolism and pharmacokinetic (DMPK) properties, it was apparent that changes in the POM side chain needed to be found to achieve this goal. Comparison of compounds <b>2f</b> and <b>2h</b> illustrated that introduction of heteroatoms into the ester functionality could be tolerated with respect to CoA generation, and a more extensive exploration of heterocycle containing ester functionality was made. <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a> shows a number of five-membered aromatic heterocycle replacements for the pivaloyl group that were initially evaluated as diastereomeric mixtures in the PANk2<sup>–/–</sup> assay and in a human whole blood stability assay. The consistent chromatographic behavior of the individual cis and trans-isomers in this series allowed data on the stability of the individual isomers to be obtained following incubation of the mixture. Thiazole <b>2k</b> and isothiazole <b>2l</b>, generated 88- and 37-fold improved CoA levels, respectively, in the PANk2<sup>–/–</sup> assay but were rapidly degraded in human blood. The introduction of substituents at the carbon α to the carbonyl of <b>2k</b> was explored to create a more sterically encumbered environment around the ester group. Compounds <b>2m</b> and <b>2n</b> highlight the success of this strategy with regard to blood stability, with the trans-isomers clearly emerging as more stable than the cis. The increased blood stability of the more sterically crowded methyl analogue <b>2m</b> and <i>tert</i>-butyl analogue <b>2n</b> came at the expense of progressively attenuating the production of CoA in the PANk2<sup>–/–</sup> cell model, with the latter compound generating a significantly lower CoA response than <b>2k</b>. The oxazole analogue of <b>2o</b> was prepared and found to show a similar profile with blood stability somewhat lower for the trans-isomer and marginally improved for the cis. Of the heterocycles, explored pyrazoles provided the most attractive overall profiles. Analogues <b>2p</b>–<b>r</b>, which contain an <i>N</i>-methyl substituent aimed at mimicking the effect of methyl functionality in <b>2m</b>, gave good to high levels of CoA. Furthermore, the trans-isomers of these compounds consistently showed half-lives between 1 and 4 h in human whole blood. Interestingly, pyrazoles retained good CoA levels and blood stability even in the absence of methyl functionality on the ring nitrogen atom, as illustrated with <b>2s</b>.</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. CoA Regeneration in PanK2 Knockdown Cells and Human Blood Stability for 1,3,2-Dioxaphosphinane Heterocycles Containing Optimized Heteroaryloxymethyl Side Chains</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01531/20201218/images/medium/jm0c01531_0012.gif" alt="" id="fx5" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup><sup>a</sup></sup><p class="last">Human plasma stability.</p></div></div><div></div></div><div class="NLM_p">The single trans-isomers of <b>2m</b>, <b>2r</b>, and <b>2s</b> were isolated and profiled as described in <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a></a>. CoA production in PANk2<sup>–/–</sup> neuroblastoma cells from the individual isomers was similar to that of the mixture for <i><b>trans</b></i><b>-2m</b> and <i><b>trans</b></i><b>-2s</b> but was markedly lower for <i><b>trans</b></i><b>-2r</b>. Compounds <i><b>trans</b></i><b>-2r</b> and <b><i>trans</i>-2m</b> were isolated as oils, while importantly compound <i><b>trans</b></i><b>-2s</b> was solid. For all three compounds, the human blood stability data were in line with the values measured for each compound in the diastereomeric mixture. Human hepatocyte half-lives were determined to be in the 30 min range, somewhat improved with respect to the original lead <b>2a</b>. The presence of more heterocyclic functionality in place of the pivaloyl group in <b>2a</b> somewhat impaired BBB permeability in the PBEC assay, but good (<i><b>trans-</b></i><b>2r</b>, <i>P</i><sub>app</sub> = 11.8 × 10<sup>–6</sup> cm/s) to moderate (<i><b>trans-</b></i><b>2m</b>, <i>P</i><sub>app</sub> = 5.1 × 10<sup>–6</sup> cm/s; <i><b>trans-</b></i><b>2s</b>, <i>P</i><sub>app</sub> = 5.3 × 10<sup>–6</sup> cm/s) apparent permeability (<i>P</i><sub>app</sub>-values) was nonetheless retained.</div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. <i>In Vitro</i> Assay Data and Physical Properties for Optimized PPA Prodrugs</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="left"> </th><th class="colsep0 rowsep0" align="center"><b><i>trans</i>-2r</b></th><th class="colsep0 rowsep0" align="center"><b><i>trans</i>-2m</b></th><th class="colsep0 rowsep0" align="center"><b><i>trans</i>-2s</b></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">PANk2<sup>–/–</sup> assay CoA (fold)</td><td class="colsep0 rowsep0" align="left">14</td><td class="colsep0 rowsep0" align="left">40</td><td class="colsep0 rowsep0" align="left">101</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">physical state</td><td class="colsep0 rowsep0" align="left">oil</td><td class="colsep0 rowsep0" align="left">oil</td><td class="colsep0 rowsep0" align="left">solid</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">human blood <i>T</i><sub>1/2</sub> (h)</td><td class="colsep0 rowsep0" align="left">>1</td><td class="colsep0 rowsep0" align="left">>1</td><td class="colsep0 rowsep0" align="left">>1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">human hepatocytes <i>T</i><sub>1/2</sub> (h)</td><td class="colsep0 rowsep0" align="left">0.3</td><td class="colsep0 rowsep0" align="left">0.5</td><td class="colsep0 rowsep0" align="left">0.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">BBB <i>P</i><sub>app</sub> (10<sup>–6</sup> cm/s)</td><td class="colsep0 rowsep0" align="left">11.8</td><td class="colsep0 rowsep0" align="left">5.1</td><td class="colsep0 rowsep0" align="left">5.3</td></tr></tbody></table></div></div><div class="NLM_p">As an alternative to the POM prodrug strategy, phosphotriesters were explored. Simplifying the POM fragment in this way is expected to affect the mechanism by which the prodrug releases PPA, while POM-like side chains are expected to degrade after hydrolysis of their terminal ester functionality, and simple phosphates more likely release PPA by direct hydrolytic cleavage at phosphorus. Cyclic 1,3,2-dioxaphosphinane PPA prodrugs containing simple alkyl phosphates in place of the POM side chain consistently failed to generate CoA in PanK2-deficient cells (data not shown). This finding likely reflects the relatively poor leaving group potential for alkoxy groups in phosphates. Phenoxy leaving groups on phosphorus that are activated by electron-withdrawing functionality in their para-position were explored (<a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a></a>) and proved more promising. Although compounds with a simple phenoxy leaving group did not show increased generation of CoA in the PANk2<sup>–/–</sup> assay (data not shown), the presence of even moderately electron-withdrawing substituents, such as F (compound <b>3a</b>), were found to be sufficient to generate significant increases in CoA level. The markedly higher CoA increase from the cis-isomer <b>3a</b> with respect to the <b><i>trans</i>-3b</b> was a consistent trend and could reflect that hydrolytic cleavage at phosphorus is more facile from attack at the less hindered face of the 1,3,2-dioxaphosphinane ring or that the trans isomer is more stable due to the anomeric effect. No direct correlation between the electron-withdrawing potential (Hammet sigma coefficient<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a>) of the phenoxy 4-substituent in compounds <b>3a</b>–<b>g</b> and the CoA levels generated in the PANk2<sup>–/–</sup> assay could be identified. The strongly electron-withdrawing nitrile analogue, <b>3c</b>, generated relatively low levels of CoA in this assay, while <b>3d</b> and <b>3e</b> generated CoA levels within 2–3-fold of the simple 4-F analogue <b>3a</b> despite being activated with more powerful electron-withdrawing functionality. Phenoxy leaving groups that would ultimately generate known/benign byproducts following their displacement from the prodrug were explored, and though relatively low levels of CoA were generated from <b>3f</b> (that ultimately should release salicylic acid), a surprisingly robust effect was noted for <b>3g</b> that does not contain an electron-withdrawing group on the phenyl ring and should generate tyrosine methyl ester as a byproduct. Compound <b>3g</b> was also the only compound in this series that could be isolated as a solid. When incubated in human whole blood, all compounds in <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a></a> (aside from <b>3f</b> which was not tested) showed human whole blood stability ≥0.5 h, with longer half-lives (1–4 h) being measured for <b>3a</b> and <b>3d</b>. Further profiling of analogue <b>3c</b> demonstrated that its half-life in human hepatocytes was comparable to that found in blood and that it had excellent BBB permeability with <i>P</i><sub>app</sub> = 16 × 10<sup>–6</sup> cm/s, close to that of the assay’s positive control.</div><div class="NLM_table-wrap" id="tbl6"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 6. CoA Regeneration in PanK2 Knockdown Cells and Human Blood Stability for 1,3,2-Dioxaphosphinane Heterocycles Containing an Aryloxy Side Chain</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01531/20201218/images/medium/jm0c01531_0013.gif" alt="" id="fx6" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01531/20201218/images/medium/jm0c01531_0014.gif" alt="" id="fx7" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t6fn1"><div class="footnote" id="t6fn1"><sup><sup>a</sup></sup><p class="last">Determined on the diasteroisomers mixture.</p></div></div><div></div></div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i13">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_74657" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_74657" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">We have reported here two new series of cyclic phosphate prodrugs of PPA and have described optimization work aiming to balance compound profiles between release of PPA for conversion to CoA together with <i>in vitro</i> stability in blood and liver. Early compounds were able to generate very high CoA levels in a PANk2<sup>–/–</sup> neuroblastoma cell model but were rapidly turned over in blood and hepatocytes. Improving <i>in vitro</i> metabolic stability consistently attenuated the levels of CoA in the cellular model, where the release of PPA is also dependent on metabolism of the prodrugs. However, optimized compounds such as <b>2m</b> and <b>2s</b> demonstrate improved capacity to generate CoA in this brain cell model with respect to first-generation prodrugs. In addition, both <b>2s</b> and <i><b>trans-</b></i><b>2s</b> are solids addressing another vexing issue of Fosmetpantotenate. Importantly, given the known deficiency of the PanK2 enzyme in the CNS of PKAN patients, optimized compounds retained acceptable levels of blood–brain barrier penetration in a mammalian <i>in vitro</i> model of brain permeability. The ability of cyclic prodrugs of PPA to both reach the brain and to liberate PPA for productive biosynthesis to CoA following oral administration was demonstrated in mouse for an early second-generation prodrug <b>2a</b> despite its suboptimal metabolic stability. The finding that at least 5% of CoA in mouse brain 6 h after an oral dose of <b>2a</b> contains the intact PPA moiety from this compound provides a validation for the PANk2<sup>–/–</sup> assay, and the screening funnel reported, as a means to identify viable CoA prodrugs, highlighting the potential of these new prodrugs as therapeutic agents.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i14">Experimental Procedures</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_38687" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_38687" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">All solvents and chemical reagents were purchased with purity grades >90% from chemical suppliers and, unless otherwise stated, were used as received. β-Alanine +4 amu (<sup>15</sup>Nx1, <sup>13</sup>Cx3, CAS number: 285978-07-6) was purchased from the Sigma-Aldrich chemical company (product code: 490822, 98 atom %) and was used without further purification. All reactions were followed by thin-layer chromatography (TLC) analysis (TLC plates GF254, Merck) or ultra performance liquid chromatography (UPLC-MS). The purity was determined using UPLC-MS analysis conducted on a Waters Acquity UPLC system with both diode array detection and electrospray (+ve and −ve ion) MS detection. The stationary phase was a Waters Acquity UPLC BEH C<sub>18</sub> 1.7 μm, 2.1 × 50 mm<sup>2</sup>. The mobile phase was a mixture of H<sub>2</sub>O containing 0.1% formic acid (A) and AcCN containing 0.1% formic acid (B) in the following linear gradient: 90% A (0.1 min), 90–0% A (2.5 min), 0% A (0.3 min), 90% A (0.1 min); the flow rate was 0.5 mL/min. Purity of all compounds is >95% except for isotopically labeled <b>2a</b>, which has a purity of 92%. Reversed-phase (C<sub>18</sub>) column chromatography was carried out using as mobile phase H<sub>2</sub>O containing 0.1% of TFA and AcCN containing 0.1% of TFA. NMR spectra were collected on Bruker instruments operating at the indicated frequencies. Diasteromeric ratios were determined by <sup>31</sup>P NMR. Melting points were determined for solid single diastereoisomers using a Buchi B-540 apparatus and are reported as the mean of three independent measurements. All studies using animals were conducted in accordance with protocols approved by the Institutional Animal Care and Use Committee (IACUC) of IRBM Science Park, in full compliance with the EU Directive 63/2010 and its Italian transposition as well as with all applicable Italian legislation and guidelines. IRBM Science Park is authorized by the Italian Ministry of Health and by local veterinary authority to house, breed, and use laboratory rodents for scientific purposes.</div><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> <i>In Vitro</i> Studies in PanK2 Knockdown Cell Line</h3><div class="NLM_p last">The <i>in vitro</i> model to evaluate the efficacy of analogues was developed using the human neuroblastoma IMR32 cell line (ATCC) described in the <a href="/doi/suppl/10.1021/acs.jmedchem.0c01531/suppl_file/jm0c01531_si_002.pdf" class="ext-link">Supporting Information</a>. Cells were cultured in minimum essential medium (MEM) (Invitrogen) supplemented with 10% fetal bovine serum, 2 mM glutamine, 1% penicillin–streptomycin, 1 mM sodium pyruvate, 1 mM nonessential amino acids, 1.5 g/L sodium bicarbonate, and 1 μg/mL puromycin. The cells were plated on 12-well culture plates at a density of 0.2 × 10<sup>6</sup> cells per well. After 72 h, test compounds were added as freshly dissolved dimethyl sulfoxide (DMSO) stock solutions (the final DMSO concentration was 0.1%, v/v). The cells were incubated for 24 h at 37 °C, then the treatment was repeated after 24 h with newly dissolved test compound or control vehicle. The cells were further incubated for 24 h, then harvested, collected in a 15 mL falcon tube, and centrifuged at 200<i>g</i> for 5 min at 4 °C. The supernatant was removed, and the cell pellet was washed in ice-cold phosphate-buffered saline, centrifuged again, then rapidly frozen in liquid nitrogen, and stored at −80 °C until liquid chromatography-tandem mass spectrometry (LC-MS/MS) analysis for CoA formation. Samples were reconstituted with ammonium acetate buffer (pH 5.1) containing dextrorphan (50 ng/mL) as the internal standard, stirred for 2 min, sonicated in an ultrasonic bath for 1 min, and stirred again for 1 min before LC-MS/MS analysis for determination of intracellular CoA levels. Intracellular CoA concentration was calculated considering an intracellular volume of 10<sup>6</sup> cells equal to 2 μL. The measurement of intracellular volume of cultured cells was performed following the distribution of [<sup>14</sup>C]urea and [<sup>14</sup>C]mannitol with time.</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> <i>In Vivo</i> Mouse Study to Determine Brain Levels of Stable Isotope Labeled <b>2a</b> Following Oral Administration</h3><div class="NLM_p">C57BL6 mice (three animals per time point) received a single oral dose of 500 mg/kg isotopically labeled <b>2a</b>, and brain samples were collected at 0, 1, 6, and 24 h post dose. Samples were analyzed by UPLC-quadrupole-time-of-flight mass spectrometry, with the electrospray source scanning in positive-ion mode. The relative percentages of +6 amu CoA, +4 amu CoA, and unlabeled CoA were determined from the peak intensity of the corresponding molecular ions, where the sum of the three peak intensities represented 100%. The identity of each peak was confirmed by matching the fragment ions from the MS/MS fragmentation pattern to the indicator ions of the CoA standard accurate mass. Brain tissues were homogenized in a Precellys homogenizer (Bertin Technologies, Montigny-le-Bretonneux, France) using 3 mL of water for 1 g of tissue (v/w). Protein was precipitated by adding 500 μL of MeOH to 100 μL of a homogenate (1:6 dilution), mixed, and centrifuged. The supernatants (200 μL) were dried under nitrogen, reconstituted with 100 μL of 10 mM ammonium acetate (pH ∼ 5) and injected (10 μL) into the LC-MS system.</div><div id="sec4_2_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i17" class="anchor-spacer"></div><h4 class="article-section__title" id="_i17"> CoA Determination</h4><div class="NLM_p last">An Acquity UPLC (Waters) system was used. Samples were chromatographed on a Luna C<sub>18</sub> column (50 × 2.0 mm<sup>2</sup>; 5 μm), with a 0.4 mL/min flow rate and a 10 μL injection volume. The mobile phases were (A), 10 mM ammonium acetate in H<sub>2</sub>O, pH 6.8, and (B) acetonitrile/2-propanol (9:1; v/v). The gradient was started with 2% (B) and was increased linearly to reach 20% (B) at 5 min, the gradient was ramped to reach 90% (B) at 5.1 min, and kept isocratic at 90% (B) through 7.1 min. Conditions were returned to initial 2% (B) at 7.2 min, and the column was equilibrated at initial conditions until the run reached 11.2 min. The detector was a Waters QTOF Synapt mass spectrometer, with an electrospray ion source operating in the positive scanning mode acquiring in full-scan mode (accuracy <5 ppm). The following exact masses were determined: 768.1230 for CoA, 772.1301 for CoA +4 amu, and 774.1344 for CoA +6 amu. The CoA levels obtained by MS/MS analyses were corrected for <sup>18</sup>O isotopic incorporation but were not adjusted for the 1 and 2% of <sup>12</sup>C and <sup>14</sup>N, respectively, in labeled <b>2a</b>. The amount of CoA formed after dosing <b>2a</b> was calculated using the observed isotopic pattern and correcting for the <sup>18</sup>O content of labeled <b>2a</b> as follows: The % CoA derived from intact compound <b>2a</b>-PPA = (100/<sup>18</sup>O% in prodrug) × % +6 amu, while the % CoA derived from compound <b>2a</b>-derived PA (or from oxygen exchange) = % +4 amu – ((100 – <sup>18</sup>O% in prodrug)/<sup>18</sup>O% in prodrug) × % +6 amu, where % +6 and % +4 amu are the percents of the +6 and +4 amu [M + H]<sup>+</sup> CoA ions experimentally determined by high-resolution mass spectrometry (HRMS) from the isotopic pattern in brain samples. The levels of endogenous CoA in brain samples were estimated using the standard addition method, where aliquots of the untreated samples were spiked with different known amounts of the analytical standard (CoA) and all aliquots including the nonspiked sample (pre-dose) were analyzed in the same way. Due to the limited dynamic range of the QTOF analyzer, a five-point calibration curve (1000, 2000, 4000, 8000, and 16 000 ng/mL) was run.</div></div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> Methyl 3-((4<i>R</i>)-2-(((<i>S</i>)-1-Methoxy-1-oxopropan-2-yl)amino)-5,5-dimethyl-2-oxido-1,3,2-dioxaphosphinane-4-carboxamido)propanoate (<b>1</b>)</h3><div class="NLM_p last">A stirred solution of methyl 3-((2<i>R</i>)-2-hydroxy-4-(((((<i>S</i>)-1-methoxy-1-oxopropan-2-yl)amino)(phenoxy)phosphoryl)oxy)-3,3-dimethylbutanamido)propanoate<a onclick="showRef(event, 'ref100'); return false;" href="javascript:void(0);" class="ref ref100">(32)</a> (Fosmetpantotenate, 500 mg, 1.05 mmol) in DCM (10.5 mL) was treated slowly with Et<sub>3</sub>N (0.29 mL, 2.1 mmol), and stirring was continued for 16 h. The solvent was removed in vacuo, and the residue was purified by SiO<sub>2</sub> chromatography (0–5% MeOH/EtOAc) to afford a mixture of diastereoisomers (46:54*) of the title compound (200 mg, 50%) as a colorless sticky solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>, 300 K) δ 7.28* and 7.14 (bs, 1 H), 4.76 and 4.51* (d, <i>J</i> = 1.5 Hz, <i>J</i>* = 5.0 Hz, 1H), 4.36 (dd, <i>J</i> = 11.5, 1.6 Hz, 0.5H) 4.15–4.00 (m, 2H), 3.92* (dd, <i>J</i> = 11.57, 20.10 Hz, 0.5 H), 3.79 (s, 3H), 3.71 (s, 3H), 3.61–3.46 (m, 3H), 2.60 (m, 2H), 1.50 and 1.46* (d and d*, <i>J</i> = 7.2 Hz, <i>J*</i> = 6.8 Hz, 3H), 1.19* and 1.18 (s, 3H), 1.13* and 1.09 (s, 3H). <sup>31</sup>P NMR (162 MHz, CDCl<sub>3</sub>, 300 K) δ 4.70 and 1.59*; UPLC <i>t</i><sub>R</sub> 0.95* min and 1.03 min; MS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 381 (M + H)<sup>+</sup>.</div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> Methyl 3-((4<i>R</i>)-2-(Benzyloxy)-5,5-dimethyl-2-oxido-1,3,2-dioxaphosphinane-4-carboxamido)propanoate (<b>5</b>)</h3><div class="NLM_p last">Methyl 3-[[(2<i>R</i>)-2,4-dihydroxy-3,3-dimethyl-butanoyl]amino]propanoate (<b>4</b>) (10.0 g, 42.9 mmol) was dissolved in THF (112 mL) and treated with a solution of Et<sub>3</sub>N (12.6 mL, 90 mmol) in THF (15 mL). A solution of POCl<sub>3</sub> (4.41 mL, 47.16 mmol) in THF (10 mL) was added dropwise at −78 °C, and after 0.5 h, the cooling bath was removed and the reaction mixture was warmed to ambient temperature over 1 h. The mixture was cooled to −78 °C, then treated dropwise sequentially with a solution of TEA (12.6 mL, 90 mmol) in THF (15 mL) and benzyl alcohol (5.1 mL, 47.16 mmol) in THF (10 mL). The reaction was left to reach ambient temperature and stirred for 12 h. DCM and H<sub>2</sub>O were added, and the organic layer was separated and washed with 5% aqueous citric acid solution, H<sub>2</sub>O, and brine, and then dried over Na<sub>2</sub>SO<sub>4</sub>. Filtration and solvent removal in vacuo afforded a residue that was purified by column chromatography on SiO<sub>2</sub> (0–90% EtOAc in DCM) to afford a single diastereoisomer of the title compound (4.17 g, 25%) as a white solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>, 300 K) δ 7.45–7.39 (m, 5H), 6.70 (bs, 1H), 5.26–5.22 (m, 2H), 4.74 (d, <i>J</i> = 1.5 Hz, 1H), 4.36–4.32 (dd, <i>J</i> = 3.0, 3.2 Hz, 1H), 3.86–3.78 (m, 1H), 3.68 (s, 3H), 3.49–3.47 (m, 2H), 2.51 (t, <i>J</i> = 6.4 Hz, 2H), 1.16 (s, 3H), 1.06 (s, 3H); <sup>31</sup>P NMR (162 MHz, CDCl<sub>3</sub>, 300 K) δ −3.13; UPLC <i>t</i><sub>R</sub> 1.42 min; MS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 386 (M + H)<sup>+</sup>.</div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> Methyl 3-((4<i>R</i>)-2-Hydroxy-5,5-dimethyl-2-oxido-1,3,2-dioxaphosphinane-4-carboxamido)propanoate (<b>6</b>)</h3><div class="NLM_p last">Compound <b>5</b> (2.90 g, 7.53 mmol) was dissolved in EtOAc (50 mL) and treated with Pd/C (5% w/w, 0.58 g). The mixture was stirred 4 h under an atmosphere of hydrogen gas. The catalyst was filtered, and the solvent was evaporated to afford the title compound (2.13 g, 96%) as an oil that was used directly in subsequent steps. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>, 300 K) δ 7.99 (m, 1H), 4.40 (s, 1H), 4.0–3.98 (m, 1H), 3.77–3.69 (m, 1H), 3.57 (s, 3H), 3.41–3.29 (m, 2H), 2.48 (m, 2H), 0.95 (s, 3H), 0.91 (s, 3H); <sup>31</sup>P NMR (162 MHz, CDCl<sub>3</sub>, 300 K) δ −6.48 and −6.63.</div></div><div id="sec4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> Methyl 3-((4<i>R</i>)-2-(Chloromethoxy)-5,5-dimethyl-2-oxido-1,3,2-dioxaphosphinane-4-carboxamido)propanoate (<b>7</b>)</h3><div class="NLM_p last">Compound <b>6</b> (3.29 g, 11.4 mmol) was dissolved in H<sub>2</sub>O (34 mL), then tetrabutylammonium hydrogen sulfate (0.37 g, 1.11 mmol) and NaHCO<sub>3</sub> (3.74 g, 44.6 mmol) were added sequentially at 0 °C. The mixture was stirred for 10 min, then a solution of chloromethyl sulfurochloridate (2.21 g, 13.37 mmol) in DCM (54 mL) was added. The reaction was warmed to 20 °C and stirred for 16 h. The organic phase was separated, washed with brine, and dried. Filtration and solvent removal in vacuo afforded a residue that was purified by flash chromatography on SiO<sub>2</sub> using petroleum ether (PE)/EtOAc as eluent, affording a mixture of diastereoisomers (58:42*) of the title compound (510 mg, 10%) as a colorless oil. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>, 300 K) δ 7.01 and 6.96* (bs, 1H), 5.86–5.72 (m, 2H), 4.80 and 4.68* (d and s*, <i>J</i> = 2.4 Hz, 1H), 4.38 and 4.27 (dd and d*, <i>J</i> = 3.6, 12.2 Hz, <i>J</i>* = 10.9 Hz, 1H), 4.0–3.87 (m, 1H), 3.73 (s, 3H), 3.67–3.55 (m, 2H), 2.62–2.58 (m, 2H), 1.23 and 1.19* (s, 3H), 1.16 and 1.14* (s, 3H); <sup>31</sup>P NMR (162 MHz, CDCl<sub>3</sub>, 300 K) δ −5.00, −8.93*; UPLC <i>t</i><sub>R</sub> 1.13* and 1.15 min; MS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 366 [M + Na]<sup>+</sup>.</div></div><div id="sec4_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> (((4<i>R</i>)-4-((3-Methoxy-3-oxopropyl)carbamoyl)-5,5-dimethyl-2-oxido-1,3,2-dioxaphosphinan-2-yl)oxy)methyl Pivalate (<b>2a</b>)</h3><div class="NLM_p last">A solution of compound <b>6</b> (2.12 g, 7.20 mmol) in DMF (29 mL) was cooled to −78 °C and treated with DIEA (3.51 mL, 20.15 mmol) and chloromethyl-2,2-dimethylpropanoate (1.84 g, 12.23 mmol). The cooling bath was removed, and the mixture was warmed over 1 h to 20 °C and then heated at 80 °C for 16 h. The cooled mixture was concentrated in vacuo, and the residue was purified by flash chromatography over C<sub>18</sub> using H<sub>2</sub>O/MeCN, to furnish a mixture of diasteroisomers (44:56*) of the title compound (0.89 g, 30%) as an oily solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>, 300 K) δ 7.13–7.05* and 7.00–6.85 (m, 1H), 5.78–5.76* and 5.71–5.68 (m, 1H), 4.77* and 4.55 (s, 1H), 4.35–4.27* and 4.09–4.17 (m, 2H), 3.87–3.81 (m, 1H), 3.7 (s, 3H), 3.64–3.47 (m, 2H), 2.62–2.49 (m, 2H), 1.19* and 1.16 (s, 9H), 1.18* and 1.12 (s, 3H), 1.11 and 1.09* (s, 3H); <sup>31</sup>P NMR (162 MHz, CDCl<sub>3</sub>, 300 K) δ −5.34 and −9.26*; UPLC <i>t</i><sub>R</sub> 1.42 min and 1.46* min; MS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 410 (M + H)<sup>+</sup>.</div></div><div id="sec4_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> (((2<i>R</i>,4<i>R</i>)-4-((3-Methoxy-3-oxopropyl)carbamoyl)-5,5-dimethyl-2-oxido-1,3,2-dioxaphosphinan-2-yl)oxy)methyl Pivalate (<i><b>cis</b></i><b>-2a</b>)</h3><div class="NLM_p last">The title compound was obtained by RP-HPLC separation of compound <b>2a</b><sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>, 300 K) δ 7.13 (bs, 1H), 5.79 (dd, <i>J</i> = 4.8, 11.4 Hz, 1H), 5.70 (dd, <i>J</i> = 4.8, 14.0 Hz, 1H), 4.78 (d, <i>J</i> = 1.7 Hz, 1H), 4.34 (dd, <i>J</i> = 3.9, 11.8 Hz, 1H), 3.86 (dd, <i>J</i> = 11.4, 22.8 Hz, 1H), 3.71 (s, 3H), 3.65–3.52 (m, 2H), 2.61–2.58 (m, 2H), 1.27 (s, 9H), 1.20 (s, 3H), 1.10 (s, 3H); <sup>31</sup>P NMR (162 MHz, CDCl<sub>3</sub>, 300 K) δ −6.69; UPLC <i>t</i><sub>R</sub> 1.44 min; MS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 410 [M + H]<sup>+</sup>.</div></div><div id="sec4_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> (((2<i>S</i>,4<i>R</i>)-4-((3-Methoxy-3-oxopropyl)carbamoyl)-5,5-dimethyl-2-oxido-1,3,2-dioxaphosphinan-2-yl)oxy)methyl Pivalate (<i><b>trans</b></i><b>-2a</b>)</h3><div class="NLM_p last">The title compound was obtained as described above for compound <b><i>cis</i>-2a</b><sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>, 300 K) δ 6.93 (bs, 1H), 5.74–5.71 (m, 1H), 5.70–5.68 (m, 1H), 4.56 (s, 1H), 4.17 (d, <i>J</i> = 10.9 Hz, 1H), 3.84 (dd, <i>J</i> =11.4, 24.9 Hz, 1H), 3.72 (s, 3H), 3.65–3.59 (m, 1H), 3.57–3.50 (m, 1H), 2.59–2.55 (m, 2H), 1.24 (s, 9H), 1.14 (s, 3H), 1.12 (s, 3H); <sup>31</sup>P NMR (162 MHz, CDCl<sub>3</sub>, 300 K) δ −10.6; UPLC <i>t</i><sub>R</sub> 1.48 min; MS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 410 [M + H]<sup>+</sup>; M.P. 65 °C.</div></div><div id="sec4_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> (((4<i>R</i>)-4-((3-Methoxy-3-oxopropyl)carbamoyl)-5,5-dimethyl-2-oxido-1,3,2-dioxaphosphinan-2-yl)oxy)methyl 2-Ethylbutanoate (<b>2b</b>)</h3><div class="NLM_p last">Following the same procedure as <b>2a</b>, treatment of <b>6</b> (0.33 g, 1.11 mmol) with chloromethyl-2-ethylbutanoate (0.31 g, 1.90 mmol) afforded a mixture of diastereomers (11*:89) of the title compound (193 mg, 39%) as a colorless oil. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>, 300 K) δ 6.93 (bs, 1H), 5.81–5.75* and 5.73–5.70 (m, 2H), 4.77* and 4.57 (s, 1H), 4.34* and 4.17 (dd* and d, <i>J</i>* = 3.6, 10.9 Hz, <i>J</i> = 10.9 Hz, 1H), 3.83 (dd, <i>J</i> =12.2, 25.5 Hz, 1H), 3.71 and 3.70* (s, 3H), 3.65–3.58 (m, 1H), 3.55–3.47 (m, 1H), 2.59–2.55 (m, 2H), 2.34–2.26 (m, 1H), 1.72–1.53 (m, 4H), 1.19* and 1.13 (s, 3H), 1.12 and 1.09* (s, 3H), 0.91 (t, <i>J</i> = 7.3 Hz, 6H); <sup>31</sup>P NMR (162 MHz, CDCl<sub>3</sub>, 300 K) δ −5.42* and −9.45; UPLC <i>t</i><sub>R</sub> 1.58 and 1.61* min; MS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 446 [M + Na]<sup>+</sup>.</div></div><div id="sec4_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> (((4<i>R</i>)-4-((3-Methoxy-3-oxopropyl)carbamoyl)-5,5-dimethyl-2-oxido-1,3,2-dioxaphosphinan-2-yl)oxy)methyl Isobutyrate (<b>2c</b>)</h3><div class="NLM_p last">2-Methylpropanoic acid (76.9 mg, 0.87 mmol) and Cs<sub>2</sub>CO<sub>3</sub> (283.7 mg, 0.87 mmol) were dissolved in DMF (3 mL) and then treated with compound <b>7</b> (250.0 mg, 0.73 mmol). The reaction mixture was stirred for 5 h, then filtered through a pad of SiO<sub>2</sub>, and concentrated. The residue was purified by flash chromatography on C<sub>18</sub> using H<sub>2</sub>O/CH<sub>3</sub>CN as an eluent to afford a 78:22* mixture of diastereoisomers of the title compound (33.6 mg, 12%) as a colorless oil. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>, 300 K) δ 7.11 and 6.93* (t, <i>J</i> = 5.2 Hz, 1H), 5.79 and 5.76 and 5.73–5.66* (dd and m*, <i>J</i> = 4.8, 11.4 Hz, 2H), 4.76 and 4.56* (d and s*, <i>J</i> = 2.2 Hz, 1H), 4.33 and 4.16* (dd and d*, <i>J</i> = 3.5, 11.4 Hz, <i>J</i>* = 11.4 Hz, 1H), 3.85 and 3.83* (dd, <i>J</i> =11.8, 23.2 Hz, <i>J</i>* = 11.4, 24.9 Hz, 1H), 3.71* and 3.70 (s, 3H), 3.63–3.49 (m, 2H), 2.71–2.64 (m, 1H), 2.62–2.55 (m, 2H), 1.23 and 1.21* (s, 3H), 1.22 and 1.20* (s, 3H), 1.19 and 1.13* (s, 3H), 1.11* and 1.09 (s, 3H); <sup>31</sup>P NMR (162 MHz, CDCl<sub>3</sub>, 300 K) δ −6.64, −10.70*; UPLC <i>t</i><sub>R</sub> 1.19 and 1.22* min; MS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 418 [M + Na]<sup>+</sup>.</div></div><div id="sec4_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> (((4<i>R</i>)-4-((3-Methoxy-3-oxopropyl)carbamoyl)-5,5-dimethyl-2-oxido-1,3,2-dioxaphosphinan-2-yl)oxy)methyl Butyrate (<b>2d</b>)</h3><div class="NLM_p last">Following the same procedure as <b>2a</b>, treatment of <b>6</b> (300.0 mg, 1.01 mmol) with chloromethyl butanoate (236.0 mg, 1.72 mmol) afforded a 23*:77 mixture of diastereomers of the title compound (128.0 mg, 32%) as a colorless oil. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>, 300 K) δ 7.12* and 6.94 (bs, 1H), 5.80–5.75* and 5.73–5.68 (dd* and m, <i>J</i>* = 4.9, 8.2 Hz, 2H), 4.77* and 4.57 (d* and s, <i>J</i>* = 2.4 Hz, 1H), 4.34* and 4.17 (dd* and d, <i>J</i>* = 3.6, 12.2 Hz, <i>J</i> = 10.9 Hz, 1H), 3.90–3.80 (m, 1H), 3.71 and 3.70* (s, 3H), 3.65–3.49 (m, 2H), 2.60–2.55 (m, 2H), 2.43 (t, <i>J</i> = 7.3 Hz, 1H), 2.37 (t, <i>J</i> = 7.3 Hz, 1H), 1.73–1.67 (m, 2H), 1.19* and 1.13 (s, 3H), 1.12 and 1.10* (s, 3H), 1.0–0.95 (m, 3H); <sup>31</sup>P NMR (162 MHz, CDCl<sub>3</sub>, 300 K) δ −6.68* and −10.84; UPLC <i>t</i><sub>R</sub> 1.34 and 1.36* min; MS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 418 [M + Na]<sup>+</sup>.</div></div><div id="sec4_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> (((4<i>R</i>)-4-((3-Methoxy-3-oxopropyl)carbamoyl)-5,5-dimethyl-2-oxido-1,3,2-dioxaphosphinan-2-yl)oxy)methyl 1-Carbamoylcyclopropane-1-carboxylate (<b>2e</b>)</h3><div class="NLM_p last">Following the same procedure as <b>2c</b>, treatment of <b>7</b> (200.0 mg, 0.58 mmol) with 1-carbamoylcyclopropanecarboxylic acid (90.1 mg, 0.70 mmol) afforded a mixture of diastereomers (86:14*) of the title compound (65 mg, 26%) as a colorless oil. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>, 300 K) δ 8.41 and 8.33* (bs, 1H), 7.07 and 6.97* (bs, 1H), 5.99–5.93 (bs, 1H), 5.82–5.70 (m, 2H), 4.79 and 4.60* (d and s*, <i>J</i> = 2.4 Hz, 1H), 4.36 and 4.17* (dd and d*, <i>J</i> = 4.87, 12.2 Hz, <i>J</i>* = 12.2 Hz, 1H), 3.91 and 3.90* (dd, <i>J</i> = 12.2, 23.1 Hz, <i>J</i>* = 10.9, 25.5 Hz, 1H), 3.73 (s, 3H), 3.61–3.57 (m, 2H), 2.62–2.59 (m, 2H), 1.88–1.75 (m, 4H), 1.22 and 1.17* (s, 3H), 1.15* and 1.11 (s, 3H); <sup>31</sup>P NMR (162 MHz, CDCl<sub>3</sub>, 300 K) δ −4.99, −9.69*; UPLC <i>t</i><sub>R</sub> 0.96 min; MS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 459 [M + Na]<sup>+</sup>.</div></div><div id="sec4_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> (((4<i>R</i>)-4-((3-Methoxy-3-oxopropyl)carbamoyl)-5,5-dimethyl-2-oxido-1,3,2-dioxaphosphinan-2-yl)oxy)methyl Benzoate (<b>2f</b>)</h3><div class="NLM_p last">Following the same procedure as <b>2a</b>, treatment of <b>6</b> (300.0 mg, 1.02 mmol) with chloromethyl benzoate (294.7 mg, 1.72 mmol) afforded a mixture of diastereomers (17*:83) of the title compound (128 mg, 30%) as a colorless oil. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>, 300 K) δ 8.14–8.07 (m, 2H), 7.67–7.61 (m, 1H), 7.53–7.47 (m, 2H), 7.05* and 6.86 (bs, 1H), 6.04* and 5.99–5.92 (dd* and m, <i>J</i>* = 4.9, 12.2 Hz, 2H), 4.80* and 4.59 (d* and s, <i>J</i>* = 2.4 Hz, 1H), 4.35* and 4.17 (dd* and d, <i>J</i> * = 3.5, 10.9 Hz, <i>J</i> = 10.9 Hz, 1H), 3.89* and 3.82 (dd, <i>J</i> =10.9, 24.3 Hz, 1H), 3.71 (s, 3H), 3.58–3.50 (m, 1H), 3.43–3.35 (m, 1H), 2.55–2.45 (m, 2H), 1.20* and 1.10 (s, 6H); <sup>31</sup>P NMR (162 MHz, CDCl<sub>3</sub>, 300 K) δ −5.31* and −9.36; UPLC <i>t</i><sub>R</sub> 1.43 and 1.47* min; MS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 452 [M + Na]<sup>+</sup>.</div></div><div id="sec4_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> (((4<i>R</i>)-4-((3-Methoxy-3-oxopropyl)carbamoyl)-5,5-dimethyl-2-oxido-1,3,2-dioxaphosphinan-2-yl)oxy)methyl Isonicotinate (<b>2g</b>)</h3><div class="NLM_p last">Following the same procedure as <b>2c</b>, treatment of <b>7</b> (300.0 mg, 0.87 mmol) with isonicotinic acid (128.9, 1.05 mmol) afforded a mixture of diastereomers (81:19*) of the title compound (42 mg, 25%) as a colorless oil. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>, 300 K) δ 8.87–8.85 (m, 2H), 8.20 and 8.13* (m, 1H), 7.88 −7.86 (m, 2H), 5.97–5.90 (m, 2H), 4.71 and 4.61 (d and s*, <i>J</i> = 7.3 Hz, 1H), 4.27–4.13 and 4.05–3.93* (m, 2H), 3.59 (s, 3H), 3.29–3.21 (m, 2H), 2.47 (t, <i>J</i> = 6.1 Hz, 2H), 1.08 and 1.01* (s, 3H), 0.94 and 0.93* (s, 3H); <sup>31</sup>P NMR (162 MHz, DMSO-<i>d</i><sub>6</sub>, 300 K) δ −7.77 and −9.22*; UPLC <i>t</i><sub>R</sub> 1.36 min; MS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 453 [M + Na]<sup>+</sup>.</div></div><div id="sec4_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> (((4<i>R</i>)-4-((3-Methoxy-3-oxopropyl)carbamoyl)-5,5-dimethyl-2-oxido-1,3,2-dioxaphosphinan-2-yl)oxy)methyl Pyrazine-2-carboxylate (<b>2h</b>)</h3><div class="NLM_p last">Following the same procedure as <b>2c</b>, treatment of <b>7</b> (200.0 mg, 0.58 mmol) with pyrazine-2-carboxylic acid (86.6 mg, 0.70 mmol) afforded a mixture of diastereomers (78:22*) of the title compound (28 mg, 11%) as a colorless oil. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>, 300 K) δ 9.26–9.24 (m, 1H), 8.97–8.95 (m, 1H), 7.85–8.90 (m, 1H), 8.18 and 8.12 (bs, 1H), 6.00–5.94 (m, 2H), 4.71 and 4.64* (d and s*, <i>J</i> = 6.7 Hz, 1H), 4.25–4.14 and 4.02–3.96 (m, 2H), 3.58 (s, 3H), 3.31–3.27 (m, 2H), 2.47 (t, <i>J</i> = 6.7 Hz, 2H), 1.08 and 1.01* (s, 3H), 0.95 and 0.93 (s, 3H); <sup>31</sup>P NMR (162 MHz, DMSO-<i>d</i><sub>6</sub>, 300 K) δ −7.69 and −9.29*; UPLC <i>t</i><sub>R</sub> 1.00 min; MS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 432 [M + H]<sup>+</sup>.</div></div><div id="sec4_17" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> Methyl 3-((4<i>R</i>)-2-(((Isopropoxycarbonyl)oxy)methoxy)-5,5-dimethyl-2-oxido-1,3,2-dioxaphosphinane-4-carboxamido)propanoate (<b>2i</b>)</h3><div class="NLM_p last">Following the same procedure as <b>2a</b>, treatment of <b>6</b> (1.00 g, 3.39 mmol) with chloromethyl propan-2-yl carbonate (1.03 g, 6.77 mmol) afforded a mixture of diastereomers (43*:57) of the title compound (82 mg, 6%) as a colorless oil. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>, 300 K) δ 7.13* and 6.96 (bs, 1H), 5.79–5.69 (m, 2H), 5.03–4.93 (m, 1H), 4.81* and 4.61 (d* and s, <i>J</i>* = 2.4 Hz, 1H), 4.39* and 4.22 (dd* and d, <i>J</i>* = 3.6, 10.9 Hz, <i>J</i> = 10.9 Hz, 1H), 3.90 (dd, <i>J</i> = 12.2 Hz, 23.1 Hz, 1H), 3.73 (s, 3H), 3.69–3.49 (m, 2H), 2.63–2.58 (m, 2H), 1.37 (d, <i>J</i> = 6.1 Hz, 3H), 1.35 (d, <i>J</i> = 6.1 Hz, 3H), 1.22* and 1.16 (s, 3H), 1.15 and 1.12* (s, 3H); <sup>31</sup>P NMR (162 MHz, CDCl<sub>3</sub>, 300 K) δ −5.89 and −9.78*; UPLC <i>t</i><sub>R</sub> 1.31 and 1.35* min; MS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 434 [M + Na]<sup>+</sup>.</div></div><div id="sec4_18" class="NLM_sec NLM_sec_level_2"><div id="ac_i33" class="anchor-spacer"></div><h3 class="article-section__title" id="_i33"> 1-(((2<i>R</i>,4<i>R</i>)-4-((3-Methoxy-3-oxopropyl)carbamoyl)-5,5-dimethyl-2-oxido-1,3,2-dioxaphosphinan-2-yl)oxy)ethyl Pivalate (<b>2j</b>)</h3><div class="NLM_p last">Following the same procedure as <b>2a</b>, treatment of <b>6</b> (280.0 mg, 0.95 mmol) with 1-chloroethyl 2,2-dimethylpropanoate (249.8 mg, 1.52 mmol) afforded a mixture of diastereomers (43*:57) both as a single trans isomer at phosphorus of the title compound (23 mg, 5%) as a colorless oil. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>, 300 K) δ 7.02–6.93 (bs, 1H), 6.55–6.48 (m, 1H), 4.57 and 4.55 (s, 1H), 4.20 and 4.15 (d and d, <i>J</i> = 11.2, 11.2 Hz, 1H), 3.83 (dd, <i>J</i> = 11.4, 25.2 Hz, 1H), 3.72 (s, 3H), 3.68–3.58 (m, 1H), 3.56–3.46 (m, 1H), 2.61–2.55 (m, 2H), 1.63 and 1.62 (s and s, 3H), 1.24 and 1.21 (s and s, 9H), 1.14 and 1.12 (s and s, 6H); <sup>31</sup>P NMR (162 MHz, CDCl<sub>3</sub>, 300 K) δ −12.99 and −12.99; UPLC <i>t</i><sub>R</sub> 1.57 min; MS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 446 [M + Na]<sup>+</sup>.</div></div><div id="sec4_19" class="NLM_sec NLM_sec_level_2"><div id="ac_i34" class="anchor-spacer"></div><h3 class="article-section__title" id="_i34"> (((4<i>R</i>)-4-((3-Methoxy-3-oxopropyl)carbamoyl)-5,5-dimethyl-2-oxido-1,3,2-dioxaphosphinan-2-yl)oxy)methylthiazole-5-carboxylate (<b>2k</b>)</h3><div class="NLM_p last">Following the same procedure as <b>2c</b>, treatment of <b>7</b> (600.0 mg, 1.74 mmol) with thiazole-5-carboxylic acid (270.5 mg, 2.09 mmol) afforded a mixture of diastereomers (88:12*) of the title compound (166 mg, 22%) as a colorless oil. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>, 300 K) δ 9.08 and 9.07* (s, 1H), 8.69 and 8.64* (s, 1H), 7.08 and 6.96* (bs, 1H), 6.03–5.92 (m, 2H), 4.81 and 4.61* (d and s*, <i>J</i> = 2.4 Hz, 1H), 4.38 and 4.21* (dd and d*, <i>J</i> = 3.6, 10.9 Hz, <i>J</i>* = 10.9 Hz, 1H), 3.91 (dd, <i>J</i> = 10.9, 23.1 Hz, 1H), 3.73* and 3.71 (s, 3H), 3.60–3.55 (m, 2H), 2.59 (t, <i>J</i> = 6.1 Hz, 2H), 1.22 and 1.15* (s, 3H), 1.14* and 1.12 (s, 3H); <sup>31</sup>P NMR (162 MHz, CDCl<sub>3</sub>, 300 K) δ −5.33, −9.61*; UPLC <i>t</i><sub>R</sub> 1.05* and 1.08 min; MS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 459 [M + Na]<sup>+</sup>.</div></div><div id="sec4_20" class="NLM_sec NLM_sec_level_2"><div id="ac_i35" class="anchor-spacer"></div><h3 class="article-section__title" id="_i35"> (((4<i>R</i>)-4-((3-Methoxy-3-oxopropyl)carbamoyl)-5,5-dimethyl-2-oxido-1,3,2-dioxaphosphinan-2-yl)oxy)methyl Isothiazole-5-carboxylate (<b>2l</b>)</h3><div class="NLM_p last">Following the same procedure as <b>2c</b>, treatment of <b>7</b> (242.0 mg, 0.70 mmol) with 1,2-thiazole-5-carboxylic acid (109.1 mg, 0.84 mmol) afforded a mixture of diastereomers (92:8*) of the title compound (17 mg, 5%) as a colorless oil. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>, 300 K) δ 8.62 (d, <i>J</i> = 1.7 Hz, 1H), 7.94 and 7.90* (d, <i>J</i> = 1.7 Hz, 1H), 7.04 (bs, 1H), 6.03–5.93 and 5.86–5.76* (m, 2H), 4.80 and 4.60* (d and s*, <i>J</i> = 2.2 Hz, 1H), 4.36 and 4.20* (dd and d*, <i>J</i> = 3.9, 11.8 Hz, <i>J</i>* = 10.9 Hz, 1H), 3.91 (dd, <i>J</i> = 11.4, 22.8 Hz, 1H), 3.73* and 3.70 (s, 3H), 3.61–3.52 (m, 2H), 2.61–2.53 (m, 2H), 1.22 and 1.14* (s, 3H), 1.15* and 1.12 (s, 3H); <sup>31</sup>P NMR (162 MHz, CDCl<sub>3</sub>, 300 K) δ −6.58, −11.00*; UPLC <i>t</i><sub>R</sub> 1.22*, 1.26; MS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 459 [M + Na]<sup>+</sup>.</div></div><div id="sec4_21" class="NLM_sec NLM_sec_level_2"><div id="ac_i36" class="anchor-spacer"></div><h3 class="article-section__title" id="_i36"> (((4<i>R</i>)-4-((3-Methoxy-3-oxopropyl)carbamoyl)-5,5-dimethyl-2-oxido-1,3,2-dioxaphosphinan-2-yl)oxy)methyl 4-Methylthiazole-5-carboxylate (<b>2m</b>)</h3><div class="NLM_p last">Following the same procedure as <b>2c</b>, treatment of <b>7</b> (242.0 mg, 0.70 mmol) with 4-methyl-1,3-thiazole-5-carboxylic acid (121.0 mg, 0.84 mmol) afforded a mixture of diastereomers (69:31*) of the title compound (116 mg, 37%) as an oily solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>, 300 K) δ 8.89 and 8.88* (s, 1H), 7.08 and 6.91* (bs, 1H), 6.01–5.89 (m, 2H), 4.80 and 4.60* (d and s*, <i>J</i> = 1.7 Hz, 1H), 4.36 and 4.20* (dd and d*, <i>J</i> = 11.4 Hz, <i>J</i>* = 10.9 Hz, 1H), 3.90 and 3.87* (dd, <i>J</i> = 11.4, 22.8 Hz, <i>J</i>* = 11.4, 25.8 Hz, 1H), 3.73* and 3.70 (s, 3H), 3.60–3.54 and 3.64–3.42* (m, 2H), 2.85 and 2.83 (s, 3H), 2.60–2.54 (m, 2H), 1.22 and 1.14* (s, 3H), 1.13* and 1.12 (s, 3H); <sup>31</sup>P NMR (162 MHz, CDCl<sub>3</sub>, 300 K) δ −6.50, −10.87*; UPLC <i>t</i><sub>R</sub> 1.18*, 1.21; MS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 473 [M + Na]<sup>+</sup>. This material was purified by column chromatography on silica gel eluting with ethyl acetate/petroleum ether (from 0 to 100% of EtOac) to afford (((2<i>S</i>,4<i>R</i>)-4-((3-methoxy-3-oxopropyl)carbamoyl)-5,5-dimethyl-2-oxido-1,3,2-dioxaphosphinan-2-yl)oxy)methyl 4-methylthiazole-5-carboxylate (<b><i>trans</i>-2m</b>) as an oil. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>, 300 K) δ 8.91 (s, 1H), 6.91 (bs, 1H), 5.94–5.88 (m, 2H), 4.61 (s, 1H), 4.21 (d, <i>J</i> = 11.4 Hz, 1H), 3.87 (dd, <i>J</i> = 11.4, 24.9 Hz, 1H), 3.73 (s, 3H), 3.64–3.56 (m, 1H), 3.51–3.42 (m, 1H), 2.83 (s, 3H), 2.58–2.51 (m, 2H), 1.14 (s, 3H), 1.13 (s, 3H); <sup>31</sup>P NMR (162 MHz, CDCl<sub>3</sub>, 300 K) δ −10.88; UPLC <i>t</i><sub>R</sub> 1.18 min; MS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 451 [M + H]<sup>+</sup>.</div></div><div id="sec4_22" class="NLM_sec NLM_sec_level_2"><div id="ac_i37" class="anchor-spacer"></div><h3 class="article-section__title" id="_i37"> (((4<i>R</i>)-4-((3-Methoxy-3-oxopropyl)carbamoyl)-5,5-dimethyl-2-oxido-1,3,2-dioxaphosphinan-2-yl)oxy)methyl 4-(<i>tert</i>-Butyl)thiazole-5-carboxylate (<b>2n</b>)</h3><div class="NLM_p last">Following the same procedure as <b>2a</b>, treatment of <b>6</b> (270.0 mg, 0.91 mmol) with chloromethyl 4-<i>tert</i>-butyl-1,3-thiazole-5-carboxylate (363.4 mg, 1.55 mmol) afforded a mixture of diastereomers (7*:93) of the title compound (15 mg, 3%) as a colorless oil. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>, 300 K) δ 8.91* and 8.89 (s, 1H), 7.37* and 7.11 (bs, 1H), 5.97–5.93* and 5.91–5.85 (m, 2H), 4.84* and 4.63 (s, 1H), 4.40–4.35 and 4.22–4.19 (m, 1H), 3.91–3.82 (m, 1H), 3.71 and 3.69* (s, 3H), 3.65–3.57 (m, 1H), 3.52–3.43 (m, 1H), 2.64–2.50 (m, 2H), 1.53* and 1.52 (s, 9H), 1.12 and 1.11* (s, 6H); <sup>31</sup>P NMR (162 MHz, CDCl<sub>3</sub>, 300 K) δ −7.01*, −10.96; UPLC <i>t</i><sub>R</sub> 1.65 min; MS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 493 [M + H]<sup>+</sup>.</div></div><div id="sec4_23" class="NLM_sec NLM_sec_level_2"><div id="ac_i38" class="anchor-spacer"></div><h3 class="article-section__title" id="_i38"> (((4<i>R</i>)-4-((3-Methoxy-3-oxopropyl)carbamoyl)-5,5-dimethyl-2-oxido-1,3,2-dioxaphosphinan-2-yl)oxy)methyl 4-Methyloxazole-5-carboxylate (<b>2o</b>)</h3><div class="NLM_p last">A mixture of chloromethyl 4-methyl-1,3-oxazole-5-carboxylate (261.7 mg, 1.49 mmol), compound <b>6</b> (400.0 mg, 1.35 mmol), and AgO (471.0 mg, 2.03 mmol) in MeCN (13.5 mL) was stirred under reflux for 3 h. The mixture was cooled, the solvent was evaporated, and then the residue was purified by flash chromatography on SiO<sub>2</sub> (0–100% EtOAc/DCM) to obtain a mixture of diastereomers (10*:90) of the title compound as a colorless oil (28.0 mg, 5%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>, 300 K) δ 7.99* and 7.97 (s, 1H), 7.07* and 6.94 (bs, 1H), 5.98–5.91 (m, 2H), 4.81* and 4.63 (d* and s, <i>J</i>* = 1.7 Hz, 1H), 4.37* and 4.21 (dd* and d, <i>J</i>* = 3.9, 11.4 Hz, <i>J</i> = 11.4 Hz, 1H), 3.80 (dd, <i>J</i> = 11.4, 24.9 Hz, 1H), 3.73 and 3.71* (s, 3H), 3.67–3.56 (m, 1H), 3.54–3.45 (m, 1H), 2.59–2.56 (m, 5H), 1.22* and 1.15 (s, 3H), 1.14 and 1.12* (s, 3H); <sup>31</sup>P NMR (162 MHz, CDCl<sub>3</sub>, 300 K) δ −6.57*, −10.97; UPLC <i>t</i><sub>R</sub> 1.10; MS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 457 [M + Na]<sup>+</sup>.</div></div><div id="sec4_24" class="NLM_sec NLM_sec_level_2"><div id="ac_i39" class="anchor-spacer"></div><h3 class="article-section__title" id="_i39"> (((4<i>R</i>)-4-((3-Methoxy-3-oxopropyl)carbamoyl)-5,5-dimethyl-2-oxido-1,3,2-dioxaphosphinan-2-yl)oxy)methyl 1-Methyl-1<i>H</i>-pyrazole-5-carboxylate (<b>2p</b>)</h3><div class="NLM_p last">Following the same procedure as <b>2c</b>, treatment of <b>7</b> (220.0 mg, 0.64 mmol) with 2-methylpyrazole-3-carboxylic acid (96.9 mg, 0.77 mmol) afforded a mixture of diastereomers (85:15*) of the title compound (21 mg, 8%) as a colorless oil. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>, 300 K) δ 7.54 and 7.53* (d, <i>J</i> = 2.2 Hz, 1H), 7.01 and 6.97* (d, <i>J</i> = 2.2 Hz, 1H), 7.03 and 6.91* (bs, 1H), 6.02–5.90 (m, 2H), 4.81 and 4.61* (d and s*, <i>J</i> = 1.7 Hz, 1H), 4.37 and 4.20* (dd and d*, <i>J</i> = 3.5, 11.4 Hz, <i>J</i>* = 11.4 Hz,1H), 4.25 and 4.23* (s, 3H), 3.90 and 3.86* (dd, <i>J</i> = 11.8, 23.2 Hz, <i>J</i>* = 11.4, 25.4 Hz, 1H), 3.73* and 3.69 (s, 3H), 3.57–3.51 and 3.63–3.42* (m, 2H), 2.58–2.55 (m, 2H), 1.22 and 1.14* (s, 3H), 1.13* and 1.11 (s, 3H); <sup>31</sup>P NMR (162 MHz, CDCl<sub>3</sub>, 300 K) δ −6.33, −10.87*; UPLC <i>t</i><sub>R</sub> 1.17* and 1.20; MS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 434 [M + H]<sup>+</sup>.</div></div><div id="sec4_25" class="NLM_sec NLM_sec_level_2"><div id="ac_i40" class="anchor-spacer"></div><h3 class="article-section__title" id="_i40"> (((4<i>R</i>)-4-((3-Methoxy-3-oxopropyl)carbamoyl)-5,5-dimethyl-2-oxido-1,3,2-dioxaphosphinan-2-yl)oxy)methyl 1,3-Dimethyl-1<i>H</i>-pyrazole-5-carboxylate (<b>2q</b>)</h3><div class="NLM_p last">Following the same procedure as <b>2c</b>, treatment of <b>7</b> (250.0 mg, 0.73 mmol) with 1,3-dimethyl-1<i>H</i>-pyrazole-5-carboxylic acid (122.3 mg, 0.87 mmol) afforded a mixture of diastereomers (61:39*) of the title compound (28 mg, 8%) as a colorless oil. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>, 300 K) δ 7.01 and 6.89* (bs, 1H), 6.76 and 6.72* (s, 1H), 5.98–5.85 (m, 2H), 4.79 and 4.59* (d and s*, <i>J</i> = 1.7 Hz, 1H), 4.35 and 4.18* (dd and d*, <i>J</i> = 3.5, 11.4 Hz, <i>J</i>* = 11.4 Hz, 1H), 4.16 and 4.13* (s, 3H), 3.91 and 3.85* (dd, <i>J</i> = 11.8, 22.8 Hz, 1H), 3.71* and 3.68 (s, 3H), 3.62–3.39* and 3.54–3.51 (m, 2H), 2.58–2.51 (m, 2H), 2.29 and 2.28* (s, 3H), 1.20 and 1.13* (s, 3H), 1.12* and 1.10 (s, 3H); <sup>31</sup>P NMR (162 MHz, CDCl<sub>3</sub>, 300 K) δ −6.33, −10.87*; UPLC <i>t</i><sub>R</sub> 1.21* and 1.25; MS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 448 [M + H]<sup>+</sup>.</div></div><div id="sec4_26" class="NLM_sec NLM_sec_level_2"><div id="ac_i41" class="anchor-spacer"></div><h3 class="article-section__title" id="_i41"> (((4<i>R</i>)-4-((3-Methoxy-3-oxopropyl)carbamoyl)-5,5-dimethyl-2-oxido-1,3,2-dioxaphosphinan-2-yl)oxy)methyl 3-Ethyl-1-methyl-1<i>H</i>-pyrazole-5-carboxylate (<b>2r</b>)</h3><div class="NLM_p last">Following the same procedure as <b>2c</b>, treatment of <b>7</b> (200.0 mg, 0.58 mmol) with 5-ethyl-2-methyl-pyrazole-3-carboxylic acid (107.6 mg, 0.70 mmol) afforded a mixture of diastereomers (75:25*) of the title compound (106 mg, 40%) as a colorless oil. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>, 300 K) δ 8.18 and 8.12* (bs, 1H), 6.76 and 6.74* (s, 1H), 5.88–5.82 (m, 2H), 4.69 and 4.58* (d and s*, <i>J</i> = 6.7 Hz, 1 H), 4.24-412 and 4.39–3.92 (m, 2H), 4.03 and 4.02* (s, 3H), 3.58 (s, 3H), 3.21–3.38 (m, 2H), 2.57 (q, <i>J</i> = 7.31 Hz, 2H), 2.48–2.44 (m, 2H), 1.17 (t, <i>J</i> = 7.61 Hz, 3H), 1.07 and 1.01* (s, 3H), 0.94 and 0.93* (s, 3H); <sup>31</sup>P NMR (162 MHz, DMSO-<i>d</i><sub>6</sub>, 300 K) δ −7.57 and −9.23*; UPLC <i>t</i><sub>R</sub> 1.37* and 1.40 min; MS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 462 [M + H]<sup>+</sup>. This material was purified by column chromatography on silica gel eluting with dichloromethane/ethyl acetate (from 0 to 100% of EtOac) to afford (((2<i>S</i>,4<i>R</i>)-4-((3-methoxy-3-oxopropyl)carbamoyl)-5,5-dimethyl-2-oxido-1,3,2-dioxaphosphinan-2-yl)oxy)methyl 3-ethyl-1-methyl-1<i>H</i>-pyrazole-5-carboxylate (<i><b>trans-</b></i><b>2r</b>) as a colorless oil. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>, 300 K) δ 8.13 (bs, 1H), 6.73 (s, 1H), 5.87–5.81 (m, 2H), 4.58 (s, 1H), 4.13 (d, <i>J</i> = 11.0 Hz, 1H), 4.02 (s, 3H), 3.96–3.92 (m, 1H), 3.58 (s, 3H), 3.27–3.22 (m, 2H), 2.56 (q, <i>J</i> = 7.5 Hz, 2H), 2.48–2.44 (m, 2H), 1.17 (t, <i>J</i> =7.5, 3H), 1.00 (s, 3H), 0.93 (s, 3H); <sup>31</sup>P NMR (162 MHz, DMSO-<i>d</i><sub>6</sub>, 300 K) δ −10.58*; UPLC <i>t</i><sub>R</sub> 1.37 min; MS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 462 [M + H]<sup>+</sup>.</div></div><div id="sec4_27" class="NLM_sec NLM_sec_level_2"><div id="ac_i42" class="anchor-spacer"></div><h3 class="article-section__title" id="_i42"> (((4<i>R</i>)-4-((3-Methoxy-3-oxopropyl)carbamoyl)-5,5-dimethyl-2-oxido-1,3,2-dioxaphosphinan-2-yl)oxy)methyl 3-(<i>tert</i>-Butyl)-1<i>H</i>-pyrazole-5-carboxylate (<b>2s</b>)</h3><div class="NLM_p last">Following the same procedure as <b>2c</b>, treatment of <b>7</b> (300.0 mg, 0.87 mmol) with 3-(<i>tert</i>-butyl)-1<i>H</i>-pyrazole-5-carboxylic acid (176.2 mg, 1.05 mmol) afforded a mixture of diastereomers (79:21*) of the title compound (34 mg, 8%) as a white solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>, 300 K) δ 7.54 and 7.19* (bs, 1H), 6.77 and 6.75* (s, 1H), 6.68 (bs, 1H), 6.12 and 5.94* and 5.80 (dd and d*, <i>J</i> = 5.3, 17.9 Hz, <i>J</i>* = 13.6 Hz, 2H), 4.84 and 4.66* (s, 1H), 4.43 and 4.21* (dd and d*, <i>J</i> = 2.2, 11.8 Hz, <i>J</i>* = 11.8 Hz, 1H), 3.91 and 3.84* (dd, <i>J</i> = 11.4, 23.6 Hz, <i>J</i>* = 10.9, 24.9 Hz, 1H), 3.76 and 3.72* (s, 3H), 3.65–3.61 and 3.56–3.50* (m, 2H), 2.73–2.69 and 2.57* (m and t*, <i>J</i>* = 6.5 Hz, 2H), 1.39 and 1.38* (s, 9H), 1.21 and 1.14* (s, 3H), 1.15 and 1.11 (s, 3H); <sup>31</sup>P NMR (162 MHz, CDCl<sub>3</sub>, 300 K) δ −6.77, −10.73*; UPLC <i>t</i><sub>R</sub> 1.43* and 1.46 min; MS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 476 [M + H]<sup>+</sup>. This material was purified by RP-HPLC (Waters XBridge C<sub>18</sub> 5 μm, 19 × 150 mm<sup>2</sup>; flow rate, 20 mL/min) eluting with water and acetonitrile containing 0.1% TFA (from 10 to 50% of acetonitrile) to afford (((2<i>S</i>,4<i>R</i>)-4-((3-methoxy-3-oxopropyl)carbamoyl)-5,5-dimethyl-2-oxido-1,3,2-dioxaphosphinan-2-yl)oxy)methyl 3-(<i>tert</i>-butyl)-1<i>H</i>-pyrazole-5-carboxylate (<i><b>trans</b></i><b>-2s</b>) as a white solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>, 300 K) δ 7.20 (bs, 1H), 6.75 (s, 1H), 5.94 (d, <i>J</i> = 13.37 Hz, 2H), 4.66 (s, 1H), 4.22–4.17 (m, 1H) overlay with water, 3.86 (dd, <i>J</i> =11.4, 25.2 Hz, 1H), 3.72 (s, 3H), 3.55–3.52 (m, 2H), 2.57 (t, <i>J</i> = 6.25 Hz, 2H), 1.38 (s, 9H), 1.15 (s, 3H), 1.11 (s, 3H); <sup>31</sup>P NMR (162 MHz, CDCl<sub>3</sub>, 300 K) δ −10.69; UPLC <i>t</i><sub>R</sub> 1.44 min; MS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 476 [M + H]<sup>+</sup>; M.P. 102 °C.</div></div><div id="sec4_28" class="NLM_sec NLM_sec_level_2"><div id="ac_i43" class="anchor-spacer"></div><h3 class="article-section__title" id="_i43"> <i>tert</i>-Butyl-(<i>R</i>)-3-(2,4-dihydroxy-3,3-dimethylbutanamido)propanoate (<b>8</b>)</h3><div class="NLM_p last"><i>tert</i>-Butyl 3-aminopropanoate (48.7 g, 335.4 mmol) was treated with (3<i>R</i>)-4,4-dimethyl-3-oxidanyl-oxolan-2-one (56.8 g, 436.0 mmol) and heated with stirring at 85 °C. This mixture melted to give a pale yellow oil that after 48 h was cooled and taken up in the minimum amount of DCM and purified by flash chromatography on SiO<sub>2</sub> (0–70% EtOAc/PE) to furnish the title compound (80.7 g, 88%) as a colorless oil. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>, 300 K) δ 7.18 (bs, 1H), 4.03 (s, 1H), 3.60–3.49 (m, 4H), 2.51–2.48 (t, <i>J</i> = 5.8 Hz, 2H), 1.47 (s, 9H), 1.04 (s, 3H), 0.93 (s, 3H); UPLC <i>t</i><sub>R</sub> 1.17 min; MS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 276 [M + H]<sup>+</sup>.</div></div><div id="sec4_29" class="NLM_sec NLM_sec_level_2"><div id="ac_i44" class="anchor-spacer"></div><h3 class="article-section__title" id="_i44"> (((4<i>R</i>)-4-((3-(<i>tert</i>-Butoxy)-3-oxopropyl)carbamoyl)-5,5-dimethyl-2-oxido-1,3,2-dioxaphosphinan-2-yl)oxy)methyl Pivalate (<b>9b</b>)</h3><div class="NLM_p last">Following the procedure described for <b>5</b>, treatment of <b>8</b> (80.7 g, 293 mmol) with POCl<sub>3</sub> (24.8 mL, 258.8 mmol) furnished after flash chromatography on SiO<sub>2</sub> (petroleum ether/EtOAc) a mixture of two diastereomers (59:41*) of <i>tert</i>-butyl 3-((4<i>R</i>)-2-(benzyloxy)-5,5-dimethyl-2-oxido-1,3,2-dioxaphosphinane-4-carboxamido) propanoate (110.0 g, 49%) as a white solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>, 300 K) δ 7.47–7.39 (m, 5H), 6.91* and 6.81 (bs, 1H), 5.26–5.24 and 5.16–5.13* (d, <i>J</i> = 9.8 and 9.4 Hz*, 2H), 4.77 and 4.42* (m, 1H), 4.39–4.35 and 4.06–4.03* (m, 1H), 4.17–4.12 and 3.86–3.73* (m, 1H), 3.60–3.53 (m, 1H), 3.51–3.53 (m, 1H), 2.51–2.42 (m, 2H), 1.43* and 1.45 (s, 9H), 1.19 and 1.11* (s, 3H), 1.10 and 1.09* (s, 3H); <sup>31</sup>P NMR (162 MHz, CDCl<sub>3</sub>, 300 K) δ −4.59, −8.67*; UPLC <i>t</i><sub>R</sub> 1.72*, 1.80 min; MS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 428 [M + H]<sup>+</sup>. Treatment of this material (1.82 g, 4.26 mmol) as described for compound <b>6</b> furnished <i>tert</i>-butyl 3-((4<i>R</i>)-2-hydroxy-5,5-dimethyl-2-oxido-1,3,2-dioxaphosphinane-4-carboxamido)propanoate (1.40 g, 97%) as a colorless oil. <sup>31</sup>P NMR (162 MHz, DMSO-<i>d</i><sub>6</sub>, 300 K) δ −3.36; UPLC <i>t</i><sub>R</sub> 0.89 min; MS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 338 [M + H]<sup>+</sup>. Following the general procedure for compound <b>2a</b>, treatment of the preceding material (1.3 g, 3.85 mmol) afforded a mixture of diastereomers (5*:95) of the title compound (2.3 g, 58%) as a white solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>, 300 K) δ 7.02 (bs, 1H), 5.73–5.70 (d, <i>J</i> = 13.2 Hz, 2H), 4.82* and 4.59 (s, 1H), 4.4–4.36* and 4.21–4.18 (d, <i>J</i> = 15.6 Hz* and <i>J</i> = 11.1 Hz, 1H), 3.91–3.82 (dd, <i>J</i> = 11.2 Hz, 24.8 Hz, 1H), 3.64–3.56 (m, 1H), 3.52–3.44 (m, 1H), 2.51–2.47 (m, 2H), 1.48 (s, 9H), 1.28* and 1.25 (s, 9H), 1.21* and 1.15 (s, 3H), 1.14 and 1.12*(s, 3H); <sup>31</sup>P NMR (162 MHz, CDCl<sub>3</sub>, 300 K) δ −5.50* and −9.36; UPLC <i>t</i><sub>R</sub> 2.14 and 2.20* min; MS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 452 [M + H]<sup>+</sup>; M.P. 101 °C.</div></div><div id="sec4_30" class="NLM_sec NLM_sec_level_2"><div id="ac_i45" class="anchor-spacer"></div><h3 class="article-section__title" id="_i45"> 3-((2<i>S</i>,4<i>R</i>)-5,5-Dimethyl-2-oxido-2-((pivaloyloxy)methoxy)-1,3,2-dioxaphosphinane-4-carboxamido)propanoic Acid (<b>9a</b>)</h3><div class="NLM_p last">Compound <b>9b</b> (13.0 g, 28.8 mmol) was dissolved in DCM (140 mL); then, TFA (60 mL) was added dropwise. The mixture was stirred for 45 min, then the solvent was evaporated, and the residue was purified by flash chromatography on C<sub>18</sub> silica eluting with H<sub>2</sub>O/CH<sub>3</sub>CN to give the title compound (8.0 g, 87%) as a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>, 300 K) δ 12.27 (bs, 1H), 8.13 (bs, 1H), 5.68–5.60 (m, 2H), 4.54 (s, 1H), 4.11–4.08 (d, <i>J</i> = 10.1 Hz, 1H), 4.02–3.92 (dd, <i>J</i> = 11.2, 24.4 Hz, 1H), 3.31 (m, 2H), 2.41 (m, 2H), 1.17 (s, 9H), 1.02 (s, 3H), 0.95 (s, 3H); <sup>31</sup>P NMR (162 MHz, DMSO-<i>d</i><sub>6</sub>, 300 K) δ −10.33; UPLC <i>t</i><sub>R</sub> 1.24 min; MS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 418 [M + Na]<sup>+</sup>; M.P. 74 °C.</div></div><div id="sec4_31" class="NLM_sec NLM_sec_level_2"><div id="ac_i46" class="anchor-spacer"></div><h3 class="article-section__title" id="_i46"> (((2<i>S</i>,4<i>R</i>)-4-((3-Ethoxy-3-oxopropyl)carbamoyl)-5,5-dimethyl-2-oxido-1,3,2-dioxaphosphinan-2-yl)oxy)methyl Pivalate (<b>9c</b>)</h3><div class="NLM_p last">Compound <b>9a</b> (300.0 mg, 0.76 mmol) and TBTU (365.5 mg, 1.14 mmol) were dissolved in MeCN (2.50 mL) and stirred for 20 min. Ethyl alcohol (0.05 mL, 0.91 mmol) and DIEA (0.26 mL, 1.52 mmol) were added and stirring was continued for 16 h. The mixture was then filtered through a Si carbonate SPE cartridge eluting with DCM. The volatiles were evaporated, and the residue was purified by RP-HPLC to afford the title compound as a white solid (131.2 mg, 41%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>, 300 K) δ 6.96 (bs, 1H), 5.74–5.69 (m, 2H), 4.57 (s, 1H), 4.20–4.15 (m, 3H), 3.85 (dd, <i>J</i> = 11.4, 25.2 Hz, 1H), 3.64–3.58 (m, 1H), 3.56–3.50 (m, 1H), 2.58–2.54 (m, 2H), 1.28 (t, <i>J</i> = 7.1 Hz, 3H), 1.24 (s, 9H), 1.14 (s, 3H), 1.13 (s, 3H); <sup>31</sup>P NMR (162 MHz, CDCl<sub>3</sub>, 300 K) δ −10.62; UPLC <i>t</i><sub>R</sub> 1.56 min; MS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 424 [M + H]<sup>+</sup>; M.P. 59 °C.</div></div><div id="sec4_32" class="NLM_sec NLM_sec_level_2"><div id="ac_i47" class="anchor-spacer"></div><h3 class="article-section__title" id="_i47"> (((2<i>S</i>,4<i>R</i>)-5,5-Dimethyl-2-oxido-4-((3-oxo-3-(thiazol-5-ylmethoxy)propyl)carbamoyl)-1,3,2-dioxaphosphinan-2-yl)oxy)methyl Pivalate (<b>9d</b>)</h3><div class="NLM_p last">Following the same procedure as <b>9c</b>, treatment of <b>9a</b> (90.0 mg, 0.23 mmol) with thiazol-5-ylmethanol (31.4 mg, 0.27 mmol) afforded the title compound (24 mg, 21%) as a white solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>, 300 K) δ 9.0 (s, 1H), 7.97 (s, 1H), 6.94 (bs, 1H), 5.75–5.69 (m, 2H), 5.39 (s, 2H), 4.56 (s, 1H), 4.17 (d, <i>J</i> = 10.9 Hz, 1H), 3.85 (dd, <i>J</i> = 10.9, 25.5 Hz, 1H), 3.67–3.52 (m, 2H), 2.65–2.61 (m, 2H), 1.25 (s, 9H), 1.14 (s, 3H), 1.06 (s, 3H); <sup>31</sup>P NMR (162 MHz, CDCl<sub>3</sub>, 300 K) δ −9.33; UPLC <i>t</i><sub>R</sub> 1.46 min; MS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 493 [M + H]<sup>+</sup>; M.P. 57 °C.</div></div><div id="sec4_33" class="NLM_sec NLM_sec_level_2"><div id="ac_i48" class="anchor-spacer"></div><h3 class="article-section__title" id="_i48"> (((2<i>S</i>,4<i>R</i>)-5,5-Dimethyl-2-oxido-4-((3-oxo-3-(2-(pyridin-2-yl)ethoxy)propyl)carbamoyl)-1,3,2-dioxaphosphinan-2-yl)oxy)methyl Pivalate (<b>9e</b>)</h3><div class="NLM_p last">Following the same procedure as <b>9c</b>, treatment of <b>9a</b> (125.0 mg, 0.32 mmol) with 2-(2-pyridyl)ethanol (41.4 mg, 0.38 mmol) afforded the title compound (70 mg, 61%) as a pale oil. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>, 300 K) δ 8.88 (d, <i>J</i> = 6.1 Hz, 1H), 8.34 (t, <i>J</i> = 8.5 Hz, 1H), 7.81–7.76 (m, 2H), 6.99 (bs, 1H), 5.77–5.68 (m, 2H), 4.60–4.58 (m, 3H), 4.18 (d, <i>J</i> = 10.9 Hz, 1H), 3.87 (dd, <i>J</i> = 25.5 Hz, 12.2 Hz, 1H), 3.53–3.48 (m, 2H), 3.58–3.55 (m, 2H), 2.58–2.56 (t, <i>J</i> = 6.1 Hz, 2H), 1.25 (s, 9H), 1.14 (s, 3H), 1.12 (s, 3H); <sup>31</sup>P NMR (162 MHz, CDCl<sub>3</sub>, 300 K) δ −10.67; UPLC <i>t</i><sub>R</sub> 1.09 min; MS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 501 [M + H]<sup>+</sup>.</div></div><div id="sec4_34" class="NLM_sec NLM_sec_level_2"><div id="ac_i49" class="anchor-spacer"></div><h3 class="article-section__title" id="_i49"> (((2<i>S</i>,4<i>R</i>)-5,5-Dimethyl-4-((3-(2-(methylsulfonyl)ethoxy)-3-oxopropyl)carbamoyl)-2-oxido-1,3,2-dioxaphosphinan-2-yl)oxy)methyl Pivalate (<b>9f</b>)</h3><div class="NLM_p last">Following the same procedure as <b>9c</b>, treatment of <b>9a</b> (90.0 mg, 0.23 mmol) with 2-methylsulfonylethanol (33.9 mg, 0.27 mmol) afforded the title compound (26 mg, 23%) as a colorless oil. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>, 300 K) δ 7.37 (bs, 1H), 5.79–5.62 (m, 2H), 4.67–4.60 (m, 2H), 4.58 (s, 1H), 4.18 (d, <i>J</i> = 11.2 Hz, 1H), 3.85 (dd, <i>J</i> = 11.3, 24.7 Hz, 1H), 3.66–3.52 (m, 2H), 3.49–3.41 (m, 1H), 3.39–3.31 (m, 1H), 3.09 (s, 3H), 2.60 (t, <i>J</i> = 6.1 Hz, 2H), 1.24 (s, 9H), 1.15 (s, 3H), 1.13 (s, 3H); <sup>31</sup>P NMR (162 MHz, CDCl<sub>3</sub>, 300 K) δ −9.16; UPLC <i>t</i><sub>R</sub> 1.34 min; MS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 524 [M + Na]<sup>+</sup>.</div></div><div id="sec4_35" class="NLM_sec NLM_sec_level_2"><div id="ac_i50" class="anchor-spacer"></div><h3 class="article-section__title" id="_i50"> (((2<i>S</i>,4<i>R</i>)-4-((3-((1-Benzylpyrrolidin-3-yl)oxy)-3-oxopropyl)carbamoyl)-5,5-dimethyl-2-oxido-1,3,2-dioxaphosphinan-2-yl)oxy)methyl Pivalate (<b>9g</b>)</h3><div class="NLM_p last">Following the same procedure as <b>9c</b>, treatment of <b>9a</b> (90.0 mg, 0.23 mmol) with 1-benzylpyrrolidin-3-ol (48.4 mg, 0.27 mmol) afforded the title compound (8.1 mg, 29%) as a pale oil. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub> + TFA, 300 K) δ 9.02–8.88 (bs, 1H), 7.94 (m, 1H), 7.51–7.47 (m, 3H), 7.42–7.40 (m, 2H), 5.84–5.77 (m, 2H), 5.56–5.49 (m, 1H), 4.90–4.88 (m, 1H), 4.50–4.44 (m, 2H), 4.36–4.32 (m, 1H), 4.15–3.95 (m, 2H), 3.89–3.86 (m, 1H), 3.77–3.63 (m, 2H), 3.48–3.31 (m, 2H), 2.80–2.77 (m, 1H), 2.73–2.69 (m, 1H), 2.65–2.43 (m, 1H), 2.35–2.28 (m, 1H), 1.29–1.28 (m, 9H), 1.19–1.14 (m, 6H); <sup>31</sup>P NMR (162 MHz, CDCl<sub>3</sub> + TFA, 300 K) δ −9.48; UPLC <i>t</i><sub>R</sub> 1.14 min; MS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 555 [M + H]<sup>+</sup>.</div></div><div id="sec4_36" class="NLM_sec NLM_sec_level_2"><div id="ac_i51" class="anchor-spacer"></div><h3 class="article-section__title" id="_i51"> Methyl 3-((2<i>R</i>,4<i>R</i>)-2-(4-Fluorophenoxy)-5,5-dimethyl-2-oxido-1,3,2-dioxaphosphinane-4-carboxamido)propanoate (<b>3a</b>) and Methyl 3-((2<i>S</i>,4<i>R</i>)-2-(4-Fluorophenoxy)-5,5-dimethyl-2-oxido-1,3,2-dioxaphosphinane-4-carboxamido)propanoate (<b>3b</b>)</h3><div class="NLM_p last">Compound <b>4</b> (10.0 g, 42.9 mmol) was dissolved in THF (112 mL) and treated with a solution of TEA (12.6 mL, 90 mmol) in THF (15 mL). This mixture was cooled to −78 °C and treated dropwise with a solution of POCl<sub>3</sub> (4.41 mL, 47.2 mmol) in THF (10 mL). After stirring for 0.5 h, the mixture was warmed to 20 °C over 1 h. The mixture was filtered through a pad of solka floc, and the volatiles were evaporated to give methyl 3-((4<i>R</i>)-2-chloro-5,5-dimethyl-2-oxido-1,3,2-dioxaphosphinane-4-carboxamido)propanoate (13.3 g). A portion of this material (355.0 mg, 1.13 mmol) was dissolved in DCM (6 mL) and cooled to 0 °C. 4-Fluorophenol (103.3 mg, 0.93 mmol) and a solution of TEA (0.55 mL, 4.09 mmol) in Et<sub>2</sub>O (3 mL) were added, and the mixture was stirred for 16 h at 20 °C. The mixture was diluted with H<sub>2</sub>O, then the organic layer was separated, and washed with 5% aqueous citric acid, NaOH (1 N), and brine. The organic phase was dried, filtered, and concentrated to give a residue that was purified by flash chromatography on SiO<sub>2</sub> (50–100% EtOAc/DCM) to afford a mixture of diastereomers as the title compounds. RP-HPLC purification of this material afforded <b>3a</b> (64.0 mg, 14%) as a colorless oil. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>, 300 K) δ 7.30–7.13 (m, 2H), 7.13–7.07 (m, 2H), 6.98 (br s, 1H), 4.81 (d, <i>J</i> = 1.0 Hz, 1 H), 4.40 (dd, <i>J</i> = 2.6, 11.6 Hz, 1 H), 3.87 (dd, <i>J</i> = 11.6, 23.5 Hz, 1H), 3.74 (s, 3H), 3.66–3.47 (m, 2H), 2.58–2.53 (m, 2H), 1.16 (s, 3H), 0.85 (s, 3H); <sup>31</sup>P NMR (162 MHz, CDCl<sub>3</sub>, 300 K) δ −10.84; UPLC <i>t</i><sub>R</sub> 1.46 min; MS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 390 [M + H]<sup>+</sup>; and <b>3b</b> (24.0 mg, 5%) as a colorless oil. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>, 300 K) δ 7.25–7.18 (m, 2H), 7.09–7.01 (m, 2H), 6.97 (br s, 1H), 4.72 (s, 1 H), 4.29 (d, <i>J</i> = 11.4 Hz, 1H), 3.92 (d, <i>J</i> = 11.4 Hz, 1H), 3.97 (dd, <i>J</i> = 11.4, 25.4 Hz, 1H), 3.72 (s, 3H), 3.59–3.69 (m, 1H), 3.58–3.49 (m, 1H), 2.63–2.55 (m, 2H), 1.20 (s, 3H), 1.15 (s, 3H); <sup>31</sup>P NMR (162 MHz, CDCl<sub>3</sub>, 300 K) δ −14.84; UPLC <i>t</i><sub>R</sub> 1.43 min; MS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 390 [M + H]<sup>+</sup>.</div></div><div id="sec4_37" class="NLM_sec NLM_sec_level_2"><div id="ac_i52" class="anchor-spacer"></div><h3 class="article-section__title" id="_i52"> Methyl 3-((2<i>R</i>,4<i>R</i>)-2-(4-Cyanophenoxy)-5,5-dimethyl-2-oxido-1,3,2-dioxaphosphinane-4-carboxamido)propanoate (<b>3c</b>)</h3><div class="NLM_p last">A solution of 4-hydroxybenzonitrile (162.3 mg, 1.36 mmol) in Et<sub>2</sub>O (2 mL) was stirred under nitrogen and cooled to −78 °C before a solution of TEA (0.55 mL, 4.09 mmol) in Et<sub>2</sub>O (3 mL) and POCl<sub>3</sub> (0.13 mL, 1.36 mmol) were slowly added. The mixture was stirred for 15 min at −78 °C and then warmed to 20 °C over 1 h. The mixture was filtered through a pad of solka floc, and the filtrate was evaporated. The residue was dissolved in THF (4 mL) and cooled to −78 °C. A solution of compound <b>4</b> (317.8 mg, 1.36 mmol) in THF (1 mL) and TEA (0.75 mL, 4.9 mmol) were added. After 10 min, the cooling bath was removed and the mixture was stirred for 30 min, then eluted through a pad of solka floc with DCM. The solution was washed with 5% aqueous citric acid, NaOH (1 N), and brine, and then dried and filtered. Removal of the volatiles gave a residue that was purified by flash chromatography on SiO<sub>2</sub> (50–100% EtOAc/DCM) to afford the title compound (100 mg, 18%) as a colorless oil. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>, 300 K) δ 8.34 (br t, <i>J</i> = 5.6 Hz, 1H), 7.92 (d, <i>J</i> = 8.6 Hz, 2H), 7.43 (d, <i>J</i> = 8.1 Hz, 2H), 4.73 (d, <i>J</i> = 11.4 Hz, 1H), 4.52 (app t, <i>J</i> = 11.0 Hz, 1H), 4.15 (dd, <i>J</i> = 11.0, 13.6 Hz, 1H), 3.58 (s, 3H), 3.40–3.27 (m, 2H), 2.48–2.42 (m, 2H), 1.14 (s, 3H), 0.76–0.84 (m, 3H); <sup>31</sup>P NMR (162 MHz, DMSO-<i>d</i><sub>6</sub>, 300 K) δ −15.08; UPLC <i>t</i><sub>R</sub> 1.34 min; MS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 397 [M + H]<sup>+</sup>.</div></div><div id="sec4_38" class="NLM_sec NLM_sec_level_2"><div id="ac_i53" class="anchor-spacer"></div><h3 class="article-section__title" id="_i53"> Methyl 3-((2<i>R</i>,4<i>R</i>)-5,5-Dimethyl-2-oxido-2-(4-(trifluoromethyl)phenoxy)-1,3,2-dioxaphosphinane-4-carboxamido)propanoate (<b>3d</b>)</h3><div class="NLM_p last">Following the same procedure as <b>3c</b>, treatment of <b>4</b> (431.7 mg, 1.85 mmol) with 4-trifluoromethylphenol (300.0 mg, 1.85 mmol) afforded the title compound (22 mg, 3%) as a colorless oil. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>, 300 K) δ 7.70 (d, <i>J</i> = 8.8 Hz, 2H), 7.42 (d, <i>J</i> = 8.6 Hz, 2H), 7.05 (br s, 1H), 4.85 (d, <i>J</i> = 2.0 Hz, 1H), 4.42 (dd, <i>J</i> = 3.3, 11.6 Hz, 1H), 3.93 (dd, <i>J</i> = 11.4, 23.2, 1H), 3.72 (s, 3H), 3.67–3.57 (m, 1H), 3.57–3.48 (m, 1H), 2.61–2.53 (m, 2H), 1.19 (s, 3H), 0.91 (s, 3H); <sup>31</sup>P NMR (162 MHz, CDCl<sub>3</sub>, 300 K) δ −11.47; UPLC <i>t</i><sub>R</sub> 1.70 min; MS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 440 [M + H]<sup>+</sup>.</div></div><div id="sec4_39" class="NLM_sec NLM_sec_level_2"><div id="ac_i54" class="anchor-spacer"></div><h3 class="article-section__title" id="_i54"> Methyl 3-((2<i>R</i>,4<i>R</i>)-5,5-Dimethyl-2-oxido-2-(4-(pentafluoro-l6-sulfanyl)phenoxy)-1,3,2-dioxaphosphinane-4-carboxamido)propanoate (<b>3e</b>)</h3><div class="NLM_p last">Following the same procedure as <b>3c</b>, treatment of <b>4</b> (317.85 mg, 1.36 mmol) with 4-(pentafluorothio)phenol (300.0 mg, 1.36 mmol) afforded the title compound (59 mg, 8%) as a colorless oil. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>, 300 K) δ 7.84 (d, <i>J</i> = 8.7 Hz, 2H), 7.42 (d, <i>J</i> = 8.7 Hz, 2H), 7.06 (bs, 1H), 4.84 (d, <i>J</i> = 2.2 Hz, 1H), 4.42 (dd, <i>J</i> = 3.9, 11.4 Hz, 1H), 3.97 (dd, <i>J</i> = 11.4, 22.8 Hz, 1H), 3.73 (s, 3H), 3.68–3.51 (m, 2H), 5.58 (t, <i>J</i> = 5.7 Hz, 2H), 1.22 (s, 3H), 0.97 (s, 3H); <sup>31</sup>P NMR (162 MHz, CDCl<sub>3</sub>, 300 K) δ −11.35; UPLC <i>t</i><sub>R</sub> 1.79 min; MS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 498 [M + H]<sup>+</sup>.</div></div><div id="sec4_40" class="NLM_sec NLM_sec_level_2"><div id="ac_i55" class="anchor-spacer"></div><h3 class="article-section__title" id="_i55"> Methyl 2-(((2<i>R</i>,4<i>R</i>)-4-((3-Methoxy-3-oxopropyl)carbamoyl)-5,5-dimethyl-2-oxido-1,3,2-dioxaphosphinan-2-yl)oxy)benzoate (<b>3f</b>)</h3><div class="NLM_p last">Following the same procedure as <b>3c</b>, treatment of <b>4</b> (317.85 mg, 1.36 mmol) with methyl 2-hydroxybenzoate (207.3 mg, 1.36 mmol) afforded the title compound (120 mg, 20%) as a colorless oil. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>, 300 K) δ 7.94–7.92 (m, 1H), 7.59–7.55 (m, 1H), 7.46 (bs, 1H), 7.40–7.38 (m, 1H), 7.33–7.29 (m, 1H), 4.81 (d, <i>J</i> = 2.8, 1H), 4.40 (dd, <i>J</i> = 3.1, 11.6 Hz, 1H), 3.94 (dd, <i>J</i> = 11.6, 23.9 Hz, 1H), 3.95 (s, 3H), 3.68 (s, 3H), 3.62–3.57 (m, 2H), 2.6 (t, <i>J</i> = 6.5 Hz, 2H), 1.19 (s, 3H), 0.96 (s, 3H); <sup>31</sup>P NMR (162 MHz, CDCl<sub>3</sub>, 300 K) δ −12.57; UPLC <i>t</i><sub>R</sub> 1.40 min; MS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 430 [M + H]<sup>+</sup>.</div></div><div id="sec4_41" class="NLM_sec NLM_sec_level_2"><div id="ac_i56" class="anchor-spacer"></div><h3 class="article-section__title" id="_i56"> Methyl (<i>S</i>)-2-Amino-3-(4-(((2<i>R</i>,4<i>R</i>)-4-((3-methoxy-3-oxopropyl)carbamoyl)-5,5-dimethyl-2-oxido-1,3,2-dioxaphosphinan-2-yl)oxy)phenyl)propanoate Hydrochloride (<b>3g</b>)</h3><div class="NLM_p last">Following the same procedure as <b>3c</b>, treatment of <b>4</b> (500.0 mg, 1.69 mmol) with methyl 3-[[(2<i>R</i>)-3,3-dimethyl-2,4-bis(oxidanyl)butanoyl]amino]propanoate (394.9 mg, 1.69 mmol) afforded (<i>S</i>)-2-((<i>tert</i>-butoxycarbonyl)amino)-3-(4-(((2R,4<i>R</i>)-4-((3-methoxy-3-oxopropyl)carbamoyl)-5,5-dimethyl-2-oxido-1,3,2-dioxaphosphinan-2-yl)oxy)phenyl)propanoate. Treatment of this material with a solution of HCl (0.2 M in Et<sub>2</sub>O, 0.5 mL) gave a precipitate that was filtered and dried to afford the title compound (15 mg, 23%) as a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>, 300 K) δ 8.38–8.33 (bs, 2H), 8.29–8.27 (bs, 1H), 7.27–7.20 (m, 4H), 4.72 (d, <i>J</i> = 9.0 Hz, 1H), 4.40–4.34 (m, 1H), 4.30–4.27 (m, 1H), 4.17–4.12 (m, 1H), 3.68 (s, 3H), 3.60 (s, 3H), 3.38–3.33 (m, 1H), 3.08 (m, 2H), 2-52–2.50 (m, 2H), 1.10 (s, 3H), 0.82 (s, 3H); <sup>31</sup>P NMR (162 MHz, DMSO-<i>d</i><sub>6</sub>, 300 K) δ −13.33; UPLC <i>t</i><sub>R</sub> 0.93 min; MS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 473 [M + H]<sup>+</sup>; M.P. 50 °C.</div></div><div id="sec4_42" class="NLM_sec NLM_sec_level_2"><div id="ac_i57" class="anchor-spacer"></div><h3 class="article-section__title" id="_i57"> (3-Methoxy-3-oxopropyl-1,2,3-<sup>13</sup>C<sub>3</sub>)amide-<sup>15</sup>N HCl Salt (<b>10</b>)</h3><div class="NLM_p last">Thionyl chloride (4.1 mL, 56.4 mmol) was added dropwise to a stirred solution of β-alanine-<sup>13</sup>C<sub>3</sub>,<sup>15</sup>N 3-aminopropanoic acid in methanol (2.0 mL) at 0 °C. The reaction was allowed to warm to RT and then heated to reflux (<i>T</i> = 68 °C) for 2 h. The solution was concentrated in vacuo, treated with <i>tert</i>-butyl methyl ether, and the resulting crystals were removed by filtration to afford the title compound (590.0 mg, 99%). <sup>1</sup>H NMR (methanol-<i>d</i><sub>4</sub>, 400 MHz) δ 3.7–3.8 (m, 3H), 3.3–3.5 (m, 1H), 3.0–3.1 (m, 1H), 2.9–3.0 (m, 1H), 2.5–2.6 (m, 1H)</div></div><div id="sec4_43" class="NLM_sec NLM_sec_level_2"><div id="ac_i58" class="anchor-spacer"></div><h3 class="article-section__title" id="_i58"> Methyl (<i>R</i>)-3-(2,4-Dihydroxy-3,3-dimethylbutanamido-<sup>15</sup>N)propanoate-1,2,3-<sup>13</sup>C<sub>3</sub> (<b>11</b>)</h3><div class="NLM_p last">To a stirred solution of (<i>R</i>)-pantolactone (3127.7 mg, 24.3 mmol) in methanol (11.9 mL) were added (3-methoxy-3-oxopropyl-1,2,3-<sup>13</sup>C<sub>3</sub>)amide-<sup>15</sup>N HCl salt (10) and TEA (2.3 mL, 16.4 mmol). The mixture was stirred at reflux overnight. After cooling to RT, the solvent was evaporated and the resulting residue was purified by column chromatography on SiO<sub>2</sub> (0–90% EtOAc in PE) to afford the title compound (653.0 mg, 67%). <sup>1</sup>H NMR (chloroform-<i>d</i>, 400 MHz, 300 K) δ 7.2–7.3 and 7.1–7.0 (m, 1H), 4.04 (s, 1H), 3.8–3.8 (m, 1H), 3.7–3.7 (m, 3H), 3.5–3.6 (m, 2H), 3.4–3.5 (m, 1H), 2.7–2.8 (m, 1H), 2.4–2. 5 (m, 1H), 2.07 (s, 1H), 1.06 (s, 3H), 0.94 (s, 3H).</div></div><div id="sec4_44" class="NLM_sec NLM_sec_level_2"><div id="ac_i59" class="anchor-spacer"></div><h3 class="article-section__title" id="_i59"> Methyl 3-((4<i>R</i>)-2-(Benzyloxy)-5,5-dimethyl-2-(oxido-<sup>18</sup>O)-1,3,2-dioxaphosphinane-4-carboxamido-<sup>15</sup>N)propanoate-1,2,3-<sup>13</sup>C<sub>3</sub> (<b>12</b>)</h3><div class="NLM_p last">Following the same procedure as <b>5</b>, using <b>11</b> (4.4 g, 18.5 mmol) and P<sup>18</sup>OCl<sub>3</sub> afforded a mixture of diastereomers (50:50) of the title compound (5.0 g, 69%). <sup>31</sup>P NMR (162 MHz, CDCl<sub>3</sub>, 300 K) δ −3.13 and −7.31; UPLC <i>t</i><sub>R</sub> 1.33 and 1.39 min; MS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 392 (M + H)<sup>+</sup>.</div></div><div id="sec4_45" class="NLM_sec NLM_sec_level_2"><div id="ac_i60" class="anchor-spacer"></div><h3 class="article-section__title" id="_i60"> Methyl 3-((4<i>R</i>)-2-Hydroxy-5,5-dimethyl-2-(oxido-<sup>18</sup>O)-1,3,2-dioxaphosphinane-4-carboxamido-<sup>15</sup>N)propanoate-1,2,3-<sup>13</sup>C<sub>3</sub> (<b>13</b>)</h3><div class="NLM_p last">Following the same procedure as <b>6</b>, using <b>12</b> (2.0 g, 5.1 mmol) afforded the title compound (1.5 g, 99%). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz, 300 K) δ 8.1–8.2 and 8.0–7.9 (m, 1H), 4.43 (s, 1H), 3.9–4.1 (m, 1H), 3.7–3.9 (m, 1H), 3.6–3.6 (m, 3H), 3.4–3.5 (m, 1H), 3.1–3.3 (m, 1H), 2.5–2.7 (m, 1H), 2.3–2.5 (m, 1H), 0.98 (s, 3H), 0.94 (s, 3H); <sup>31</sup>P NMR (162 MHz, DMSO-<i>d</i><sub>6</sub>, 300 K) δ −8.11.</div></div><div id="sec4_46" class="NLM_sec NLM_sec_level_2"><div id="ac_i61" class="anchor-spacer"></div><h3 class="article-section__title" id="_i61"> (((4<i>R</i>)-4-((3-Methoxy-3-oxopropyl-1,2,3-<sup>13</sup>C<sub>3</sub>)carbamoyl-<sup>15</sup>N)-5,5-dimethyl-2-(oxido-<sup>18</sup>O)-1,3,2-dioxaphosphinan-2-yl)oxy)methyl Pivalate (<b>2a</b> +6 amu)</h3><div class="NLM_p">Following the same procedure as <b>2a</b>, treatment of <b>13</b> (1.5 g, 5.1 mmol) with chloromethyl-2,2-dimethylpropanoate (1.3 mL, 8.7 mmol) afforded a mixture of diastereomers (5*:95) of the title compound (700 mg, 33%) as a colorless oil.</div><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>, 300 K) δ 7.08–7.02 and 6.84–6.78 (br s, 1H), 5.81–5.65 (m, 2H), 4.78–4.56 (m, 1H), 4.35–4.16 (m, 1H), 3.91–3.77 (m, 2H), 3.71 (s, 3H), 3.48–3.30 (m, 1H), 2.79–2.67 (m, 1H), 2.47–2.33 (m, 1H), 1.23 (s, 9H), 1.13 (s, 3H), 1.11 (s, 3H); <sup>31</sup>P NMR (162 MHz, CDCl<sub>3</sub>, 300 K) δ −5.38* and −9.27; UPLC <i>t</i><sub>R</sub> 1.47 and 1.52* min; MS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 416 [M + H]<sup>+</sup>.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-5"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i62"><a href="/doi/suppl/10.1021/acs.jmedchem.0c01531" class="ext-link">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_58746" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_58746" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge at <a href="/doi/10.1021/acs.jmedchem.0c01531?goto=supporting-info" class="ext-link">https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c01531</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Procedure for the PBEC BBB assay, assessment of the effect of compound <b>2a</b> on tubulin and histone acetylation, ROESY spectra of compound <b>1</b>, ROESY spectra of compound <b>2a</b>, X-ray crystal structure of compound <b>2a</b>, <sup>1</sup>H and <sup>31</sup>P NMR spectra of key compounds, and UPLC chromatograms of key compounds (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01531/suppl_file/jm0c01531_si_002.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01531/suppl_file/jm0c01531_si_001.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c01531/suppl_file/jm0c01531_si_001.csv">jm0c01531_si_001.csv (3.14 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c01531/suppl_file/jm0c01531_si_002.pdf">jm0c01531_si_002.pdf (15.08 MB)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.0c01531" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_32282" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_32282" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Daniel Elbaum</span> - <span class="hlFld-Affiliation affiliation">Travere, 3721 Valley Centre Drive, San Diego, California 92130, United States</span>; 
    <span>Present Address:
                        QurAlis, 100 Cambridgepark Drive, Suite 500, Cambridge, Massachusetts 02140, United States (D.E.)</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-6012-7965" title="Orcid link">http://orcid.org/0000-0002-6012-7965</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#ee8a8a8b828c8f9b83ae89838f8782c08d8183"><span class="__cf_email__" data-cfemail="e88c8c8d848a899d85a88f85898184c68b8785">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Giulio Auciello</span> - <span class="hlFld-Affiliation affiliation">Departments
of Chemistry and Biology, IRBM Science Park, Via Pontina km 30,600, 00071 Pomezia, Rome, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Annalise Di Marco</span> - <span class="hlFld-Affiliation affiliation">Departments
of Chemistry and Biology, IRBM Science Park, Via Pontina km 30,600, 00071 Pomezia, Rome, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Odalys Gonzalez Paz</span> - <span class="hlFld-Affiliation affiliation">Departments
of Chemistry and Biology, IRBM Science Park, Via Pontina km 30,600, 00071 Pomezia, Rome, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Savina Malancona</span> - <span class="hlFld-Affiliation affiliation">Departments
of Chemistry and Biology, IRBM Science Park, Via Pontina km 30,600, 00071 Pomezia, Rome, Italy</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-5388-6533" title="Orcid link">http://orcid.org/0000-0002-5388-6533</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Steven Harper</span> - <span class="hlFld-Affiliation affiliation">Departments
of Chemistry and Biology, IRBM Science Park, Via Pontina km 30,600, 00071 Pomezia, Rome, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Maria Beconi</span> - <span class="hlFld-Affiliation affiliation">Travere, 3721 Valley Centre Drive, San Diego, California 92130, United States</span>; 
    <span>Present Address:
                        Disc Medicine, 150 Cambridgepark Drive, Suite 103, Cambridge, Massachusetts 02140, United States (M.B.)</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ilaria Rossetti</span> - <span class="hlFld-Affiliation affiliation">Departments
of Chemistry and Biology, IRBM Science Park, Via Pontina km 30,600, 00071 Pomezia, Rome, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Alina Ciammaichella</span> - <span class="hlFld-Affiliation affiliation">Departments
of Chemistry and Biology, IRBM Science Park, Via Pontina km 30,600, 00071 Pomezia, Rome, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Paola Fezzardi</span> - <span class="hlFld-Affiliation affiliation">Departments
of Chemistry and Biology, IRBM Science Park, Via Pontina km 30,600, 00071 Pomezia, Rome, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Andrea Vecchi</span> - <span class="hlFld-Affiliation affiliation">Departments
of Chemistry and Biology, IRBM Science Park, Via Pontina km 30,600, 00071 Pomezia, Rome, Italy</span>; 
    <span>Present Address:
                        Birra Peroni, Rome Plant, Via Renato Birolli 8, 00155 Rome, Italy (A.V.)</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Elena Bracacel</span> - <span class="hlFld-Affiliation affiliation">Departments
of Chemistry and Biology, IRBM Science Park, Via Pontina km 30,600, 00071 Pomezia, Rome, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Daniel Cicero</span> - <span class="hlFld-Affiliation affiliation">Departments
of Chemistry and Biology, IRBM Science Park, Via Pontina km 30,600, 00071 Pomezia, Rome, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Edith Monteagudo</span> - <span class="hlFld-Affiliation affiliation">Departments
of Chemistry and Biology, IRBM Science Park, Via Pontina km 30,600, 00071 Pomezia, Rome, Italy</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d7e5059-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i66">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_88021" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_88021" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The authors thank Mabel Tse, Lachy McClean, Feriandis Greblikas, and Bob Ternansky for a critical reading of the manuscript, and Bill Rote for both a critical reading of the manuscript and shepherding it through the internal Travere publication system.</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations</td></tr><tr><td class="NLM_term">DIEA</td><td class="NLM_def"><p class="first last">diisopropylethylamine</p></td></tr><tr><td class="NLM_term">MRP</td><td class="NLM_def"><p class="first last">human multidrug resistance protein</p></td></tr><tr><td class="NLM_term">NBIA</td><td class="NLM_def"><p class="first last">neurodegeneration with brain iron accumulation</p></td></tr><tr><td class="NLM_term">PanK</td><td class="NLM_def"><p class="first last">pantothenate kinase</p></td></tr><tr><td class="NLM_term">PANK</td><td class="NLM_def"><p class="first last">gene encoding pantothenate kinase</p></td></tr><tr><td class="NLM_term">PBEC</td><td class="NLM_def"><p class="first last">porcine brain endothelial cells</p></td></tr><tr><td class="NLM_term">PKAN</td><td class="NLM_def"><p class="first last">pantothenate kinase-associated neurodegeneration</p></td></tr><tr><td class="NLM_term">POC</td><td class="NLM_def"><p class="first last">phosphonyloxycarbonate</p></td></tr><tr><td class="NLM_term">POM</td><td class="NLM_def"><p class="first last">pivaloyloxymethyl</p></td></tr><tr><td class="NLM_term">PPA</td><td class="NLM_def"><p class="first last">phosphopantothenic acid</p></td></tr><tr><td class="NLM_term">TEA</td><td class="NLM_def"><p class="first last">triethylamine</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i69">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_53868" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_53868" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 32 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gregory, A.</span>; <span class="NLM_string-name">Hayflick, S. J.</span></span> <span> </span><span class="NLM_article-title">Pantothenate Kinase-Associated Neurodegeneration Summary</span>.  <i>GeneReviews</i>; <span class="NLM_publisher-name">University of Washington</span>, <span class="NLM_year">2020</span>; pp  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">20</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2020&pages=1-20&author=A.+Gregory&author=S.+J.+Hayflick&title=GeneReviews"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DGregory%26aufirst%3DA.%26atitle%3DPantothenate%2520Kinase-Associated%2520Neurodegeneration%2520Summary%26btitle%3DGeneReviews%26pub%3DUniversity%2520of%2520Washington%26date%3D2020%26spage%3D1%26epage%3D20" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gregory, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayflick, S. J.</span></span> <span> </span><span class="NLM_article-title">Neurodegeneration with Brain Iron Accumulation</span>. <i>Folia Neuropathol.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>43</i></span>,  <span class="NLM_fpage">286</span>– <span class="NLM_lpage">296</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01531&amp;key=16416393" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01531&amp;key=1%3ACAS%3A528%3ADC%252BD28XhsFGjtrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2005&pages=286-296&author=A.+Gregoryauthor=S.+J.+Hayflick&title=Neurodegeneration+with+Brain+Iron+Accumulation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Neurodegeneration with brain iron accumulation</span></div><div class="casAuthors">Gregory, Allison; Hayflick, Susan J.</div><div class="citationInfo"><span class="NLM_cas:title">Folia Neuropathologica</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">286-296</span>CODEN:
                <span class="NLM_cas:coden">FONEEW</span>;
        ISSN:<span class="NLM_cas:issn">1641-4640</span>.
    
            (<span class="NLM_cas:orgname">Termedia Publishing House</span>)
        </div><div class="casAbstract">A review.  Neurodegeneration with brain iron accumulation (NBIA) describes a group of progressive extrapyramidal disorders with radiog. evidence of focal iron accumulation in the brain, usually in the basal ganglia.  Patients previously diagnosed with Hallervorden-Spatz syndrome fall into this category.  Mutations in the PANK2 gene account for the majority of NBIA cases and cause an autosomal recessive inborn error of CoA metab. called pantothenate kinase-assocd. neurodegeneration (PKAN).  PKAN is characterized by dystonia and pigmentary retinopathy in children or speech and neuropsychiatric disorders in adults.  In addn., a specific pattern on brain MRI, called the eye-of-the-tiger sign, is virtually pathognomonic for the disease.  Pantothenate kinase is essential to CoA biosynthesis, and the PANK2 protein is targeted to the mitochondria.  Hypotheses of PKAN pathogenesis are based on the predictions of tissue-specific CoA deficiency and the accumulation of cysteine-contg. substrates.  Identification of the major NBIA gene has led to more accurate clin. delineation of the diseases that comprise this group, a mol. diagnostic test for PKAN, and hypotheses for treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr0VuJqV4J_mbVg90H21EOLACvtfcHk0lic7MaiwztWjw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhsFGjtrw%253D&md5=92f500411aed9f540a74c3b46ee4581e</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGregory%26aufirst%3DA.%26aulast%3DHayflick%26aufirst%3DS.%2BJ.%26atitle%3DNeurodegeneration%2520with%2520Brain%2520Iron%2520Accumulation%26jtitle%3DFolia%2520Neuropathol.%26date%3D2005%26volume%3D43%26spage%3D286%26epage%3D296" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hayflick, S. J.</span></span> <span> </span><span class="NLM_article-title">Unraveling the Hallervorden-Spatz Syndrome: Pantothenate Kinase-Associated Neurodegeneration Is the Name</span>. <i>Curr. Opin. Pediatr.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">572</span>– <span class="NLM_lpage">577</span>, <span class="refDoi"> DOI: 10.1097/00008480-200312000-00005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01531&amp;key=10.1097%2F00008480-200312000-00005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01531&amp;key=14631201" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01531&amp;key=1%3ACAS%3A280%3ADC%252BD3srltVGhug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2003&pages=572-577&author=S.+J.+Hayflick&title=Unraveling+the+Hallervorden-Spatz+Syndrome%3A+Pantothenate+Kinase-Associated+Neurodegeneration+Is+the+Name&doi=10.1097%2F00008480-200312000-00005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Unraveling the Hallervorden-Spatz syndrome: pantothenate kinase-associated neurodegeneration is the name</span></div><div class="casAuthors">Hayflick Susan J</div><div class="citationInfo"><span class="NLM_cas:title">Current opinion in pediatrics</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">572-7</span>
        ISSN:<span class="NLM_cas:issn">1040-8703</span>.
    </div><div class="casAbstract">PURPOSE OF REVIEW:  After the recent discovery of the major genetic defect in neurodegeneration with brain iron accumulation (NBIA, formerly Hallervorden-Spatz syndrome), this heterogeneous group of disorders can now be differentiated by clinical, radiographic, and molecular features.  RECENT FINDINGS:  Disease caused by mutations in the gene encoding pantothenate kinase 2 (PANK2) is characterized by dystonia and pigmentary retinopathy in children or speech and neuropsychiatric defects in adults, in concert with a specific pattern on MRI of the brain.  This virtually pathognomonic radiographic abnormality, called the eye-of-the-tiger sign, comprises hyperintensities within a hypointense medial globus pallidus on T2-weighted images.  This disorder is called pantothenate kinase-associated neurodegeneration (PKAN) and accounts for most patients diagnosed with NBIA.  Pantothenate kinase is essential to coenzyme A biosynthesis, and PANK2 is targeted to mitochondria, a feature that distinguishes it from the three other human pantothenate kinase homologs.  Hypotheses of PKAN pathogenesis are based on the predictions of tissue-specific coenzyme A deficiency and the accumulation of cysteine-containing enzyme substrates, which may chelate iron and lead to the cardinal disease feature of basal ganglia iron accumulation.  SUMMARY:  Recent insight into the biochemical basis of PKAN has led to novel ideas for rational therapies.  Investigations are under way to enable testing of promising compounds, first in animal models of disease and then in human patients.  Identification of the genetic basis for the major form of NBIA has allowed more accurate clinical delineation of the specific diseases that compose this group, a new molecular diagnostic test for PKAN, and hypotheses for treatment of this neurodegenerative disorder.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ2ws0xWEcUgJZoeNcnHOQ9fW6udTcc2eYoXPBTNIyWUbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3srltVGhug%253D%253D&md5=f577dd69985cd9ec5d32e614adeb0524</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1097%2F00008480-200312000-00005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252F00008480-200312000-00005%26sid%3Dliteratum%253Aachs%26aulast%3DHayflick%26aufirst%3DS.%2BJ.%26atitle%3DUnraveling%2520the%2520Hallervorden-Spatz%2520Syndrome%253A%2520Pantothenate%2520Kinase-Associated%2520Neurodegeneration%2520Is%2520the%2520Name%26jtitle%3DCurr.%2520Opin.%2520Pediatr.%26date%3D2003%26volume%3D15%26spage%3D572%26epage%3D577%26doi%3D10.1097%2F00008480-200312000-00005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schneider, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hardy, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhatia, K. P.</span></span> <span> </span><span class="NLM_article-title">Syndromes of Neurodegeneration with Brain Iron Accumulation (NBIA): An Update on Clinical Presentations, Histological and Genetic Underpinnings, and Treatment Considerations</span>. <i>Mov. Disord.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_fpage">42</span>– <span class="NLM_lpage">53</span>, <span class="refDoi"> DOI: 10.1002/mds.23971</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01531&amp;key=10.1002%2Fmds.23971" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01531&amp;key=22031173" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01531&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsVWms7fE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&pages=42-53&author=S.+A.+Schneiderauthor=J.+Hardyauthor=K.+P.+Bhatia&title=Syndromes+of+Neurodegeneration+with+Brain+Iron+Accumulation+%28NBIA%29%3A+An+Update+on+Clinical+Presentations%2C+Histological+and+Genetic+Underpinnings%2C+and+Treatment+Considerations&doi=10.1002%2Fmds.23971"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Syndromes of neurodegeneration with brain iron accumulation (NBIA): An update on clinical presentations, histological and genetic underpinnings, and treatment considerations</span></div><div class="casAuthors">Schneider, Susanne A.; Hardy, John; Bhatia, Kailash P.</div><div class="citationInfo"><span class="NLM_cas:title">Movement Disorders</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">42-53</span>CODEN:
                <span class="NLM_cas:coden">MOVDEA</span>;
        ISSN:<span class="NLM_cas:issn">0885-3185</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  In recent years, understanding of the syndromes of neurodegeneration with brain iron accumulation (NBIA) has grown considerably.  In addn. to the core syndromes of pantothenate kinase-assocd. neurodegeneration (PKAN, NBIA1) and PLA2G6-assocd. neurodegeneration (PLAN, NBIA2), several other genetic causes have been identified.  The acknowledged clin. spectrum has broadened, age-dependent presentations have been recognized, and we are becoming aware of overlap between the different NBIA disorders as well as with other diseases.  Autopsy examn. of genetically confirmed cases has demonstrated Lewy bodies and/or tangles in some subforms, bridging the gap to more common neurodegenerative disorders such as Parkinson's disease.  NBIA genes map into related pathways, the understanding of which is important as we move toward mechanistic therapies.  Our aim in this review is to provide an overview of not only the historical developments, clin. features, investigational findings, and therapeutic results but also the genetic and mol. underpinnings of the NBIA syndromes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpsEQAFVWHgVLVg90H21EOLACvtfcHk0liZLBw2TmMUgw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsVWms7fE&md5=d9521a3a413b181f70bc2cb6f4cfc3a7</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1002%2Fmds.23971&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fmds.23971%26sid%3Dliteratum%253Aachs%26aulast%3DSchneider%26aufirst%3DS.%2BA.%26aulast%3DHardy%26aufirst%3DJ.%26aulast%3DBhatia%26aufirst%3DK.%2BP.%26atitle%3DSyndromes%2520of%2520Neurodegeneration%2520with%2520Brain%2520Iron%2520Accumulation%2520%2528NBIA%2529%253A%2520An%2520Update%2520on%2520Clinical%2520Presentations%252C%2520Histological%2520and%2520Genetic%2520Underpinnings%252C%2520and%2520Treatment%2520Considerations%26jtitle%3DMov.%2520Disord.%26date%3D2012%26spage%3D42%26epage%3D53%26doi%3D10.1002%2Fmds.23971" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Alfonso-Pecchio, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garcia, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leonardi, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jackowski, S.</span></span> <span> </span><span class="NLM_article-title">Compartmentalization of Mammalian Pantothenate Kinases</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>7</i></span>, <span class="NLM_elocation-id">e49509</span> <span class="refDoi"> DOI: 10.1371/journal.pone.0049509</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01531&amp;key=10.1371%2Fjournal.pone.0049509" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01531&amp;key=23152917" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01531&amp;key=1%3ACAS%3A528%3ADC%252BC38XhslKjtbfE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&author=A.+Alfonso-Pecchioauthor=M.+Garciaauthor=R.+Leonardiauthor=S.+Jackowski&title=Compartmentalization+of+Mammalian+Pantothenate+Kinases&doi=10.1371%2Fjournal.pone.0049509"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Compartmentalization of mammalian pantothenate kinases</span></div><div class="casAuthors">Alfonso-Pecchio, Adolfo; Garcia, Matthew; Leonardi, Roberta; Jackowski, Suzanne</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">e49509</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">The pantothenate kinases (PanK) catalyze the first and the rate-limiting step in CoA biosynthesis and regulate the amt. of CoA in tissues by differential isoform expression and allosteric interaction with metabolic ligands.  The four human and mouse PanK proteins share a homologous carboxy-terminal catalytic domain, but differ in their amino-termini.  These unique termini direct the isoforms to different subcellular compartments.  PanK1α isoforms were exclusively nuclear, with preferential assocn. with the granular component of the nucleolus during interphase.  PanK1α also assocd. with the peri-chromosomal region in condensing chromosomes during mitosis.  The PanK1β and PanK3 isoforms were cytosolic, with a portion of PanK1β assocd. with clathrin-assocd. vesicles and recycling endosomes.  Human PanK2, known to assoc. with mitochondria, was specifically localized to the inter-membrane space.  Human PanK2 was also detected in the nucleus and functional nuclear localization and export signals were identified and exptl. confirmed.  Nuclear PanK2 trafficked from the nucleus to the mitochondria, but not in the other direction and was absent from the nucleus during G2 phase of the cell cycle.  The localization of human PanK2 in these two compartments was in sharp contrast to mouse PanK2, which was exclusively cytosolic.  These data demonstrate that PanK isoforms are differentially compartmentalized allowing them to sense CoA homeostasis in different cellular compartments and enable interaction with regulatory ligands produced in these same locations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpmsISxggccgLVg90H21EOLACvtfcHk0lg3ZpAqMpKe2Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhslKjtbfE&md5=bd1a9741beacbf1181ecf99d80dcc338</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0049509&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0049509%26sid%3Dliteratum%253Aachs%26aulast%3DAlfonso-Pecchio%26aufirst%3DA.%26aulast%3DGarcia%26aufirst%3DM.%26aulast%3DLeonardi%26aufirst%3DR.%26aulast%3DJackowski%26aufirst%3DS.%26atitle%3DCompartmentalization%2520of%2520Mammalian%2520Pantothenate%2520Kinases%26jtitle%3DPLoS%2520One%26date%3D2012%26volume%3D7%26doi%3D10.1371%2Fjournal.pone.0049509" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gregory, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Polster, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayflick, S. J.</span></span> <span> </span><span class="NLM_article-title">Clinical and Genetic Delineation of Neurodegeneration with Brain Iron Accumulation</span>. <i>J. Med. Genet.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>46</i></span>,  <span class="NLM_fpage">73</span>– <span class="NLM_lpage">80</span>, <span class="refDoi"> DOI: 10.1136/jmg.2008.061929</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01531&amp;key=10.1136%2Fjmg.2008.061929" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01531&amp;key=18981035" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2008&pages=73-80&author=A.+Gregoryauthor=B.+J.+Polsterauthor=S.+J.+Hayflick&title=Clinical+and+Genetic+Delineation+of+Neurodegeneration+with+Brain+Iron+Accumulation&doi=10.1136%2Fjmg.2008.061929"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1136%2Fjmg.2008.061929&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1136%252Fjmg.2008.061929%26sid%3Dliteratum%253Aachs%26aulast%3DGregory%26aufirst%3DA.%26aulast%3DPolster%26aufirst%3DB.%2BJ.%26aulast%3DHayflick%26aufirst%3DS.%2BJ.%26atitle%3DClinical%2520and%2520Genetic%2520Delineation%2520of%2520Neurodegeneration%2520with%2520Brain%2520Iron%2520Accumulation%26jtitle%3DJ.%2520Med.%2520Genet.%26date%3D2008%26volume%3D46%26spage%3D73%26epage%3D80%26doi%3D10.1136%2Fjmg.2008.061929" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Martinez, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsuchiya, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gout, I.</span></span> <span> </span><span class="NLM_article-title">Coenzyme A Biosynthetic Machinery in Mammalian Cells</span>. <i>Biochem. Soc. Trans.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>42</i></span>,  <span class="NLM_fpage">1112</span>– <span class="NLM_lpage">1117</span>, <span class="refDoi"> DOI: 10.1042/BST20140124</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01531&amp;key=10.1042%2FBST20140124" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01531&amp;key=25110011" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01531&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtlWktLnI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2014&pages=1112-1117&author=D.+L.+Martinezauthor=Y.+Tsuchiyaauthor=I.+Gout&title=Coenzyme+A+Biosynthetic+Machinery+in+Mammalian+Cells&doi=10.1042%2FBST20140124"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Coenzyme A biosynthetic machinery in mammalian cells</span></div><div class="casAuthors">Martinez, David Lopez; Tsuchiya, Yugo; Gout, Ivan</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Society Transactions</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1112-1117</span>CODEN:
                <span class="NLM_cas:coden">BCSTB5</span>;
        ISSN:<span class="NLM_cas:issn">0300-5127</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">A review.  CoA is an essential cofactor in all living organisms.  CoA and its thioester derivs. [acetyl-CoA, malonyl-CoA, HMG-CoA (3-hydroxy-3-methylglutaryl-CoA), etc.] participate in diverse anabolic and catabolic pathways, allosteric regulatory interactions and the regulation of gene expression.  The biosynthesis of CoA requires pantothenic acid, cysteine and ATP, and involves five enzymic steps that are highly conserved from prokaryotes to eukaryotes.  The intracellular levels of CoA and its derivs. change in response to extracellular stimuli, stresses and metabolites, and in human pathologies, such as cancer, metabolic disorders and neurodegeneration.  In the present mini-review, the authors describe the current understanding of the CoA biosynthetic pathway, provide a detailed overview on expression and subcellular localization of enzymes implicated in CoA biosynthesis, their regulation and the potential to form multi-enzyme complexes for efficient and highly coordinated biosynthetic process.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpYuPC0UHqMr7Vg90H21EOLACvtfcHk0lg3ZpAqMpKe2Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtlWktLnI&md5=f448cf2e4f54db3275c3262f10dda583</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1042%2FBST20140124&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252FBST20140124%26sid%3Dliteratum%253Aachs%26aulast%3DMartinez%26aufirst%3DD.%2BL.%26aulast%3DTsuchiya%26aufirst%3DY.%26aulast%3DGout%26aufirst%3DI.%26atitle%3DCoenzyme%2520A%2520Biosynthetic%2520Machinery%2520in%2520Mammalian%2520Cells%26jtitle%3DBiochem.%2520Soc.%2520Trans.%26date%3D2014%26volume%3D42%26spage%3D1112%26epage%3D1117%26doi%3D10.1042%2FBST20140124" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Orellana, D. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santambrogio, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rubio, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yekhlef, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cancellieri, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dusi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giannelli, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Venco, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mazzara, P. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cozzi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferrari, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garavaglia, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taverna, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tiranti, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Broccoli, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Levi, S.</span></span> <span> </span><span class="NLM_article-title">Coenzyme A Corrects Pathological Defects in Human Neurons of PANK 2-associated Neurodegeneration</span>. <i>EMBO Mol. Med.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">1197</span>– <span class="NLM_lpage">1211</span>, <span class="refDoi"> DOI: 10.15252/emmm.201606391</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01531&amp;key=10.15252%2Femmm.201606391" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01531&amp;key=27516453" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01531&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtlaitbjF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2016&pages=1197-1211&author=D.+I.+Orellanaauthor=P.+Santambrogioauthor=A.+Rubioauthor=L.+Yekhlefauthor=C.+Cancellieriauthor=S.+Dusiauthor=S.+G.+Giannelliauthor=P.+Vencoauthor=P.+G.+Mazzaraauthor=A.+Cozziauthor=M.+Ferrariauthor=B.+Garavagliaauthor=S.+Tavernaauthor=V.+Tirantiauthor=V.+Broccoliauthor=S.+Levi&title=Coenzyme+A+Corrects+Pathological+Defects+in+Human+Neurons+of+PANK+2-associated+Neurodegeneration&doi=10.15252%2Femmm.201606391"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Coenzyme A corrects pathological defects in human neurons of PANK2-associated neurodegeneration</span></div><div class="casAuthors">Orellana, Daniel I.; Santambrogio, Paolo; Rubio, Alicia; Yekhlef, Latefa; Cancellieri, Cinzia; Dusi, Sabrina; Giannelli, Serena G.; Venco, Paola; Mazzara, Pietro G.; Cozzi, Anna; Ferrari, Maurizio; Garavaglia, Barbara; Taverna, Stefano; Tiranti, Valeria; Broccoli, Vania; Levi, Sonia</div><div class="citationInfo"><span class="NLM_cas:title">EMBO Molecular Medicine</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1197-1211</span>CODEN:
                <span class="NLM_cas:coden">EMMMAM</span>;
        ISSN:<span class="NLM_cas:issn">1757-4684</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Pantothenate kinase-assocd. neurodegeneration (PKAN) is an early onset and severely disabling neurodegenerative disease for which no therapy is available.  PKAN is caused by mutations in PANK2, which encodes for the mitochondrial enzyme pantothenate kinase 2.  Its function is to catalyze the first limiting step of CoA (CoA) biosynthesis.  We generated induced pluripotent stem cells from PKAN patients and showed that their derived neurons exhibited premature death, increased ROS prodn., mitochondrial dysfunctions-including impairment of mitochondrial iron-dependent biosynthesis-and major membrane excitability defects.  CoA supplementation prevented neuronal death and ROS formation by restoring mitochondrial and neuronal functionality.  Our findings provide direct evidence that PANK2 malfunctioning is responsible for abnormal phenotypes in human neuronal cells and indicate CoA treatment as a possible therapeutic intervention.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp1Jz34zLslsrVg90H21EOLACvtfcHk0lg3ZpAqMpKe2Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtlaitbjF&md5=07cfdaacde87106b2b06a30886c6ea18</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.15252%2Femmm.201606391&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.15252%252Femmm.201606391%26sid%3Dliteratum%253Aachs%26aulast%3DOrellana%26aufirst%3DD.%2BI.%26aulast%3DSantambrogio%26aufirst%3DP.%26aulast%3DRubio%26aufirst%3DA.%26aulast%3DYekhlef%26aufirst%3DL.%26aulast%3DCancellieri%26aufirst%3DC.%26aulast%3DDusi%26aufirst%3DS.%26aulast%3DGiannelli%26aufirst%3DS.%2BG.%26aulast%3DVenco%26aufirst%3DP.%26aulast%3DMazzara%26aufirst%3DP.%2BG.%26aulast%3DCozzi%26aufirst%3DA.%26aulast%3DFerrari%26aufirst%3DM.%26aulast%3DGaravaglia%26aufirst%3DB.%26aulast%3DTaverna%26aufirst%3DS.%26aulast%3DTiranti%26aufirst%3DV.%26aulast%3DBroccoli%26aufirst%3DV.%26aulast%3DLevi%26aufirst%3DS.%26atitle%3DCoenzyme%2520A%2520Corrects%2520Pathological%2520Defects%2520in%2520Human%2520Neurons%2520of%2520PANK%25202-associated%2520Neurodegeneration%26jtitle%3DEMBO%2520Mol.%2520Med.%26date%3D2016%26volume%3D8%26spage%3D1197%26epage%3D1211%26doi%3D10.15252%2Femmm.201606391" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zano, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pate, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frank, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rock, C. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jackowski, S.</span></span> <span> </span><span class="NLM_article-title">Correction of a Genetic Deficiency in Pantothenate Kinase 1 Using Phosphopantothenate Replacement Therapy</span>. <i>Mol. Genet. Metab.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>116</i></span>,  <span class="NLM_fpage">281</span>– <span class="NLM_lpage">288</span>, <span class="refDoi"> DOI: 10.1016/j.ymgme.2015.10.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01531&amp;key=10.1016%2Fj.ymgme.2015.10.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01531&amp;key=26549575" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01531&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsl2gsr7I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=116&publication_year=2015&pages=281-288&author=S.+P.+Zanoauthor=C.+Pateauthor=M.+Frankauthor=C.+O.+Rockauthor=S.+Jackowski&title=Correction+of+a+Genetic+Deficiency+in+Pantothenate+Kinase+1+Using+Phosphopantothenate+Replacement+Therapy&doi=10.1016%2Fj.ymgme.2015.10.011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Correction of a genetic deficiency in pantothenate kinase 1 using phosphopantothenate replacement therapy</span></div><div class="casAuthors">Zano, Stephen P.; Pate, Caroline; Frank, Matthew; Rock, Charles O.; Jackowski, Suzanne</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Genetics and Metabolism</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">116</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">281-288</span>CODEN:
                <span class="NLM_cas:coden">MGMEFF</span>;
        ISSN:<span class="NLM_cas:issn">1096-7192</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">CoA (CoA) is a ubiquitous cofactor involved in numerous essential biochem. transformations, and along with its thioesters is a key regulator of intermediary metab.  Pantothenate (vitamin B5) phosphorylation by pantothenate kinase (PanK) is thought to control the rate of CoA prodn.  Pantothenate kinase assocd. neurodegeneration is a hereditary disease that arises from mutations that inactivate the human PANK2 gene.  Aryl phosphoramidate phosphopantothenate derivs. were prepd. to test the feasibility of using phosphopantothenate replacement therapy to bypass the genetic deficiency in the Pank1-/- mouse model.  The efficacies of candidate compds. were first compared by measuring the ability to increase CoA levels in Pank1-/- mouse embryo fibroblasts.  Administration of selected candidate compds. to Pank1-/- mice cor. their deficiency in hepatic CoA.  The PanK bypass was confirmed by the incorporation of intact phosphopantothenate into CoA using triple-isotopically labeled compd.  These results provide strong support for PanK as a master regulator of intracellular CoA and illustrate the feasibility of employing PanK bypass therapy to restore CoA levels in genetically deficient mice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAw1zJ--PYOrVg90H21EOLACvtfcHk0lgB3TIPFoflvg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsl2gsr7I&md5=f98bdbc9d7ca784c0cc1e9009beda55b</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1016%2Fj.ymgme.2015.10.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ymgme.2015.10.011%26sid%3Dliteratum%253Aachs%26aulast%3DZano%26aufirst%3DS.%2BP.%26aulast%3DPate%26aufirst%3DC.%26aulast%3DFrank%26aufirst%3DM.%26aulast%3DRock%26aufirst%3DC.%2BO.%26aulast%3DJackowski%26aufirst%3DS.%26atitle%3DCorrection%2520of%2520a%2520Genetic%2520Deficiency%2520in%2520Pantothenate%2520Kinase%25201%2520Using%2520Phosphopantothenate%2520Replacement%2520Therapy%26jtitle%3DMol.%2520Genet.%2520Metab.%26date%3D2015%26volume%3D116%26spage%3D281%26epage%3D288%26doi%3D10.1016%2Fj.ymgme.2015.10.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Elbaum, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beconi, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monteagudo, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di Marco, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quinton, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lyons, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vaino, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harper, S.</span></span> <span> </span><span class="NLM_article-title">Fosmetpantotenate (RE-024), a Phosphopantothenate Replacement Therapy for Pantothenate Kinase-Associated Neurodegeneration: Mechanism of Action and Efficacy in Nonclinical Models</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>13</i></span>, <span class="NLM_elocation-id">e0192028</span> <span class="refDoi"> DOI: 10.1371/journal.pone.0192028</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01531&amp;key=10.1371%2Fjournal.pone.0192028" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01531&amp;key=29522513" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01531&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhslWms73E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2018&author=D.+Elbaumauthor=M.+G.+Beconiauthor=E.+Monteagudoauthor=A.+Di+Marcoauthor=M.+S.+Quintonauthor=K.+A.+Lyonsauthor=A.+Vainoauthor=S.+Harper&title=Fosmetpantotenate+%28RE-024%29%2C+a+Phosphopantothenate+Replacement+Therapy+for+Pantothenate+Kinase-Associated+Neurodegeneration%3A+Mechanism+of+Action+and+Efficacy+in+Nonclinical+Models&doi=10.1371%2Fjournal.pone.0192028"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Fosmetpantotenate (RE-024), a phosphopantothenate replacement therapy for pantothenate kinase-associated neurodegeneration: mechanism of action and efficacy in nonclinical models</span></div><div class="casAuthors">Elbaum, Daniel; Beconi, Maria G.; Monteagudo, Edith; Di Marco, Annalise; Quinton, Maria S.; Lyons, Kathryn A.; Vaino, Andrew; Harper, Steven</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">e0192028/1-e0192028/27</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">In cells, phosphorylation of pantothenic acid to generate phosphopantothenic acid by the pantothenate kinase enzymes is the first step in CoA synthesis.  Pantothenate kinase 2, the isoform localized in neuronal cell mitochondria, is dysfunctional in patients with pantothenate kinase-assocd. neurodegeneration.  Fosmetpantotenate is a phosphopantothenic acid prodrug in clin. development for treatment of pantothenate kinase-assocd. neurodegeneration, which aims to replenish phosphopantothenic acid in patients.  Fosmetpantotenate restored CoA in short-hairpin RNA pantothenate kinase 2 gene-silenced neuroblastoma cells and was permeable in a blood-brain barrier model.  The rate of fosmetpantotenate metab. in blood is species-dependent.  Following up to 700 mg/kg orally, blood exposure to fosmetpantotenate was negligible in rat and mouse, but measurable in monkey.  Consistent with the difference in whole blood half-life, fosmetpantotenate dosed orally was found in the brains of the monkey (striatal dialyzate) but was absent in mice.  Following administration of isotopically labeled-fosmetpantotenate to mice, ∼40% of liver CoA (after 500 mg/kg orally) and ∼50% of brain CoA (after 125μg intrastriatally) originated from isotopically labeled-fosmetpantotenate.  Addnl., 10-day dosing of isotopically labeled-fosmetpantotenate, 12.5μg, intracerebroventricularly in mice led to ∼30% of brain CoA contg. the stable isotopic labels.  This work supports the hypothesis that fosmetpantotenate acts to replace reduced phosphopantothenic acid in pantothenate kinase 2-deficient tissues.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpYI2R0GKG5qrVg90H21EOLACvtfcHk0lgB3TIPFoflvg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhslWms73E&md5=1bab5d1617cd78ff1bcffa17ab9d4a52</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0192028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0192028%26sid%3Dliteratum%253Aachs%26aulast%3DElbaum%26aufirst%3DD.%26aulast%3DBeconi%26aufirst%3DM.%2BG.%26aulast%3DMonteagudo%26aufirst%3DE.%26aulast%3DDi%2BMarco%26aufirst%3DA.%26aulast%3DQuinton%26aufirst%3DM.%2BS.%26aulast%3DLyons%26aufirst%3DK.%2BA.%26aulast%3DVaino%26aufirst%3DA.%26aulast%3DHarper%26aufirst%3DS.%26atitle%3DFosmetpantotenate%2520%2528RE-024%2529%252C%2520a%2520Phosphopantothenate%2520Replacement%2520Therapy%2520for%2520Pantothenate%2520Kinase-Associated%2520Neurodegeneration%253A%2520Mechanism%2520of%2520Action%2520and%2520Efficacy%2520in%2520Nonclinical%2520Models%26jtitle%3DPLoS%2520One%26date%3D2018%26volume%3D13%26doi%3D10.1371%2Fjournal.pone.0192028" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Klopstock, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Escolar, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marshall, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perez-Dueñas, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tuller, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Videnovic, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greblikas, F.</span></span> <span> </span><span class="NLM_article-title">The FOsmetpantotenate Replacement Therapy (FORT) Randomized, Double-Blind, Placebo-Controlled Pivotal Trial: Study Design and Development Methodology of a Novel Primary Efficacy Outcome in Patients with Pantothenate Kinase-Associated Neurodegeneration</span>. <i>Clin. Trials</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">410</span>– <span class="NLM_lpage">418</span>, <span class="refDoi"> DOI: 10.1177/1740774519845673</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01531&amp;key=10.1177%2F1740774519845673" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01531&amp;key=31055958" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01531&amp;key=1%3ACAS%3A280%3ADC%252BB3M7isFSlsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2019&pages=410-418&author=T.+Klopstockauthor=M.+L.+Escolarauthor=R.+D.+Marshallauthor=B.+Perez-Due%C3%B1asauthor=S.+Tullerauthor=A.+Videnovicauthor=F.+Greblikas&title=The+FOsmetpantotenate+Replacement+Therapy+%28FORT%29+Randomized%2C+Double-Blind%2C+Placebo-Controlled+Pivotal+Trial%3A+Study+Design+and+Development+Methodology+of+a+Novel+Primary+Efficacy+Outcome+in+Patients+with+Pantothenate+Kinase-Associated+Neurodegeneration&doi=10.1177%2F1740774519845673"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">The FOsmetpantotenate Replacement Therapy (FORT) randomized, double-blind, Placebo-controlled pivotal trial: Study design and development methodology of a novel primary efficacy outcome in patients with pantothenate kinase-associated neurodegeneration</span></div><div class="casAuthors">Klopstock Thomas; Klopstock Thomas; Klopstock Thomas; Escolar Maria L; Marshall Randall D; Tuller Sarah; Perez-Duenas Belen; Videnovic Aleksandar; Greblikas Feriandas</div><div class="citationInfo"><span class="NLM_cas:title">Clinical trials (London, England)</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">410-418</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND/AIMS:  Pantothenate kinase-associated neurodegeneration is a rare neurodegenerative disease with a variable clinical phenotype.  Fosmetpantotenate is in clinical development as a replacement therapy that targets the underlying cause of pantothenate kinase-associated neurodegeneration.  The FOsmetpantotenate Replacement Therapy pivotal trial-an ongoing phase 3, randomized, double-blind, placebo-controlled, multicenter trial-examines the efficacy and safety of fosmetpantotenate in patients with pantothenate kinase-associated neurodegeneration aged 6-65 years.  The FOsmetpantotenate Replacement Therapy trial required the development and validation of a novel patient-reported outcome measure specifically relevant to pantothenate kinase-associated neurodegeneration.  The Pantothenate Kinase-Associated Neurodegeneration-Activities of Daily Living scale was developed to assess activities of daily living related to motor functioning in patients with pantothenate kinase-associated neurodegeneration to evaluate clinically meaningful change as the primary efficacy endpoint in clinical trials.  This article describes the design of the FOsmetpantotenate Replacement Therapy pivotal trial and the development of the Pantothenate Kinase-Associated Neurodegeneration-Activities of Daily Living scale.  METHODS:  A systematic, iterative process consistent with the US Food and Drug Administration guidance and advice from the Committee for Medicinal Products for Human Use at the European Medicines Agency was used to evaluate and adapt or remove scale items of an existing widely used instrument for movement disorders to be pantothenate kinase-associated neurodegeneration-specific, and to create new items.  Modification of scale items was based on input from international experts, patient advocacy leaders, and primary caregivers.  A clinimetric study of the Pantothenate Kinase-Associated Neurodegeneration-Activities of Daily Living scale conducted in patients with pantothenate kinase-associated neurodegeneration or their caregivers (N = 40 at first assessment; N = 39 at second assessment) demonstrated high content and construct validity and excellent test-retest reliability over an approximately 2-week period.  The Pantothenate Kinase-Associated Neurodegeneration-Activities of Daily Living scale was developed to be broadly useful within clinical and research settings in the examination of patient response to pantothenate kinase-associated neurodegeneration therapies.  RESULTS:  Approximately 82 patients will be enrolled in the ongoing FOsmetpantotenate Replacement Therapy pivotal trial.  Change from baseline in Pantothenate Kinase-Associated Neurodegeneration-Activities of Daily Living score over the 24-week double-blind period is the primary efficacy endpoint for the FOsmetpantotenate Replacement Therapy trial.  Treatment effect will be evaluated using a mixed model for repeated measures analysis to assess data from all visits simultaneously.  CONCLUSION:  The development and implementation of the Pantothenate Kinase-Associated Neurodegeneration-Activities of Daily Living scale in the FOsmetpantotenate Replacement Therapy trial illustrates the feasibility and potential patient benefit of putting into practice the current regulatory guidance on the use of patient-reported outcomes in clinical trials.  These processes can be broadly applied to clinical trial methodology that requires newly created or revised patient-reported outcome measures to evaluate outcome change as a primary efficacy endpoint.  The goal of such measures in patients with pantothenate kinase-associated neurodegeneration is to facilitate development of disease-modifying therapeutics in multiple drug development programs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTO8rRZmCc_AijiVMCqkKxVfW6udTcc2eYPPysQ773Lerntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3M7isFSlsA%253D%253D&md5=08172503820ee6068592bc8669dc131e</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1177%2F1740774519845673&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F1740774519845673%26sid%3Dliteratum%253Aachs%26aulast%3DKlopstock%26aufirst%3DT.%26aulast%3DEscolar%26aufirst%3DM.%2BL.%26aulast%3DMarshall%26aufirst%3DR.%2BD.%26aulast%3DPerez-Due%25C3%25B1as%26aufirst%3DB.%26aulast%3DTuller%26aufirst%3DS.%26aulast%3DVidenovic%26aufirst%3DA.%26aulast%3DGreblikas%26aufirst%3DF.%26atitle%3DThe%2520FOsmetpantotenate%2520Replacement%2520Therapy%2520%2528FORT%2529%2520Randomized%252C%2520Double-Blind%252C%2520Placebo-Controlled%2520Pivotal%2520Trial%253A%2520Study%2520Design%2520and%2520Development%2520Methodology%2520of%2520a%2520Novel%2520Primary%2520Efficacy%2520Outcome%2520in%2520Patients%2520with%2520Pantothenate%2520Kinase-Associated%2520Neurodegeneration%26jtitle%3DClin.%2520Trials%26date%3D2019%26volume%3D16%26spage%3D410%26epage%3D418%26doi%3D10.1177%2F1740774519845673" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jeong, S. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hogarth, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Placzek, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gregory, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fox, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhen, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamada, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van der Zwaag, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lambrechts, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nilsen, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cobb, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pham, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gray, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ralle, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duffy, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwanemann, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rai, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Freed, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wakeman, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woltjer, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sibon, O. C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayflick, S. J.</span></span> <span> </span><span class="NLM_article-title">4′-Phosphopantetheine Corrects CoA, Iron, and Dopamine Metabolic Defects in Mammalian Models of PKAN</span>. <i>EMBO Mol. Med.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>11</i></span>, <span class="NLM_elocation-id">e10489</span> <span class="refDoi"> DOI: 10.15252/emmm.201910489</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01531&amp;key=10.15252%2Femmm.201910489" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01531&amp;key=31660701" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01531&amp;key=1%3ACAS%3A528%3ADC%252BC1MXitVeqsbvJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2019&author=S.+Y.+Jeongauthor=P.+Hogarthauthor=A.+Placzekauthor=A.+M.+Gregoryauthor=R.+Foxauthor=D.+Zhenauthor=J.+Hamadaauthor=M.+van+der+Zwaagauthor=R.+Lambrechtsauthor=H.+Jinauthor=A.+Nilsenauthor=J.+Cobbauthor=T.+Phamauthor=N.+Grayauthor=M.+Ralleauthor=M.+Duffyauthor=L.+Schwanemannauthor=P.+Raiauthor=A.+Freedauthor=K.+Wakemanauthor=R.+L.+Woltjerauthor=O.+C.+M.+Sibonauthor=S.+J.+Hayflick&title=4%E2%80%B2-Phosphopantetheine+Corrects+CoA%2C+Iron%2C+and+Dopamine+Metabolic+Defects+in+Mammalian+Models+of+PKAN&doi=10.15252%2Femmm.201910489"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">4'-Phosphopantetheine corrects CoA, iron, and dopamine metabolic defects in mammalian models of PKAN</span></div><div class="casAuthors">Jeong, Suh Young; Hogarth, Penelope; Placzek, Andrew; Gregory, Allison M.; Fox, Rachel; Zhen, Dolly; Hamada, Jeffrey; van der Zwaag, Marianne; Lambrechts, Roald; Jin, Haihong; Nilsen, Aaron; Cobb, Jared; Pham, Thao; Gray, Nora; Ralle, Martina; Duffy, Megan; Schwanemann, Leila; Rai, Puneet; Freed, Alison; Wakeman, Katrina; Woltjer, Randall L.; Sibon, Ody CM; Hayflick, Susan J.</div><div class="citationInfo"><span class="NLM_cas:title">EMBO Molecular Medicine</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">e10489</span>CODEN:
                <span class="NLM_cas:coden">EMMMAM</span>;
        ISSN:<span class="NLM_cas:issn">1757-4684</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Pantothenate kinase-assocd. neurodegeneration (PKAN) is an inborn error of CoA metab. causing dystonia, parkinsonism, and brain iron accumulation.  Lack of a good mammalian model has impeded studies of pathogenesis and development of rational therapeutics.  We took a new approach to investigating an existing mouse mutant of Pank2 and found that isolating the disease-vulnerable brain revealed regional perturbations in CoA metab., iron homeostasis, and dopamine metab. and functional deffects in complex I and pyruvate dehydrogenase.  Feeding mice a CoA pathway intermediate, 4'-phosphopantetheine, normalized levels of the CoA-, iron-, and dopamine-related biomarkers as well as activities of mitochondrial enzymes.  Human cell changes also were recovered by 4'-phosphopantetheine.  We can mechanistically link a deffect in CoA metab. to these secondary effects via the activation of mitochondrial acyl carrier protein, which is essential to oxidative phosphorylation, iron-sulfur cluster biogenesis, and mitochondrial fatty acid synthesis.  We demonstrate the fidelity of our model in recapitulating features of the human disease.  Moreover, we identify pharmacodynamic biomarkers, provide insights into disease pathogenesis, and offer evidence for 4'-phosphopantetheine as a candidate therapeutic for PKAN.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoXnCouzisj1LVg90H21EOLACvtfcHk0ljdYYh2LRWXMQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXitVeqsbvJ&md5=eac9295109744fc7f0e6c04411e902d8</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.15252%2Femmm.201910489&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.15252%252Femmm.201910489%26sid%3Dliteratum%253Aachs%26aulast%3DJeong%26aufirst%3DS.%2BY.%26aulast%3DHogarth%26aufirst%3DP.%26aulast%3DPlaczek%26aufirst%3DA.%26aulast%3DGregory%26aufirst%3DA.%2BM.%26aulast%3DFox%26aufirst%3DR.%26aulast%3DZhen%26aufirst%3DD.%26aulast%3DHamada%26aufirst%3DJ.%26aulast%3Dvan%2Bder%2BZwaag%26aufirst%3DM.%26aulast%3DLambrechts%26aufirst%3DR.%26aulast%3DJin%26aufirst%3DH.%26aulast%3DNilsen%26aufirst%3DA.%26aulast%3DCobb%26aufirst%3DJ.%26aulast%3DPham%26aufirst%3DT.%26aulast%3DGray%26aufirst%3DN.%26aulast%3DRalle%26aufirst%3DM.%26aulast%3DDuffy%26aufirst%3DM.%26aulast%3DSchwanemann%26aufirst%3DL.%26aulast%3DRai%26aufirst%3DP.%26aulast%3DFreed%26aufirst%3DA.%26aulast%3DWakeman%26aufirst%3DK.%26aulast%3DWoltjer%26aufirst%3DR.%2BL.%26aulast%3DSibon%26aufirst%3DO.%2BC.%2BM.%26aulast%3DHayflick%26aufirst%3DS.%2BJ.%26atitle%3D4%25E2%2580%25B2-Phosphopantetheine%2520Corrects%2520CoA%252C%2520Iron%252C%2520and%2520Dopamine%2520Metabolic%2520Defects%2520in%2520Mammalian%2520Models%2520of%2520PKAN%26jtitle%3DEMBO%2520Mol.%2520Med.%26date%3D2019%26volume%3D11%26doi%3D10.15252%2Femmm.201910489" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Srinivasan, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baratashvili, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van der Zwaag, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kanon, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Colombelli, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lambrechts, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schaap, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nollen, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Podgoršek, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kosec, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petkovic, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayflick, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tiranti, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reijngoud, D.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grzeschik, N. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sibon, O. C. M.</span></span> <span> </span><span class="NLM_article-title">Extracellular 4′-Phosphopantetheine Is a Source for Intracellular Coenzyme A Synthesis</span>. <i>Nat. Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">784</span>– <span class="NLM_lpage">792</span>, <span class="refDoi"> DOI: 10.1038/nchembio.1906</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01531&amp;key=10.1038%2Fnchembio.1906" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01531&amp;key=26322826" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01531&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtlylsrnI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2015&pages=784-792&author=B.+Srinivasanauthor=M.+Baratashviliauthor=M.+van+der+Zwaagauthor=B.+Kanonauthor=C.+Colombelliauthor=R.+A.+Lambrechtsauthor=O.+Schaapauthor=E.+A.+Nollenauthor=A.+Podgor%C5%A1ekauthor=G.+Kosecauthor=H.+Petkovicauthor=S.+Hayflickauthor=V.+Tirantiauthor=D.-J.+Reijngoudauthor=N.+A.+Grzeschikauthor=O.+C.+M.+Sibon&title=Extracellular+4%E2%80%B2-Phosphopantetheine+Is+a+Source+for+Intracellular+Coenzyme+A+Synthesis&doi=10.1038%2Fnchembio.1906"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Extracellular 4'-phosphopantetheine is a source for intracellular coenzyme A synthesis</span></div><div class="casAuthors">Srinivasan, Balaji; Baratashvili, Madina; van der Zwaag, Marianne; Kanon, Bart; Colombelli, Cristina; Lambrechts, Roald A.; Schaap, Onno; Nollen, Ellen A.; Podgorsek, Ajda; Kosec, Gregor; Petkovic, Hrvoje; Hayflick, Susan; Tiranti, Valeria; Reijngoud, Dirk-Jan; Grzeschik, Nicola A.; Sibon, Ody C. M.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">784-792</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The metabolic cofactor CoA gained renewed attention because of its roles in neurodegeneration, protein acetylation, autophagy and signal transduction.  The long-standing dogma is that eukaryotic cells obtain CoA exclusively via the uptake of extracellular precursors, esp. vitamin B5, which is intracellularly converted through five conserved enzymic reactions into CoA.  This study demonstrates an alternative mechanism that allows cells and organisms to adjust intracellular CoA levels by using exogenous CoA.  Here CoA was hydrolyzed extracellularly by ectonucleotide pyrophosphatases to 4'-phosphopantetheine, a biol. stable mol. able to translocate through membranes via passive diffusion.  Inside the cell, 4'-phosphopantetheine was enzymically converted back to CoA by the bifunctional enzyme CoA synthase.  Phenotypes induced by intracellular CoA deprivation were reversed when exogenous CoA was provided.  Our findings answer long-standing questions in fundamental cell biol. and have major implications for the understanding of CoA-related diseases and therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqv1LG48W_EhbVg90H21EOLACvtfcHk0ljdYYh2LRWXMQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtlylsrnI&md5=b8de40f124c4776e56f98c72bb51955c</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.1906&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.1906%26sid%3Dliteratum%253Aachs%26aulast%3DSrinivasan%26aufirst%3DB.%26aulast%3DBaratashvili%26aufirst%3DM.%26aulast%3Dvan%2Bder%2BZwaag%26aufirst%3DM.%26aulast%3DKanon%26aufirst%3DB.%26aulast%3DColombelli%26aufirst%3DC.%26aulast%3DLambrechts%26aufirst%3DR.%2BA.%26aulast%3DSchaap%26aufirst%3DO.%26aulast%3DNollen%26aufirst%3DE.%2BA.%26aulast%3DPodgor%25C5%25A1ek%26aufirst%3DA.%26aulast%3DKosec%26aufirst%3DG.%26aulast%3DPetkovic%26aufirst%3DH.%26aulast%3DHayflick%26aufirst%3DS.%26aulast%3DTiranti%26aufirst%3DV.%26aulast%3DReijngoud%26aufirst%3DD.-J.%26aulast%3DGrzeschik%26aufirst%3DN.%2BA.%26aulast%3DSibon%26aufirst%3DO.%2BC.%2BM.%26atitle%3DExtracellular%25204%25E2%2580%25B2-Phosphopantetheine%2520Is%2520a%2520Source%2520for%2520Intracellular%2520Coenzyme%2520A%2520Synthesis%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2015%26volume%3D11%26spage%3D784%26epage%3D792%26doi%3D10.1038%2Fnchembio.1906" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sharma, L. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Subramanian, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yun, M.-K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frank, M. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">White, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rock, C. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jackowski, S.</span></span> <span> </span><span class="NLM_article-title">A Therapeutic Approach to Pantothenate Kinase Associated Neurodegeneration</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>9</i></span>, <span class="NLM_elocation-id">4399</span> <span class="refDoi"> DOI: 10.1038/s41467-018-06703-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01531&amp;key=10.1038%2Fs41467-018-06703-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01531&amp;key=30352999" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01531&amp;key=1%3ACAS%3A280%3ADC%252BB3cvisFSluw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2018&author=L.+K.+Sharmaauthor=C.+Subramanianauthor=M.-K.+Yunauthor=M.+W.+Frankauthor=S.+W.+Whiteauthor=C.+O.+Rockauthor=R.+E.+Leeauthor=S.+Jackowski&title=A+Therapeutic+Approach+to+Pantothenate+Kinase+Associated+Neurodegeneration&doi=10.1038%2Fs41467-018-06703-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">A therapeutic approach to pantothenate kinase associated neurodegeneration</span></div><div class="casAuthors">Sharma Lalit Kumar; Subramanian Chitra; Frank Matthew W; Rock Charles O; Jackowski Suzanne; Sharma Lalit Kumar; Lee Richard E; Sharma Lalit Kumar; Yun Mi-Kyung; White Stephen W</div><div class="citationInfo"><span class="NLM_cas:title">Nature communications</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">4399</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Pantothenate kinase (PANK) is a metabolic enzyme that regulates cellular coenzyme A (CoA) levels.  There are three human PANK genes, and inactivating mutations in PANK2 lead to pantothenate kinase associated neurodegeneration (PKAN).  Here we performed a library screen followed by chemical optimization to produce PZ-2891, an allosteric PANK activator that crosses the blood brain barrier.  PZ-2891 occupies the pantothenate pocket and engages the dimer interface to form a PANK•ATP•Mg(2+)•PZ-2891 complex.  The binding of PZ-2891 to one protomer locks the opposite protomer in a catalytically active conformation that is refractory to acetyl-CoA inhibition.  Oral administration of PZ-2891 increases CoA levels in mouse liver and brain.  A knockout mouse model of brain CoA deficiency exhibited weight loss, severe locomotor impairment and early death.  Knockout mice on PZ-2891 therapy gain weight, and have improved locomotor activity and life span establishing pantazines as novel therapeutics for the treatment of PKAN.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcScmbQ8u9AhUCsZ1x6zOs0vfW6udTcc2eaB3mpWhl9zorntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3cvisFSluw%253D%253D&md5=ef5c45dc0713731c14e7fd0b5d65778d</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1038%2Fs41467-018-06703-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41467-018-06703-2%26sid%3Dliteratum%253Aachs%26aulast%3DSharma%26aufirst%3DL.%2BK.%26aulast%3DSubramanian%26aufirst%3DC.%26aulast%3DYun%26aufirst%3DM.-K.%26aulast%3DFrank%26aufirst%3DM.%2BW.%26aulast%3DWhite%26aufirst%3DS.%2BW.%26aulast%3DRock%26aufirst%3DC.%2BO.%26aulast%3DLee%26aufirst%3DR.%2BE.%26aulast%3DJackowski%26aufirst%3DS.%26atitle%3DA%2520Therapeutic%2520Approach%2520to%2520Pantothenate%2520Kinase%2520Associated%2520Neurodegeneration%26jtitle%3DNat.%2520Commun.%26date%3D2018%26volume%3D9%26doi%3D10.1038%2Fs41467-018-06703-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Freel
Meyers, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borch, R. F.</span></span> <span> </span><span class="NLM_article-title">Activation Mechanisms of Nucleoside Phosphoramidate Prodrugs</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>43</i></span>,  <span class="NLM_fpage">4319</span>– <span class="NLM_lpage">4327</span>, <span class="refDoi"> DOI: 10.1021/jm000302b</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm000302b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01531&amp;key=1%3ACAS%3A280%3ADC%252BD3M%252FktF2jtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2000&pages=4319-4327&author=C.+L.+Freel%0AMeyersauthor=R.+F.+Borch&title=Activation+Mechanisms+of+Nucleoside+Phosphoramidate+Prodrugs&doi=10.1021%2Fjm000302b"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Activation mechanisms of nucleoside phosphoramidate prodrugs</span></div><div class="casAuthors">Freel Meyers C L; Borch R F</div><div class="citationInfo"><span class="NLM_cas:title">Journal of medicinal chemistry</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">4319-27</span>
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    </div><div class="casAbstract">A series of thymidine and tetrahydrofurfuryl phosphoramidates bearing haloethyl or piperidyl substituents was synthesized and used to investigate the activation mechanisms of nucleoside phosphoramidate prodrugs.  Structure assignments for the tetrahydrofurfuryl reaction products were confirmed by comparison to authentic samples.  Structural assignments for thymidine phosphoramidate reaction products were made by analogy to the tetrahydrofurfuryl products.  Generation of the phosphoramidate anion leads to cyclization and subsequent nucleophilic attack at carbon and phosphorus of the resulting aziridinium ion intermediate to give the observed products.  Nucleophilic attack by water at carbon and phosphorus occurs without selectivity, supporting a mechanism of action of haloethylamine nucleoside prodrugs involving intracellular release of the nucleotide.  Activation of the benzotriazolyl piperidyl phosphoramidates is followed by P-N bond hydrolysis; this reaction is subject to specific acid catalysis and to nucleophilic catalysis by 1-hydroxybenzotriazole.  These results suggest that the mechanism of action of the piperidyl nucleoside phosphoramidates involves the intracellular release of the active nucleotide following P-N bond cleavage, presumably by the action of an endogenous phosphoramidase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRTQx53jINgre-MdeMhXAHkfW6udTcc2eaB3mpWhl9zorntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3M%252FktF2jtA%253D%253D&md5=39bc57b589e439795c8c1a1e1a3f6750</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1021%2Fjm000302b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm000302b%26sid%3Dliteratum%253Aachs%26aulast%3DFreel%2BMeyers%26aufirst%3DC.%2BL.%26aulast%3DBorch%26aufirst%3DR.%2BF.%26atitle%3DActivation%2520Mechanisms%2520of%2520Nucleoside%2520Phosphoramidate%2520Prodrugs%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2000%26volume%3D43%26spage%3D4319%26epage%3D4327%26doi%3D10.1021%2Fjm000302b" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">De
Clercq, E.</span></span> <span> </span><span class="NLM_article-title">The Clinical Potential of the Acyclic (and Cyclic) Nucleoside Phosphonates. The Magic of the Phosphonate Bond</span>. <i>Biochem. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>82</i></span>,  <span class="NLM_fpage">99</span>– <span class="NLM_lpage">109</span>, <span class="refDoi"> DOI: 10.1016/j.bcp.2011.03.027</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01531&amp;key=10.1016%2Fj.bcp.2011.03.027" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01531&amp;key=21501598" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01531&amp;key=1%3ACAS%3A528%3ADC%252BC3MXntVyqsrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=82&publication_year=2011&pages=99-109&author=E.+De%0AClercq&title=The+Clinical+Potential+of+the+Acyclic+%28and+Cyclic%29+Nucleoside+Phosphonates.+The+Magic+of+the+Phosphonate+Bond&doi=10.1016%2Fj.bcp.2011.03.027"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">The clinical potential of the acyclic (and cyclic) nucleoside phosphonates. The magic of the phosphonate bond</span></div><div class="casAuthors">De Clercq, Erik</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Pharmacology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">82</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">99-109</span>CODEN:
                <span class="NLM_cas:coden">BCPCA6</span>;
        ISSN:<span class="NLM_cas:issn">0006-2952</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  The use of the acyclic nucleoside phosphonates, starting with (S)-HPMPA as the prototype, yielded three clin. approved antiviral drugs, cidofovir for the treatment of CMV retinitis in AIDS patients, adefovir dipivoxil for the treatment of chronic hepatitis B and tenofovir disoproxil fumarate for the treatment of HIV infections (AIDS) and HBV infections.  This era has now grown to many more acyclic (and cyclic) nucleoside phosphonates (such as the "open ring" DAPy and Fd4A phosphonates) and alkoxyalkyl and phosphonoamidate prodrugs thereof, as well as new clin. applications, including new drug combination regimens for the treatment of AIDS, the chemoprophylaxis of HIV infections, and the anticancer potential against some malignant disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpIOtQhoT42-rVg90H21EOLACvtfcHk0ljciUWMAhLrDw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXntVyqsrg%253D&md5=70d42eb223d9039fc420113fe75f2310</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1016%2Fj.bcp.2011.03.027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bcp.2011.03.027%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BClercq%26aufirst%3DE.%26atitle%3DThe%2520Clinical%2520Potential%2520of%2520the%2520Acyclic%2520%2528and%2520Cyclic%2529%2520Nucleoside%2520Phosphonates.%2520The%2520Magic%2520of%2520the%2520Phosphonate%2520Bond%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2011%26volume%3D82%26spage%3D99%26epage%3D109%26doi%3D10.1016%2Fj.bcp.2011.03.027" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Meier, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balzarini, J.</span></span> <span> </span><span class="NLM_article-title">Application of the CycloSal-Prodrug Approach for Improving the Biological Potential of Phosphorylated Biomolecules</span>. <i>Antiviral Res.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>71</i></span>,  <span class="NLM_fpage">282</span>– <span class="NLM_lpage">292</span>, <span class="refDoi"> DOI: 10.1016/j.antiviral.2006.04.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01531&amp;key=10.1016%2Fj.antiviral.2006.04.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01531&amp;key=16735066" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01531&amp;key=1%3ACAS%3A528%3ADC%252BD28XotlGktLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=2006&pages=282-292&author=C.+Meierauthor=J.+Balzarini&title=Application+of+the+CycloSal-Prodrug+Approach+for+Improving+the+Biological+Potential+of+Phosphorylated+Biomolecules&doi=10.1016%2Fj.antiviral.2006.04.011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Application of the cycloSal-prodrug approach for improving the biological potential of phosphorylated biomolecules</span></div><div class="casAuthors">Meier, C.; Balzarini, J.</div><div class="citationInfo"><span class="NLM_cas:title">Antiviral Research</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">71</span>
        (<span class="NLM_cas:issue">2-3</span>),
    <span class="NLM_cas:pages">282-292</span>CODEN:
                <span class="NLM_cas:coden">ARSRDR</span>;
        ISSN:<span class="NLM_cas:issn">0166-3542</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Pronucleotides represent a promising tool to improve the biol. activity of nucleoside analogs in antiviral and cancer chemotherapy.  The cycloSal-approach is one of several conceptually different pronucleotide systems.  This approach can be applied to various nucleoside analogs.  A salicyl alc. as a cyclic bifunctional masking unit is used, and shown to afford a chem. driven release of the particular nucleotide from the lipophilic phosphate triester precursor mol.  A conceptual extension of the cycloSal-approach results in the design of "lock-in"-cycloSal-derivs.  The cycloSal-approach is not restricted to the delivery of bioactive nucleotides but also useful for the intracellular delivery of hexose-1-phosphates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqf1uTGjRu7KLVg90H21EOLACvtfcHk0ljciUWMAhLrDw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XotlGktLc%253D&md5=19f9f8927db18911f71debd985dbff51</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1016%2Fj.antiviral.2006.04.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.antiviral.2006.04.011%26sid%3Dliteratum%253Aachs%26aulast%3DMeier%26aufirst%3DC.%26aulast%3DBalzarini%26aufirst%3DJ.%26atitle%3DApplication%2520of%2520the%2520CycloSal-Prodrug%2520Approach%2520for%2520Improving%2520the%2520Biological%2520Potential%2520of%2520Phosphorylated%2520Biomolecules%26jtitle%3DAntiviral%2520Res.%26date%3D2006%26volume%3D71%26spage%3D282%26epage%3D292%26doi%3D10.1016%2Fj.antiviral.2006.04.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gunic, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Girardet, J.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramasamy, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stoisavljevic-Petkov, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chow, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yeh, L.-T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamatake, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raney, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hong, Z.</span></span> <span> </span><span class="NLM_article-title">Cyclic Monophosphate Prodrugs of Base-Modified 2′-C-Methyl Ribonucleosides as Potent Inhibitors of Hepatitis C Virus RNA Replication</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">2452</span>– <span class="NLM_lpage">2455</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2007.02.030</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01531&amp;key=10.1016%2Fj.bmcl.2007.02.030" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01531&amp;key=17331721" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01531&amp;key=1%3ACAS%3A528%3ADC%252BD2sXktVentrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=2452-2455&author=E.+Gunicauthor=J.-L.+Girardetauthor=K.+Ramasamyauthor=V.+Stoisavljevic-Petkovauthor=S.+Chowauthor=L.-T.+Yehauthor=R.+K.+Hamatakeauthor=A.+Raneyauthor=Z.+Hong&title=Cyclic+Monophosphate+Prodrugs+of+Base-Modified+2%E2%80%B2-C-Methyl+Ribonucleosides+as+Potent+Inhibitors+of+Hepatitis+C+Virus+RNA+Replication&doi=10.1016%2Fj.bmcl.2007.02.030"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Cyclic monophosphate prodrugs of base-modified 2'-C-methyl ribonucleosides as potent inhibitors of hepatitis C virus RNA replication</span></div><div class="casAuthors">Gunic, Esmir; Girardet, Jean-Luc; Ramasamy, Kanda; Stoisavljevic-Petkov, Vesna; Chow, Suetying; Yeh, Li-Tain; Hamatake, Robert K.; Raney, Anneke; Hong, Zhi</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2452-2455</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A new series of hetero-base-modified 2'-C-Me ribonucleosides was synthesized and tested as inhibitors of hepatitis C virus (HCV) RNA replication.  The nucleosides showed a weak inhibitory activity in a HCV replicon system (EC50 = 92 μM) and did not exhibit any cytotoxicity (CC50 > 300 μM).  Cyclic monophosphate (cMP) prodrugs of the same nucleosides were synthesized and also tested in the HCV replicon system.  Prodrugs exhibited strong potency (EC50 = 0.008 μM) without significant cytotoxicity (CC50 > 50 μM).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp4DkSvrNtlr7Vg90H21EOLACvtfcHk0ljciUWMAhLrDw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXktVentrc%253D&md5=a3e608835c20a504bc5753724dc09e5b</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2007.02.030&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2007.02.030%26sid%3Dliteratum%253Aachs%26aulast%3DGunic%26aufirst%3DE.%26aulast%3DGirardet%26aufirst%3DJ.-L.%26aulast%3DRamasamy%26aufirst%3DK.%26aulast%3DStoisavljevic-Petkov%26aufirst%3DV.%26aulast%3DChow%26aufirst%3DS.%26aulast%3DYeh%26aufirst%3DL.-T.%26aulast%3DHamatake%26aufirst%3DR.%2BK.%26aulast%3DRaney%26aufirst%3DA.%26aulast%3DHong%26aufirst%3DZ.%26atitle%3DCyclic%2520Monophosphate%2520Prodrugs%2520of%2520Base-Modified%25202%25E2%2580%25B2-C-Methyl%2520Ribonucleosides%2520as%2520Potent%2520Inhibitors%2520of%2520Hepatitis%2520C%2520Virus%2520RNA%2520Replication%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2007%26volume%3D17%26spage%3D2452%26epage%3D2455%26doi%3D10.1016%2Fj.bmcl.2007.02.030" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pradere, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garnier-Amblard, E. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coats, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amblard, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schinazi, R. F.</span></span> <span> </span><span class="NLM_article-title">Synthesis of Nucleoside Phosphate and Phosphonate Prodrugs</span>. <i>Chem. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>114</i></span>,  <span class="NLM_fpage">9154</span>– <span class="NLM_lpage">9218</span>, <span class="refDoi"> DOI: 10.1021/cr5002035</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cr5002035" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01531&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsVSnsL7J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=114&publication_year=2014&pages=9154-9218&author=U.+Pradereauthor=E.+C.+Garnier-Amblardauthor=S.+J.+Coatsauthor=F.+Amblardauthor=R.+F.+Schinazi&title=Synthesis+of+Nucleoside+Phosphate+and+Phosphonate+Prodrugs&doi=10.1021%2Fcr5002035"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of Nucleoside Phosphate and Phosphonate Prodrugs</span></div><div class="casAuthors">Pradere, Ugo; Garnier-Amblard, Ethel C.; Coats, Steven J.; Amblard, Franck; Schinazi, Raymond F.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">114</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">9154-9218</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Herein, we review the most important mono-, di-, and triphosphate and phosphonate prodrug approaches applied to nucleoside analogs from a chem. point of view, detailing the strengths and limitations of each approach.  We will focus on the various synthetic pathways discussing: (1) the chem. variation of the biolabile phosphonate masking groups; (2) the reliability of using P(III) and/or P(V) chem. for both phosphate and phosphonate prodrug synthesis; (3) the influence of the masking group(s) introduction conditions (solvent, temp., stoichiometry) on the overall outcome for each method; (4) the various protection/deprotection strategies used to impart improved yield and regioselectivity relative to the nature of the nucleobase and the sugar; and (5) the influence of reaction conditions or protective groups on the stereoselectivity (Rp/Sp) obsd. at the phosphorus center as well as the methods employed to sep. both Rp and Sp isomers along with the asym. strategies for the synthesis of predominantly single diastereoisomers at the phosphorus center.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo2UgEs4_SnUrVg90H21EOLACvtfcHk0ljeM-uv-Q82CQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsVSnsL7J&md5=115175a0c31890dd5b7b9f4ae9a9191f</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Fcr5002035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr5002035%26sid%3Dliteratum%253Aachs%26aulast%3DPradere%26aufirst%3DU.%26aulast%3DGarnier-Amblard%26aufirst%3DE.%2BC.%26aulast%3DCoats%26aufirst%3DS.%2BJ.%26aulast%3DAmblard%26aufirst%3DF.%26aulast%3DSchinazi%26aufirst%3DR.%2BF.%26atitle%3DSynthesis%2520of%2520Nucleoside%2520Phosphate%2520and%2520Phosphonate%2520Prodrugs%26jtitle%3DChem.%2520Rev.%26date%3D2014%26volume%3D114%26spage%3D9154%26epage%3D9218%26doi%3D10.1021%2Fcr5002035" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pradère, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roy, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Montagu, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sari, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamada, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balzarini, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Snoeck, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andrei, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Agrofoglio, L. A.</span></span> <span> </span><span class="NLM_article-title">Synthesis and Antiviral Evaluation of Bis(POM) Prodrugs of (E)-[4′-Phosphono-but-2′-En-1′-Yl]Purine Nucleosides</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">126</span>– <span class="NLM_lpage">133</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2012.08.042</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01531&amp;key=10.1016%2Fj.ejmech.2012.08.042" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01531&amp;key=23047229" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01531&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhsleisr7N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2012&pages=126-133&author=U.+Prad%C3%A8reauthor=V.+Royauthor=A.+Montaguauthor=O.+Sariauthor=M.+Hamadaauthor=J.+Balzariniauthor=R.+Snoeckauthor=G.+Andreiauthor=L.+A.+Agrofoglio&title=Synthesis+and+Antiviral+Evaluation+of+Bis%28POM%29+Prodrugs+of+%28E%29-%5B4%E2%80%B2-Phosphono-but-2%E2%80%B2-En-1%E2%80%B2-Yl%5DPurine+Nucleosides&doi=10.1016%2Fj.ejmech.2012.08.042"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and antiviral evaluation of bis(POM) prodrugs of (E)-[4'-phosphono-but-2'-en-1'-yl]purine nucleosides</span></div><div class="casAuthors">Pradere, Ugo; Roy, Vincent; Montagu, Aurelien; Sari, Ozkan; Hamada, Manabu; Balzarini, Jan; Snoeck, Robert; Andrei, Graciela; Agrofoglio, Luigi A.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">126-133</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Seventeen hitherto unknown bis(POM) (POM = CH2OCOCMe3) prodrugs of novel (E)-[4'-phosphono-but-2'-en-1'-yl]purine nucleosides were prepd. in a straight approach and at good yields.  Those compds. were synthesized by the reaction of purine nucleobases directly with the phosphonate synthon 3 bearing POM biolabile groups under Mitsunobu conditions.  All obtained compds. were evaluated for their antiviral activities against a large no. of DNA and RNA viruses including herpes simplex viruses 1 and 2, varicella zoster virus, feline herpes virus, human cytomegalovirus, HIV-1 and HIV-2.  Among these mols., some of them exhibit anti-VZV and anti-HIV activity at submicromolar concns.  This class of compd. will be of further interest for lead optimization as anti-infectious agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqxVPiJ_V4O9rVg90H21EOLACvtfcHk0ljeM-uv-Q82CQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhsleisr7N&md5=f35f9503d66add5e5258919f92fcaab0</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2012.08.042&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2012.08.042%26sid%3Dliteratum%253Aachs%26aulast%3DPrad%25C3%25A8re%26aufirst%3DU.%26aulast%3DRoy%26aufirst%3DV.%26aulast%3DMontagu%26aufirst%3DA.%26aulast%3DSari%26aufirst%3DO.%26aulast%3DHamada%26aufirst%3DM.%26aulast%3DBalzarini%26aufirst%3DJ.%26aulast%3DSnoeck%26aufirst%3DR.%26aulast%3DAndrei%26aufirst%3DG.%26aulast%3DAgrofoglio%26aufirst%3DL.%2BA.%26atitle%3DSynthesis%2520and%2520Antiviral%2520Evaluation%2520of%2520Bis%2528POM%2529%2520Prodrugs%2520of%2520%2528E%2529-%255B4%25E2%2580%25B2-Phosphono-but-2%25E2%2580%25B2-En-1%25E2%2580%25B2-Yl%255DPurine%2520Nucleosides%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2012%26volume%3D57%26spage%3D126%26epage%3D133%26doi%3D10.1016%2Fj.ejmech.2012.08.042" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sugiyama, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eastgate, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fritz, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murugesan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conlon, D. A.</span></span> <span> </span><span class="NLM_article-title">Development of a Process for the Preparation of Chloromethyl Chlorosulfate</span>. <i>Org. Process Res. Dev.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">1827</span>– <span class="NLM_lpage">1831</span>, <span class="refDoi"> DOI: 10.1021/op300246d</span> </span><div class="citationLinks">[<a href="/doi/10.1021/op300246d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01531&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsFOlsbnM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2012&pages=1827-1831&author=B.+Zhengauthor=M.+Sugiyamaauthor=M.+D.+Eastgateauthor=A.+Fritzauthor=S.+Murugesanauthor=D.+A.+Conlon&title=Development+of+a+Process+for+the+Preparation+of+Chloromethyl+Chlorosulfate&doi=10.1021%2Fop300246d"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Development of a Process for the Preparation of Chloromethyl Chlorosulfate</span></div><div class="casAuthors">Zheng, Bin; Sugiyama, Masano; Eastgate, Martin; Fritz, Alan; Murugesan, Saravanababu; Conlon, David A.</div><div class="citationInfo"><span class="NLM_cas:title">Organic Process Research & Development</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1827-1831</span>CODEN:
                <span class="NLM_cas:coden">OPRDFK</span>;
        ISSN:<span class="NLM_cas:issn">1083-6160</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A process for the prepn. of chloromethyl chlorosulfate ClCH2OSO2Cl (I) from chloroiodomethane and chlorosulfonic acid was developed.  The substitution reaction of chloroiodomethane with chlorosulfonic acid yielded I and iodine (generated by oxidn. of iodide by chlorosulfonic acid); the yield was improved by oxidizing the reaction mixt. with bleach to convert iodine to iodate (to prevent iodide-mediated decompn. of I) and by scavenging water with thionyl chloride [to prevent the formation of bis(chloromethyl) sulfate as a byproduct].  The process provided I in 92% soln. yield and high purity (>99 GC area %) on 160 g scale.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrGAQ5GFMKzgrVg90H21EOLACvtfcHk0ljeM-uv-Q82CQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsFOlsbnM&md5=4d09cacbe655ea9843e07e3d971567e0</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1021%2Fop300246d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fop300246d%26sid%3Dliteratum%253Aachs%26aulast%3DZheng%26aufirst%3DB.%26aulast%3DSugiyama%26aufirst%3DM.%26aulast%3DEastgate%26aufirst%3DM.%2BD.%26aulast%3DFritz%26aufirst%3DA.%26aulast%3DMurugesan%26aufirst%3DS.%26aulast%3DConlon%26aufirst%3DD.%2BA.%26atitle%3DDevelopment%2520of%2520a%2520Process%2520for%2520the%2520Preparation%2520of%2520Chloromethyl%2520Chlorosulfate%26jtitle%3DOrg.%2520Process%2520Res.%2520Dev.%26date%3D2012%26volume%3D16%26spage%3D1827%26epage%3D1831%26doi%3D10.1021%2Fop300246d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Meier, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mercer, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rivera, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burkart, M. D.</span></span> <span> </span><span class="NLM_article-title">Synthesis and Evaluation of Bioorthogonal Pantetheine Analogues for in Vivo Protein Modification</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>128</i></span>,  <span class="NLM_fpage">12174</span>– <span class="NLM_lpage">12184</span>, <span class="refDoi"> DOI: 10.1021/ja063217n</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja063217n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01531&amp;key=1%3ACAS%3A528%3ADC%252BD28Xos1Sgt7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=128&publication_year=2006&pages=12174-12184&author=J.+L.+Meierauthor=A.+C.+Mercerauthor=H.+Riveraauthor=M.+D.+Burkart&title=Synthesis+and+Evaluation+of+Bioorthogonal+Pantetheine+Analogues+for+in+Vivo+Protein+Modification&doi=10.1021%2Fja063217n"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and Evaluation of Bioorthogonal Pantetheine Analogues for in Vivo Protein Modification</span></div><div class="casAuthors">Meier, Jordan L.; Mercer, Andrew C.; Rivera, Heriberto, Jr.; Burkart, Michael D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">128</span>
        (<span class="NLM_cas:issue">37</span>),
    <span class="NLM_cas:pages">12174-12184</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">In vivo carrier protein tagging has recently become an attractive target for the site-specific modification of fusion systems and new approaches to natural product proteomics.  A detailed study of pantetheine analogs was performed to identify suitable partners for covalent protein labeling inside living cells.  A rapid synthesis of pantothenamide analogs was developed and used to produce a panel which was evaluated for in vitro and in vivo protein labeling.  Kinetic comparisons allowed the construction of a structure-activity relation to pinpoint the linker, dye, and bioorthogonal reporter of choice for carrier protein labeling.  Finally bioorthogonal pantetheine analogs were shown to target carrier proteins with high specificity in vivo and undergo chemoselective ligation to reporters in crude cell lysate.  The methods demonstrated here allow carrier proteins to be visualized and isolated for the first time without the need for antibody techniques and set the stage for the future use of carrier protein fusions in chem. biol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpEmOTLofNIwbVg90H21EOLACvtfcHk0lgB3lwyRoApQg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xos1Sgt7o%253D&md5=b580ba45e1a936d1795e4331109370cd</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1021%2Fja063217n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja063217n%26sid%3Dliteratum%253Aachs%26aulast%3DMeier%26aufirst%3DJ.%2BL.%26aulast%3DMercer%26aufirst%3DA.%2BC.%26aulast%3DRivera%26aufirst%3DH.%26aulast%3DBurkart%26aufirst%3DM.%2BD.%26atitle%3DSynthesis%2520and%2520Evaluation%2520of%2520Bioorthogonal%2520Pantetheine%2520Analogues%2520for%2520in%2520Vivo%2520Protein%2520Modification%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2006%26volume%3D128%26spage%3D12174%26epage%3D12184%26doi%3D10.1021%2Fja063217n" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cullis, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Snip, E.</span></span> <span> </span><span class="NLM_article-title">Stereochemical Course of Cerium(IV)-Catalyzed Hydrolysis of Cyclic Nucleotides</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>121</i></span>,  <span class="NLM_fpage">6125</span>– <span class="NLM_lpage">6130</span>, <span class="refDoi"> DOI: 10.1021/ja990686z</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja990686z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01531&amp;key=1%3ACAS%3A528%3ADyaK1MXjslOjt7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=121&publication_year=1999&pages=6125-6130&author=P.+M.+Cullisauthor=E.+Snip&title=Stereochemical+Course+of+Cerium%28IV%29-Catalyzed+Hydrolysis+of+Cyclic+Nucleotides&doi=10.1021%2Fja990686z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Stereochemical Course of Cerium(IV)-Catalyzed Hydrolysis of Cyclic Nucleotides</span></div><div class="casAuthors">Cullis, Paul M.; Snip, Erwin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">121</span>
        (<span class="NLM_cas:issue">26</span>),
    <span class="NLM_cas:pages">6125-6130</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">CeIV has been shown to catalyze the hydrolysis of thymidine 3',5'-cyclic thiophosphate (cTMPS) to give a mixt. of 3'-TMPS and 5'-TMPS with rates comparable to those previously reported for cAMP and cTMP.  The ratio of the 3'-TMPS and 5'-TMPS products was dependent on the abs. configuration of the cTMPS; starting from Rp cTMPS, with the sulfur equatorial, the 3'-TMPS:5'-TMPS ratio was ca. 7:1 whereas for the corresponding Sp cTMPS the ratio was 3:2.  Both diastereoisomers of thymidine 3',5'-cyclic [18O]thiophosphate have been synthesized, and the stereochem. course of the hydrolysis reaction catalyzed by CeIV has been detd.  In each case, the reaction proceeds with clean inversion of configuration, consistent with coordination of the metal ion to the exocyclic oxygen substituent and delivery of the hydroxide nucleophile from one of the remaining metal coordination sites with in-line geometry.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGraYfd5cpFbeLVg90H21EOLACvtfcHk0lgB3lwyRoApQg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXjslOjt7o%253D&md5=9d82bcbec6bcf898ce5626a1154a7b3b</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1021%2Fja990686z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja990686z%26sid%3Dliteratum%253Aachs%26aulast%3DCullis%26aufirst%3DP.%2BM.%26aulast%3DSnip%26aufirst%3DE.%26atitle%3DStereochemical%2520Course%2520of%2520Cerium%2528IV%2529-Catalyzed%2520Hydrolysis%2520of%2520Cyclic%2520Nucleotides%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1999%26volume%3D121%26spage%3D6125%26epage%3D6130%26doi%3D10.1021%2Fja990686z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Buchwald, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knowles, J. R.</span></span> <span> </span><span class="NLM_article-title">Determination of the Absolute Configuration of [16O,17O,18O]Phosphate Monoesters by Using Phosphorus-31 NMR</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">1980</span>,  <span class="NLM_volume"><i>102</i></span>,  <span class="NLM_fpage">6601</span>– <span class="NLM_lpage">6602</span>, <span class="refDoi"> DOI: 10.1021/ja00541a056</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja00541a056" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01531&amp;key=1%3ACAS%3A528%3ADyaL3cXmtFaktL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=1980&pages=6601-6602&author=S.+L.+Buchwaldauthor=J.+R.+Knowles&title=Determination+of+the+Absolute+Configuration+of+%5B16O%2C17O%2C18O%5DPhosphate+Monoesters+by+Using+Phosphorus-31+NMR&doi=10.1021%2Fja00541a056"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Determination of the absolute configuration of [16O,17O,18O]phosphate monoesters by using phosphorus-31 NMR</span></div><div class="casAuthors">Buchwald, Stephen L.; Knowles, Jeremy R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">1980</span>),
    <span class="NLM_cas:volume">102</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">6601-2</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    </div><div class="casAbstract">The abs. configuration of chiral [16O,17O,18O]phosphate monoesters can be detd. by high resoln. 31P NMR.  When 1-[16O,17O,18O]phospho-(S)-propane-1,2-diol is cyclized, and then methylated with diazomethane, anal. of the resulting mixt. of diastereoisomeric cyclic triesters by 31P NMR gives an 8-line spectrum.  Species contg. 17O are not obsd. because of quadrupolar broadening of the 31P resonance.  The dependence of the 18O isotopic shift on the nature of the 31P-O bond, allows an unambiguous assignment of the abs. configuration at P.  This method, while less quant. than the mass spectrometric technique developed previously, has the advantages of both conceptual and practical simplicity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrTJ5csUTXSfLVg90H21EOLACvtfcHk0li1WTfYo6Tyyw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL3cXmtFaktL4%253D&md5=53da8c33f2860d733974603ac59b24dc</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1021%2Fja00541a056&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja00541a056%26sid%3Dliteratum%253Aachs%26aulast%3DBuchwald%26aufirst%3DS.%2BL.%26aulast%3DKnowles%26aufirst%3DJ.%2BR.%26atitle%3DDetermination%2520of%2520the%2520Absolute%2520Configuration%2520of%2520%255B16O%252C17O%252C18O%255DPhosphate%2520Monoesters%2520by%2520Using%2520Phosphorus-31%2520NMR%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1980%26volume%3D102%26spage%3D6601%26epage%3D6602%26doi%3D10.1021%2Fja00541a056" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Balibar, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hollis-Symynkywicz, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tao, J.</span></span> <span> </span><span class="NLM_article-title">Pantethine Rescues Phosphopantothenoylcysteine Synthetase and Phosphopantothenoylcysteine Decarboxylase Deficiency in <i>Escherichia coli</i> but Not in <i>Pseudomonas aeruginosa</i></span>. <i>J. Bacteriol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>193</i></span>,  <span class="NLM_fpage">3304</span>– <span class="NLM_lpage">3312</span>, <span class="refDoi"> DOI: 10.1128/JB.00334-11</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01531&amp;key=10.1128%2FJB.00334-11" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01531&amp;key=21551303" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01531&amp;key=1%3ACAS%3A528%3ADC%252BC3MXosVSmsLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=193&publication_year=2011&pages=3304-3312&author=C.+J.+Balibarauthor=M.+F.+Hollis-Symynkywiczauthor=J.+Tao&title=Pantethine+Rescues+Phosphopantothenoylcysteine+Synthetase+and+Phosphopantothenoylcysteine+Decarboxylase+Deficiency+in+Escherichia+coli+but+Not+in+Pseudomonas+aeruginosa&doi=10.1128%2FJB.00334-11"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Pantethine rescues phosphopantothenoylcysteine synthetase and phosphopantothenoylcysteine decarboxylase deficiency in Escherichia coli but not in Pseudomonas aeruginosa</span></div><div class="casAuthors">Balibar, Carl J.; Hollis-Symynkywicz, Micah F.; Tao, Jianshi</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Bacteriology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">193</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">3304-3312</span>CODEN:
                <span class="NLM_cas:coden">JOBAAY</span>;
        ISSN:<span class="NLM_cas:issn">0021-9193</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">CoA plays a central and essential role in all living organisms.  The pathway leading to CoA biosynthesis has been considered an attractive target for developing new antimicrobial agents with novel mechanisms of action.  By using an arabinose-regulated expression system, the essentiality of coaBC, a single gene encoding a bifunctional protein catalyzing two consecutive steps in the CoA pathway converting 4'-phosphopantothenate to 4'-phosphopantetheine, was confirmed in Escherichia coli.  Using this regulated coaBC strain, further E. coli can effectively metabolize pantethine to bypass the requirement for coaBC.  Pantethine cannot be used by Pseudomonas aeruginosa to obviate coaBC.  Through reciprocal complementation studies in combination with biochem. characterization, it was demonstrated that the differential characteristics of pantethine use in these two microorganisms are due to the different substrate specificities assocd. with endogenous pantothenate kinase, the first enzyme in the CoA biosynthetic pathway encoded by coaA in E. coli and coaX in P. aeruginosa.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpyEk83lTpVsbVg90H21EOLACvtfcHk0li1WTfYo6Tyyw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXosVSmsLc%253D&md5=7a1eef41544e6ef5612094d228500f9f</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1128%2FJB.00334-11&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FJB.00334-11%26sid%3Dliteratum%253Aachs%26aulast%3DBalibar%26aufirst%3DC.%2BJ.%26aulast%3DHollis-Symynkywicz%26aufirst%3DM.%2BF.%26aulast%3DTao%26aufirst%3DJ.%26atitle%3DPantethine%2520Rescues%2520Phosphopantothenoylcysteine%2520Synthetase%2520and%2520Phosphopantothenoylcysteine%2520Decarboxylase%2520Deficiency%2520in%2520Escherichia%2520coli%2520but%2520Not%2520in%2520Pseudomonas%2520aeruginosa%26jtitle%3DJ.%2520Bacteriol.%26date%3D2011%26volume%3D193%26spage%3D3304%26epage%3D3312%26doi%3D10.1128%2FJB.00334-11" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brunetti, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dusi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morbin, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uggetti, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moda, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">D’Amato, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giordano, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">D’Amati, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cozzi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Levi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayflick, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tiranti, V.</span></span> <span> </span><span class="NLM_article-title">Pantothenate Kinase-Associated Neurodegeneration: Altered Mitochondria Membrane Potential and Defective Respiration in Pank2 Knock-out Mouse Model</span>. <i>Hum. Mol. Genet.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">5294</span>– <span class="NLM_lpage">5305</span>, <span class="refDoi"> DOI: 10.1093/hmg/dds380</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01531&amp;key=10.1093%2Fhmg%2Fdds380" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01531&amp;key=22983956" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01531&amp;key=1%3ACAS%3A528%3ADC%252BC38XhslKnsLfI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2012&pages=5294-5305&author=D.+Brunettiauthor=S.+Dusiauthor=M.+Morbinauthor=A.+Uggettiauthor=F.+Modaauthor=I.+D%E2%80%99Amatoauthor=C.+Giordanoauthor=G.+D%E2%80%99Amatiauthor=A.+Cozziauthor=S.+Leviauthor=S.+Hayflickauthor=V.+Tiranti&title=Pantothenate+Kinase-Associated+Neurodegeneration%3A+Altered+Mitochondria+Membrane+Potential+and+Defective+Respiration+in+Pank2+Knock-out+Mouse+Model&doi=10.1093%2Fhmg%2Fdds380"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Pantothenate kinase-associated neurodegeneration: altered mitochondria membrane potential and defective respiration in Pank2 knock-out mouse model</span></div><div class="casAuthors">Brunetti, Dario; Dusi, Sabrina; Morbin, Michela; Uggetti, Andrea; Moda, Fabio; D'Amato, Ilaria; Giordano, Carla; d'Amati, Giulia; Cozzi, Anna; Levi, Sonia; Hayflick, Susan; Tiranti, Valeria</div><div class="citationInfo"><span class="NLM_cas:title">Human Molecular Genetics</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">5294-5305</span>CODEN:
                <span class="NLM_cas:coden">HMGEE5</span>;
        ISSN:<span class="NLM_cas:issn">0964-6906</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Neurodegeneration with brain iron accumulation (NBIA) comprises a group of neurodegenerative disorders characterized by high brain content of iron and presence of axonal spheroids.  Mutations in the PANK2 gene, which encodes pantothenate kinase 2, underlie an autosomal recessive inborn error of CoA metab., called pantothenate kinase-assocd. neurodegeneration (PKAN).  PKAN is characterized by dystonia, dysarthria, rigidity and pigmentary retinal degeneration.  The pathogenesis of this disorder is poorly understood and, although PANK2 is a mitochondrial protein, perturbations in mitochondrial bioenergetics have not been reported.  A knock-out (KO) mouse model of PKAN exhibits retinal degeneration and azoospermia, but lacks any neurol. phenotype.  The absence of a clin. phenotype has partially been explained by the different cellular localization of the human and murine PANK2 proteins.  Here we demonstrate that the mouse Pank2 protein localizes to mitochondria, similar to its human orthologue.  Moreover, we show that Pank2-defective neurons derived from KO mice have an altered mitochondrial membrane potential, a defect further corroborated by the observations of swollen mitochondria at the ultra-structural level and by the presence of defective respiration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpj-jrm27dzq7Vg90H21EOLACvtfcHk0li1WTfYo6Tyyw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhslKnsLfI&md5=65f0eeb667d36c4da04b612a233a6ca7</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1093%2Fhmg%2Fdds380&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fhmg%252Fdds380%26sid%3Dliteratum%253Aachs%26aulast%3DBrunetti%26aufirst%3DD.%26aulast%3DDusi%26aufirst%3DS.%26aulast%3DMorbin%26aufirst%3DM.%26aulast%3DUggetti%26aufirst%3DA.%26aulast%3DModa%26aufirst%3DF.%26aulast%3DD%25E2%2580%2599Amato%26aufirst%3DI.%26aulast%3DGiordano%26aufirst%3DC.%26aulast%3DD%25E2%2580%2599Amati%26aufirst%3DG.%26aulast%3DCozzi%26aufirst%3DA.%26aulast%3DLevi%26aufirst%3DS.%26aulast%3DHayflick%26aufirst%3DS.%26aulast%3DTiranti%26aufirst%3DV.%26atitle%3DPantothenate%2520Kinase-Associated%2520Neurodegeneration%253A%2520Altered%2520Mitochondria%2520Membrane%2520Potential%2520and%2520Defective%2520Respiration%2520in%2520Pank2%2520Knock-out%2520Mouse%2520Model%26jtitle%3DHum.%2520Mol.%2520Genet.%26date%3D2012%26volume%3D21%26spage%3D5294%26epage%3D5305%26doi%3D10.1093%2Fhmg%2Fdds380" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tian, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wysocki, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arnold, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ravichandran, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sternson, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Looger, L. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lavis, L. D.</span></span> <span> </span><span class="NLM_article-title">Selective Esterase-Ester Pair for Targeting Small Molecules with Cellular Specificity</span>. <i>Proc. Natl. Acad. Sci. U.S.A.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>109</i></span>,  <span class="NLM_fpage">4756</span>– <span class="NLM_lpage">4761</span>, <span class="refDoi"> DOI: 10.1073/pnas.1111943109</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01531&amp;key=10.1073%2Fpnas.1111943109" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01531&amp;key=22411832" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01531&amp;key=1%3ACAS%3A528%3ADC%252BC38XltF2msbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=109&publication_year=2012&pages=4756-4761&author=L.+Tianauthor=Y.+Yangauthor=L.+M.+Wysockiauthor=A.+C.+Arnoldauthor=A.+Huauthor=B.+Ravichandranauthor=S.+M.+Sternsonauthor=L.+L.+Loogerauthor=L.+D.+Lavis&title=Selective+Esterase-Ester+Pair+for+Targeting+Small+Molecules+with+Cellular+Specificity&doi=10.1073%2Fpnas.1111943109"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Selective esterase-ester pair for targeting small molecules with cellular specificity</span></div><div class="casAuthors">Tian, Lin; Yang, Yunlei; Wysocki, Laura M.; Arnold, Alma C.; Hu, Amy; Ravichandran, Balaji; Sternson, Scott M.; Looger, Loren L.; Lavis, Luke D.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">109</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">4756-4761, S4756/1-S4756/12</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Small mols. are important tools to measure and modulate intracellular signaling pathways.  A longstanding limitation for using chem. compds. in complex tissues has been the inability to target bioactive small mols. to a specific cell class.  Here, we describe a generalizable esterase-ester pair capable of targeted delivery of small mols. to living cells and tissue with cellular specificity.  We used fluorogenic mols. to rapidly identify a small ester masking motif that is stable to endogenous esterases, but is efficiently removed by an exogenous esterase.  This strategy allows facile targeting of dyes and drugs in complex biol. environments to label specific cell types, illuminate gap junction connectivity, and pharmacol. perturb distinct subsets of cells.  We expect this approach to have general utility for the specific delivery of many small mols. to defined cellular populations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqFjIH1CDwPTrVg90H21EOLACvtfcHk0lj28SEQKE6_HA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XltF2msbo%253D&md5=739853ea85d7e1591d9ca6caa282c341</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1111943109&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1111943109%26sid%3Dliteratum%253Aachs%26aulast%3DTian%26aufirst%3DL.%26aulast%3DYang%26aufirst%3DY.%26aulast%3DWysocki%26aufirst%3DL.%2BM.%26aulast%3DArnold%26aufirst%3DA.%2BC.%26aulast%3DHu%26aufirst%3DA.%26aulast%3DRavichandran%26aufirst%3DB.%26aulast%3DSternson%26aufirst%3DS.%2BM.%26aulast%3DLooger%26aufirst%3DL.%2BL.%26aulast%3DLavis%26aufirst%3DL.%2BD.%26atitle%3DSelective%2520Esterase-Ester%2520Pair%2520for%2520Targeting%2520Small%2520Molecules%2520with%2520Cellular%2520Specificity%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2012%26volume%3D109%26spage%3D4756%26epage%3D4761%26doi%3D10.1073%2Fpnas.1111943109" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Montagu, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pradére, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roy, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nolan, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Agrofoglio, L. A.</span></span> <span> </span><span class="NLM_article-title">Expeditious Convergent Procedure for the Preparation of Bis(POC) Prodrugs of New (E)-4-Phosphono-but-2-En-1-Yl Nucleosides</span>. <i>Tetrahedron</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>67</i></span>,  <span class="NLM_fpage">5319</span>– <span class="NLM_lpage">5328</span>, <span class="refDoi"> DOI: 10.1016/j.tet.2011.05.017</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01531&amp;key=10.1016%2Fj.tet.2011.05.017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01531&amp;key=1%3ACAS%3A528%3ADC%252BC3MXnsVCku7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2011&pages=5319-5328&author=A.+Montaguauthor=U.+Prad%C3%A9reauthor=V.+Royauthor=S.+P.+Nolanauthor=L.+A.+Agrofoglio&title=Expeditious+Convergent+Procedure+for+the+Preparation+of+Bis%28POC%29+Prodrugs+of+New+%28E%29-4-Phosphono-but-2-En-1-Yl+Nucleosides&doi=10.1016%2Fj.tet.2011.05.017"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Expeditious convergent procedure for the preparation of bis(POC) prodrugs of new (E)-4-phosphono-but-2-en-1-yl nucleosides</span></div><div class="casAuthors">Montagu, Aurelien; Pradere, Ugo; Roy, Vincent; Nolan, Steven P.; Agrofoglio, Luigi A.</div><div class="citationInfo"><span class="NLM_cas:title">Tetrahedron</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">29</span>),
    <span class="NLM_cas:pages">5319-5328</span>CODEN:
                <span class="NLM_cas:coden">TETRAB</span>;
        ISSN:<span class="NLM_cas:issn">0040-4020</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A series of unsatd. acyclonucleoside bis(POC) prodrugs of E configuration were synthesized through an expeditious, highly efficient and stereoselective one-step procedure from corresponding bis(POC)allyl-phosphonate through Ru catalyzed cross-coupling metathesis reaction.  The [RuCl2(PCy3)(SIPr)(Indenylidene)] and [RuCl2(PCy3)(IMes)(benzylidene)] catalysts were employed; the unsatd. ANP were used bore C5-halovinyl uracil, C5-dihalovinyl-uracil or furano-pyrimidine motifs.  The chem. cleavage of bio-labile (POC) group is a useful pathway to acid phosphonate derivs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp5Og5ECKbRhrVg90H21EOLACvtfcHk0lj28SEQKE6_HA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXnsVCku7k%253D&md5=d8a31f7868961a908b18a72d53a88954</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1016%2Fj.tet.2011.05.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tet.2011.05.017%26sid%3Dliteratum%253Aachs%26aulast%3DMontagu%26aufirst%3DA.%26aulast%3DPrad%25C3%25A9re%26aufirst%3DU.%26aulast%3DRoy%26aufirst%3DV.%26aulast%3DNolan%26aufirst%3DS.%2BP.%26aulast%3DAgrofoglio%26aufirst%3DL.%2BA.%26atitle%3DExpeditious%2520Convergent%2520Procedure%2520for%2520the%2520Preparation%2520of%2520Bis%2528POC%2529%2520Prodrugs%2520of%2520New%2520%2528E%2529-4-Phosphono-but-2-En-1-Yl%2520Nucleosides%26jtitle%3DTetrahedron%26date%3D2011%26volume%3D67%26spage%3D5319%26epage%3D5328%26doi%3D10.1016%2Fj.tet.2011.05.017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fung, H. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stone, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piacenti, F. J.</span></span> <span> </span><span class="NLM_article-title">Tenofovir Disoproxil Fumarate: A Nucleotide Reverse Transcriptase Inhibitor for the Treatment of HIV Infection</span>. <i>Clin. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">1515</span>– <span class="NLM_lpage">1548</span>, <span class="refDoi"> DOI: 10.1016/S0149-2918(02)80058-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01531&amp;key=10.1016%2FS0149-2918%2802%2980058-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01531&amp;key=12462284" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01531&amp;key=1%3ACAS%3A528%3ADC%252BD38XpsVSqsbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2002&pages=1515-1548&author=H.+B.+Fungauthor=E.+A.+Stoneauthor=F.+J.+Piacenti&title=Tenofovir+Disoproxil+Fumarate%3A+A+Nucleotide+Reverse+Transcriptase+Inhibitor+for+the+Treatment+of+HIV+Infection&doi=10.1016%2FS0149-2918%2802%2980058-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Tenofovir disoproxil fumarate: a nucleotide reverse transcriptase inhibitor for the treatment of HIV infection</span></div><div class="casAuthors">Fung, Horatio B.; Stone, Elizabeth A.; Piacenti, Frank J.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Therapeutics</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1515-1548</span>CODEN:
                <span class="NLM_cas:coden">CLTHDG</span>;
        ISSN:<span class="NLM_cas:issn">0149-2918</span>.
    
            (<span class="NLM_cas:orgname">Excerpta Medica, Inc.</span>)
        </div><div class="casAbstract">A review.  Tenofovir disoproxil fumarate (DF) is the first nucleotide reverse transcriptase inhibitor approved for use in combination with other antiretroviral agents in the treatment of HIV-1 infection in the United States.  Unlike the nucleoside reverse transcriptase inhibitors, which must undergo 3 intracellular phosphorylation steps for activation, nucleotide analogs such as tenofovir require only 2 such steps.  This redn. in the phosphorylation requirement has the potential to produce more rapid and complete conversion of the drug to its pharmacol. active metabolite.  This article describes the pharmacol. properties and potential clin. usefulness of tenofovir DF.  Relevant information was identified through searches of MEDLINE (1996-Apr. 2002), Iowa Drug Information Service (1996-Apr. 2002), and International Pharmaceutical Abstrs. (1970-Apr. 2002), as well as from meeting abstrs. of major HIV/AIDS conferences (1996-2002), using the search terms tenofovir, tenofovir disoproxil fumarate, PMPA, bis(POC)PMPA, GS-4331-05, acyclic nucleoside phosphonate, and nucleotide reverse transcriptase inhibitor.  Addnl. information was obtained from material submitted to the US Food and Drug Administration by the manufacturer of tenofovir DF in support of its New Drug Application.  In vitro, tenofovir DF has exhibited anti-HIV activity in various HIV-infected cell lines and has produced a synergistic or additive effect against HIV when combined with other antiretroviral agents.  In adult humans, tenofovir has a vol. of distribution of 0.813 L/kg, is minimally bound to plasma protein (7.2%), has a plasma elimination half-life of 12.0 to 14.4 h, and is mainly excreted unchanged in urine (70%-80%).  Dose adjustment based on sex or body wt. does not appear to be necessary, although dose redn. may be necessary in the elderly; there are currently no data on tenofovir DF in renal or hepatic insufficiency.  The results of clin. trials suggest the efficacy of tenofovir DF in reducing plasma levels of HIV-1 RNA when used as an add-on to a stable antiretroviral regimen.  The most commonly (>3%) reported adverse events in clin. trials have included nausea, diarrhea, asthenia, headache, vomiting, flatulence, abdominal pain, and anorexia.  The most commonly (>2%) reported lab. abnormalities (grade III or IV) included increases in creatine kinase, triglycerides, amylase, aspartate aminotransferase, and alanine aminotransferase, as well as hyperglycemia and glucosuria.  Serious adverse events leading to discontinuation of tenofovir DF were infrequent (5%), occurring with an incidence similar to that with placebo (8%).  The recommended dosage of tenofovir DF in adults is 300 mg/d PO; pharmacokinetic and efficacy studies in children are ongoing.  Although addnl. studies are needed, tenofovir DF appears to be a promising agent for the treatment of HIV infection.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp_At-9GMM12LVg90H21EOLACvtfcHk0lj28SEQKE6_HA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XpsVSqsbc%253D&md5=716b9b05811ed7a100bfc50280094e25</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1016%2FS0149-2918%2802%2980058-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0149-2918%252802%252980058-3%26sid%3Dliteratum%253Aachs%26aulast%3DFung%26aufirst%3DH.%2BB.%26aulast%3DStone%26aufirst%3DE.%2BA.%26aulast%3DPiacenti%26aufirst%3DF.%2BJ.%26atitle%3DTenofovir%2520Disoproxil%2520Fumarate%253A%2520A%2520Nucleotide%2520Reverse%2520Transcriptase%2520Inhibitor%2520for%2520the%2520Treatment%2520of%2520HIV%2520Infection%26jtitle%3DClin.%2520Ther.%26date%3D2002%26volume%3D24%26spage%3D1515%26epage%3D1548%26doi%3D10.1016%2FS0149-2918%2802%2980058-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cederbaum, A. I.</span></span> <span> </span><span class="NLM_article-title">Alcohol Metabolism</span>. <i>Clin. Liver Dis.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">667</span>– <span class="NLM_lpage">685</span>, <span class="refDoi"> DOI: 10.1016/j.cld.2012.08.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01531&amp;key=10.1016%2Fj.cld.2012.08.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01531&amp;key=23101976" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01531&amp;key=1%3ACAS%3A280%3ADC%252BC3s%252FosVyjsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2012&pages=667-685&author=A.+I.+Cederbaum&title=Alcohol+Metabolism&doi=10.1016%2Fj.cld.2012.08.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Alcohol metabolism</span></div><div class="casAuthors">Cederbaum Arthur I</div><div class="citationInfo"><span class="NLM_cas:title">Clinics in liver disease</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">667-85</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">This article describes the pathways and factors that modulate blood alcohol levels and metabolism and describes how the body disposes of alcohol.  The various factors that play a role in the distribution of alcohol in the body, influence the absorption of alcohol, and contribute to first-pass metabolism of alcohol are described.  Most alcohol is oxidized in the liver, and general principles and overall mechanisms for alcohol oxidation are summarized.  The kinetics of alcohol elimination in-vivo and the various genetic and environmental factors that can modify the rate of alcohol metabolism are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT137Qxyuzmxk2yPDyEFiigfW6udTcc2eYBCUfGy8f3kLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3s%252FosVyjsQ%253D%253D&md5=f95cf0d488509d8c5ab3ad5345e50c2f</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1016%2Fj.cld.2012.08.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cld.2012.08.002%26sid%3Dliteratum%253Aachs%26aulast%3DCederbaum%26aufirst%3DA.%2BI.%26atitle%3DAlcohol%2520Metabolism%26jtitle%3DClin.%2520Liver%2520Dis.%26date%3D2012%26volume%3D16%26spage%3D667%26epage%3D685%26doi%3D10.1016%2Fj.cld.2012.08.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hansch, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rockwell, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jow, P. Y. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leo, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steller, E. E.</span></span> <span> </span><span class="NLM_article-title">Substituent Constants for Correlation Analysis</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1977</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">304</span>– <span class="NLM_lpage">306</span>, <span class="refDoi"> DOI: 10.1021/jm00212a024</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm00212a024" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01531&amp;key=1%3ACAS%3A528%3ADyaE2sXltVOqsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=1977&pages=304-306&author=C.+Hanschauthor=S.+D.+Rockwellauthor=P.+Y.+C.+Jowauthor=A.+Leoauthor=E.+E.+Steller&title=Substituent+Constants+for+Correlation+Analysis&doi=10.1021%2Fjm00212a024"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Substituent constants for correlation analysis</span></div><div class="casAuthors">Hansch, Corwin; Rockwell, Sharon D.; Jow, Priscilla Y. C.; Leo, Albert; Steller, Edward E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1977</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">304-6</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    </div><div class="casAbstract">Consts. for π and σ were measured for 48 misc. arom. substituents of interest to medicinal chemists.  Swain and Lupton's ℱ and ℘ values were calcd. from the σ consts.  Values for molar refractivity are given for each of the substituents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpAn5OlCZr0DLVg90H21EOLACvtfcHk0lirXpFB63Th1Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE2sXltVOqsw%253D%253D&md5=9b7aaf958d1387060416b9fe9a6adad1</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1021%2Fjm00212a024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00212a024%26sid%3Dliteratum%253Aachs%26aulast%3DHansch%26aufirst%3DC.%26aulast%3DRockwell%26aufirst%3DS.%2BD.%26aulast%3DJow%26aufirst%3DP.%2BY.%2BC.%26aulast%3DLeo%26aufirst%3DA.%26aulast%3DSteller%26aufirst%3DE.%2BE.%26atitle%3DSubstituent%2520Constants%2520for%2520Correlation%2520Analysis%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1977%26volume%3D20%26spage%3D304%26epage%3D306%26doi%3D10.1021%2Fjm00212a024" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref100"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref100'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit100"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vaino, A.</span>; <span class="NLM_string-name">Biestek, M.</span>; <span class="NLM_string-name">Shkreli, M.</span></span><span> </span><span class="NLM_article-title">Pantothenate derivatives for the treatment of neuroligic disorders</span>. <span class="NLM_patent">WO2013163576</span>, Published 31 Oct <span class="NLM_year">2013</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&author=A.+Vaino&author=M.+Biestek&author=M.+Shkreli&title=Pantothenate+derivatives+for+the+treatment+of+neuroligic+disorders"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit100&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DVaino%26aufirst%3DA.%26atitle%3DPantothenate%2520derivatives%2520for%2520the%2520treatment%2520of%2520neuroligic%2520disorders%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref100':['cit100']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article has not yet been cited by other publications.</p></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01531/20201218/images/medium/jm0c01531_0015.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01531/20201218/images/large/jm0c01531_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01531&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="cht1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Chart 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01531/20201218/images/medium/jm0c01531_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01531/20201218/images/large/jm0c01531_0002.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Chart 1. Biosynthetic Intermediates in CoA Synthesis and New PPA Prodrugs</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01531/20201218/images/large/jm0c01531_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01531&amp;id=cht1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01531/20201218/images/medium/jm0c01531_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01531/20201218/images/large/jm0c01531_0004.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01531/20201218/images/large/jm0c01531_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01531&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) POCl<sub>3</sub>, triethylamine (TEA), tetrahydrofuran (THF), −78 to 20 °C, then BnOH, TEA, THF, −78 to 20 °C; (b) H<sub>2</sub>, Pd/C, EtOAc; (c) RC(O)OCH<sub>2</sub>Cl, DIEA, dimethylformamide (DMF), 0–80 °C; (d) RC(O)OCH<sub>2</sub>Cl, Ag<sub>2</sub>O, AcCN, 80 °C; (e) chloromethyl sulfurochloridate, <i>t</i>-Bu<sub>4</sub>NHSO<sub>4</sub>, NaHCO<sub>3</sub>, H<sub>2</sub>O, dichloromethane (DCM), 0–20 °C; (f) RCO<sub>2</sub>H, Cs<sub>2</sub>CO<sub>3</sub>, DMF.</p></p></figure><figure data-id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01531/20201218/images/medium/jm0c01531_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01531/20201218/images/large/jm0c01531_0005.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01531/20201218/images/large/jm0c01531_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01531&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) SOCl<sub>2</sub>, MeOH, reflux, 2 h; (b) (<i>R</i>)-pantolactone, TEA, MeOH, reflux, on; (c) PO(18)Cl<sub>3</sub>, TEA, THF, −78 to 20 °C, then BnOH, TEA, THF, −78 to 20 °C; (d) H<sub>2</sub>, Pd/C, EtOAc; (e) RC(O)OCH<sub>2</sub>Cl, DIEA, DMF, 0–80 °C;</p></p></figure><figure data-id="sch3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01531/20201218/images/medium/jm0c01531_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01531/20201218/images/large/jm0c01531_0006.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01531/20201218/images/large/jm0c01531_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01531&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) (3<i>R</i>)-4,4-dimethyl-3-oxidanyl-oxolan-2-one, 85 °C; (b) POCl<sub>3</sub>, TEA, THF, −78 °C, then BnOH, NMI, THF, −78 °C; (c) H<sub>2</sub>, Pd/C; (d) chloromethyl-2,2-dimethylpropanoate, DIEA, 80 °C; (e) TFA, DCM; (f) R′OH, TBTU, AcCN.</p></p></figure><figure data-id="sch4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01531/20201218/images/medium/jm0c01531_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01531/20201218/images/large/jm0c01531_0007.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01531/20201218/images/large/jm0c01531_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01531&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) POCl<sub>3</sub>, TEA, THF, −78 °C; (b) R-C6H4-OH, TEA, Et<sub>2</sub>O, 0 °C; (c) POCl<sub>3</sub>, TEA, Et<sub>2</sub>O, −78 to 20 °C; (d) <b>4</b>, TEA, THF, −78 to 20 °C.</p></p></figure><figure data-id="fig1" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01531/20201218/images/medium/jm0c01531_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01531/20201218/images/large/jm0c01531_0003.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Effect of compound <b>2a</b> on lipid droplet content in PANk2<sup>–/–</sup> cells. (A) Two representative images of wild-type (mock) and PANk2<sup>–/–</sup> cells (untreated and treated with compound <b>2a</b> at 10 μM for 48 h); cells were fixed and stained with 100 ng/mL Nile Red and imaged by an inverted axiovert microscope (Zeiss) at 60× magnification. (B) Fluorimetric quantification of lipid droplet content using a Tecan Safire microplate detection system. Results are reported as mean ± standard deviation (sd) (two biological replicates, each in duplicate) **<i>p</i> < 0.01, two-tailed paired Student’s <i>t</i>-test.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01531/20201218/images/large/jm0c01531_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01531&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i69">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_00253" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_00253" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 32 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gregory, A.</span>; <span class="NLM_string-name">Hayflick, S. J.</span></span> <span> </span><span class="NLM_article-title">Pantothenate Kinase-Associated Neurodegeneration Summary</span>.  <i>GeneReviews</i>; <span class="NLM_publisher-name">University of Washington</span>, <span class="NLM_year">2020</span>; pp  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">20</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2020&pages=1-20&author=A.+Gregory&author=S.+J.+Hayflick&title=GeneReviews"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DGregory%26aufirst%3DA.%26atitle%3DPantothenate%2520Kinase-Associated%2520Neurodegeneration%2520Summary%26btitle%3DGeneReviews%26pub%3DUniversity%2520of%2520Washington%26date%3D2020%26spage%3D1%26epage%3D20" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gregory, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayflick, S. J.</span></span> <span> </span><span class="NLM_article-title">Neurodegeneration with Brain Iron Accumulation</span>. <i>Folia Neuropathol.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>43</i></span>,  <span class="NLM_fpage">286</span>– <span class="NLM_lpage">296</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01531&amp;key=16416393" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01531&amp;key=1%3ACAS%3A528%3ADC%252BD28XhsFGjtrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2005&pages=286-296&author=A.+Gregoryauthor=S.+J.+Hayflick&title=Neurodegeneration+with+Brain+Iron+Accumulation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Neurodegeneration with brain iron accumulation</span></div><div class="casAuthors">Gregory, Allison; Hayflick, Susan J.</div><div class="citationInfo"><span class="NLM_cas:title">Folia Neuropathologica</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">286-296</span>CODEN:
                <span class="NLM_cas:coden">FONEEW</span>;
        ISSN:<span class="NLM_cas:issn">1641-4640</span>.
    
            (<span class="NLM_cas:orgname">Termedia Publishing House</span>)
        </div><div class="casAbstract">A review.  Neurodegeneration with brain iron accumulation (NBIA) describes a group of progressive extrapyramidal disorders with radiog. evidence of focal iron accumulation in the brain, usually in the basal ganglia.  Patients previously diagnosed with Hallervorden-Spatz syndrome fall into this category.  Mutations in the PANK2 gene account for the majority of NBIA cases and cause an autosomal recessive inborn error of CoA metab. called pantothenate kinase-assocd. neurodegeneration (PKAN).  PKAN is characterized by dystonia and pigmentary retinopathy in children or speech and neuropsychiatric disorders in adults.  In addn., a specific pattern on brain MRI, called the eye-of-the-tiger sign, is virtually pathognomonic for the disease.  Pantothenate kinase is essential to CoA biosynthesis, and the PANK2 protein is targeted to the mitochondria.  Hypotheses of PKAN pathogenesis are based on the predictions of tissue-specific CoA deficiency and the accumulation of cysteine-contg. substrates.  Identification of the major NBIA gene has led to more accurate clin. delineation of the diseases that comprise this group, a mol. diagnostic test for PKAN, and hypotheses for treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr0VuJqV4J_mbVg90H21EOLACvtfcHk0ljrLn2G9wxzjQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhsFGjtrw%253D&md5=92f500411aed9f540a74c3b46ee4581e</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGregory%26aufirst%3DA.%26aulast%3DHayflick%26aufirst%3DS.%2BJ.%26atitle%3DNeurodegeneration%2520with%2520Brain%2520Iron%2520Accumulation%26jtitle%3DFolia%2520Neuropathol.%26date%3D2005%26volume%3D43%26spage%3D286%26epage%3D296" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hayflick, S. J.</span></span> <span> </span><span class="NLM_article-title">Unraveling the Hallervorden-Spatz Syndrome: Pantothenate Kinase-Associated Neurodegeneration Is the Name</span>. <i>Curr. Opin. Pediatr.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">572</span>– <span class="NLM_lpage">577</span>, <span class="refDoi"> DOI: 10.1097/00008480-200312000-00005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01531&amp;key=10.1097%2F00008480-200312000-00005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01531&amp;key=14631201" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01531&amp;key=1%3ACAS%3A280%3ADC%252BD3srltVGhug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2003&pages=572-577&author=S.+J.+Hayflick&title=Unraveling+the+Hallervorden-Spatz+Syndrome%3A+Pantothenate+Kinase-Associated+Neurodegeneration+Is+the+Name&doi=10.1097%2F00008480-200312000-00005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Unraveling the Hallervorden-Spatz syndrome: pantothenate kinase-associated neurodegeneration is the name</span></div><div class="casAuthors">Hayflick Susan J</div><div class="citationInfo"><span class="NLM_cas:title">Current opinion in pediatrics</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">572-7</span>
        ISSN:<span class="NLM_cas:issn">1040-8703</span>.
    </div><div class="casAbstract">PURPOSE OF REVIEW:  After the recent discovery of the major genetic defect in neurodegeneration with brain iron accumulation (NBIA, formerly Hallervorden-Spatz syndrome), this heterogeneous group of disorders can now be differentiated by clinical, radiographic, and molecular features.  RECENT FINDINGS:  Disease caused by mutations in the gene encoding pantothenate kinase 2 (PANK2) is characterized by dystonia and pigmentary retinopathy in children or speech and neuropsychiatric defects in adults, in concert with a specific pattern on MRI of the brain.  This virtually pathognomonic radiographic abnormality, called the eye-of-the-tiger sign, comprises hyperintensities within a hypointense medial globus pallidus on T2-weighted images.  This disorder is called pantothenate kinase-associated neurodegeneration (PKAN) and accounts for most patients diagnosed with NBIA.  Pantothenate kinase is essential to coenzyme A biosynthesis, and PANK2 is targeted to mitochondria, a feature that distinguishes it from the three other human pantothenate kinase homologs.  Hypotheses of PKAN pathogenesis are based on the predictions of tissue-specific coenzyme A deficiency and the accumulation of cysteine-containing enzyme substrates, which may chelate iron and lead to the cardinal disease feature of basal ganglia iron accumulation.  SUMMARY:  Recent insight into the biochemical basis of PKAN has led to novel ideas for rational therapies.  Investigations are under way to enable testing of promising compounds, first in animal models of disease and then in human patients.  Identification of the genetic basis for the major form of NBIA has allowed more accurate clinical delineation of the specific diseases that compose this group, a new molecular diagnostic test for PKAN, and hypotheses for treatment of this neurodegenerative disorder.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ2ws0xWEcUgJZoeNcnHOQ9fW6udTcc2ebxLWeqOowel7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3srltVGhug%253D%253D&md5=f577dd69985cd9ec5d32e614adeb0524</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1097%2F00008480-200312000-00005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252F00008480-200312000-00005%26sid%3Dliteratum%253Aachs%26aulast%3DHayflick%26aufirst%3DS.%2BJ.%26atitle%3DUnraveling%2520the%2520Hallervorden-Spatz%2520Syndrome%253A%2520Pantothenate%2520Kinase-Associated%2520Neurodegeneration%2520Is%2520the%2520Name%26jtitle%3DCurr.%2520Opin.%2520Pediatr.%26date%3D2003%26volume%3D15%26spage%3D572%26epage%3D577%26doi%3D10.1097%2F00008480-200312000-00005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schneider, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hardy, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhatia, K. P.</span></span> <span> </span><span class="NLM_article-title">Syndromes of Neurodegeneration with Brain Iron Accumulation (NBIA): An Update on Clinical Presentations, Histological and Genetic Underpinnings, and Treatment Considerations</span>. <i>Mov. Disord.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_fpage">42</span>– <span class="NLM_lpage">53</span>, <span class="refDoi"> DOI: 10.1002/mds.23971</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01531&amp;key=10.1002%2Fmds.23971" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01531&amp;key=22031173" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01531&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsVWms7fE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&pages=42-53&author=S.+A.+Schneiderauthor=J.+Hardyauthor=K.+P.+Bhatia&title=Syndromes+of+Neurodegeneration+with+Brain+Iron+Accumulation+%28NBIA%29%3A+An+Update+on+Clinical+Presentations%2C+Histological+and+Genetic+Underpinnings%2C+and+Treatment+Considerations&doi=10.1002%2Fmds.23971"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Syndromes of neurodegeneration with brain iron accumulation (NBIA): An update on clinical presentations, histological and genetic underpinnings, and treatment considerations</span></div><div class="casAuthors">Schneider, Susanne A.; Hardy, John; Bhatia, Kailash P.</div><div class="citationInfo"><span class="NLM_cas:title">Movement Disorders</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">42-53</span>CODEN:
                <span class="NLM_cas:coden">MOVDEA</span>;
        ISSN:<span class="NLM_cas:issn">0885-3185</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  In recent years, understanding of the syndromes of neurodegeneration with brain iron accumulation (NBIA) has grown considerably.  In addn. to the core syndromes of pantothenate kinase-assocd. neurodegeneration (PKAN, NBIA1) and PLA2G6-assocd. neurodegeneration (PLAN, NBIA2), several other genetic causes have been identified.  The acknowledged clin. spectrum has broadened, age-dependent presentations have been recognized, and we are becoming aware of overlap between the different NBIA disorders as well as with other diseases.  Autopsy examn. of genetically confirmed cases has demonstrated Lewy bodies and/or tangles in some subforms, bridging the gap to more common neurodegenerative disorders such as Parkinson's disease.  NBIA genes map into related pathways, the understanding of which is important as we move toward mechanistic therapies.  Our aim in this review is to provide an overview of not only the historical developments, clin. features, investigational findings, and therapeutic results but also the genetic and mol. underpinnings of the NBIA syndromes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpsEQAFVWHgVLVg90H21EOLACvtfcHk0lh3zw_IvoFRDA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsVWms7fE&md5=d9521a3a413b181f70bc2cb6f4cfc3a7</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1002%2Fmds.23971&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fmds.23971%26sid%3Dliteratum%253Aachs%26aulast%3DSchneider%26aufirst%3DS.%2BA.%26aulast%3DHardy%26aufirst%3DJ.%26aulast%3DBhatia%26aufirst%3DK.%2BP.%26atitle%3DSyndromes%2520of%2520Neurodegeneration%2520with%2520Brain%2520Iron%2520Accumulation%2520%2528NBIA%2529%253A%2520An%2520Update%2520on%2520Clinical%2520Presentations%252C%2520Histological%2520and%2520Genetic%2520Underpinnings%252C%2520and%2520Treatment%2520Considerations%26jtitle%3DMov.%2520Disord.%26date%3D2012%26spage%3D42%26epage%3D53%26doi%3D10.1002%2Fmds.23971" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Alfonso-Pecchio, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garcia, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leonardi, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jackowski, S.</span></span> <span> </span><span class="NLM_article-title">Compartmentalization of Mammalian Pantothenate Kinases</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>7</i></span>, <span class="NLM_elocation-id">e49509</span> <span class="refDoi"> DOI: 10.1371/journal.pone.0049509</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01531&amp;key=10.1371%2Fjournal.pone.0049509" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01531&amp;key=23152917" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01531&amp;key=1%3ACAS%3A528%3ADC%252BC38XhslKjtbfE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&author=A.+Alfonso-Pecchioauthor=M.+Garciaauthor=R.+Leonardiauthor=S.+Jackowski&title=Compartmentalization+of+Mammalian+Pantothenate+Kinases&doi=10.1371%2Fjournal.pone.0049509"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Compartmentalization of mammalian pantothenate kinases</span></div><div class="casAuthors">Alfonso-Pecchio, Adolfo; Garcia, Matthew; Leonardi, Roberta; Jackowski, Suzanne</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">e49509</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">The pantothenate kinases (PanK) catalyze the first and the rate-limiting step in CoA biosynthesis and regulate the amt. of CoA in tissues by differential isoform expression and allosteric interaction with metabolic ligands.  The four human and mouse PanK proteins share a homologous carboxy-terminal catalytic domain, but differ in their amino-termini.  These unique termini direct the isoforms to different subcellular compartments.  PanK1α isoforms were exclusively nuclear, with preferential assocn. with the granular component of the nucleolus during interphase.  PanK1α also assocd. with the peri-chromosomal region in condensing chromosomes during mitosis.  The PanK1β and PanK3 isoforms were cytosolic, with a portion of PanK1β assocd. with clathrin-assocd. vesicles and recycling endosomes.  Human PanK2, known to assoc. with mitochondria, was specifically localized to the inter-membrane space.  Human PanK2 was also detected in the nucleus and functional nuclear localization and export signals were identified and exptl. confirmed.  Nuclear PanK2 trafficked from the nucleus to the mitochondria, but not in the other direction and was absent from the nucleus during G2 phase of the cell cycle.  The localization of human PanK2 in these two compartments was in sharp contrast to mouse PanK2, which was exclusively cytosolic.  These data demonstrate that PanK isoforms are differentially compartmentalized allowing them to sense CoA homeostasis in different cellular compartments and enable interaction with regulatory ligands produced in these same locations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpmsISxggccgLVg90H21EOLACvtfcHk0lh3zw_IvoFRDA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhslKjtbfE&md5=bd1a9741beacbf1181ecf99d80dcc338</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0049509&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0049509%26sid%3Dliteratum%253Aachs%26aulast%3DAlfonso-Pecchio%26aufirst%3DA.%26aulast%3DGarcia%26aufirst%3DM.%26aulast%3DLeonardi%26aufirst%3DR.%26aulast%3DJackowski%26aufirst%3DS.%26atitle%3DCompartmentalization%2520of%2520Mammalian%2520Pantothenate%2520Kinases%26jtitle%3DPLoS%2520One%26date%3D2012%26volume%3D7%26doi%3D10.1371%2Fjournal.pone.0049509" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gregory, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Polster, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayflick, S. J.</span></span> <span> </span><span class="NLM_article-title">Clinical and Genetic Delineation of Neurodegeneration with Brain Iron Accumulation</span>. <i>J. Med. Genet.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>46</i></span>,  <span class="NLM_fpage">73</span>– <span class="NLM_lpage">80</span>, <span class="refDoi"> DOI: 10.1136/jmg.2008.061929</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01531&amp;key=10.1136%2Fjmg.2008.061929" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01531&amp;key=18981035" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2008&pages=73-80&author=A.+Gregoryauthor=B.+J.+Polsterauthor=S.+J.+Hayflick&title=Clinical+and+Genetic+Delineation+of+Neurodegeneration+with+Brain+Iron+Accumulation&doi=10.1136%2Fjmg.2008.061929"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1136%2Fjmg.2008.061929&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1136%252Fjmg.2008.061929%26sid%3Dliteratum%253Aachs%26aulast%3DGregory%26aufirst%3DA.%26aulast%3DPolster%26aufirst%3DB.%2BJ.%26aulast%3DHayflick%26aufirst%3DS.%2BJ.%26atitle%3DClinical%2520and%2520Genetic%2520Delineation%2520of%2520Neurodegeneration%2520with%2520Brain%2520Iron%2520Accumulation%26jtitle%3DJ.%2520Med.%2520Genet.%26date%3D2008%26volume%3D46%26spage%3D73%26epage%3D80%26doi%3D10.1136%2Fjmg.2008.061929" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Martinez, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsuchiya, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gout, I.</span></span> <span> </span><span class="NLM_article-title">Coenzyme A Biosynthetic Machinery in Mammalian Cells</span>. <i>Biochem. Soc. Trans.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>42</i></span>,  <span class="NLM_fpage">1112</span>– <span class="NLM_lpage">1117</span>, <span class="refDoi"> DOI: 10.1042/BST20140124</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01531&amp;key=10.1042%2FBST20140124" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01531&amp;key=25110011" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01531&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtlWktLnI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2014&pages=1112-1117&author=D.+L.+Martinezauthor=Y.+Tsuchiyaauthor=I.+Gout&title=Coenzyme+A+Biosynthetic+Machinery+in+Mammalian+Cells&doi=10.1042%2FBST20140124"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Coenzyme A biosynthetic machinery in mammalian cells</span></div><div class="casAuthors">Martinez, David Lopez; Tsuchiya, Yugo; Gout, Ivan</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Society Transactions</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1112-1117</span>CODEN:
                <span class="NLM_cas:coden">BCSTB5</span>;
        ISSN:<span class="NLM_cas:issn">0300-5127</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">A review.  CoA is an essential cofactor in all living organisms.  CoA and its thioester derivs. [acetyl-CoA, malonyl-CoA, HMG-CoA (3-hydroxy-3-methylglutaryl-CoA), etc.] participate in diverse anabolic and catabolic pathways, allosteric regulatory interactions and the regulation of gene expression.  The biosynthesis of CoA requires pantothenic acid, cysteine and ATP, and involves five enzymic steps that are highly conserved from prokaryotes to eukaryotes.  The intracellular levels of CoA and its derivs. change in response to extracellular stimuli, stresses and metabolites, and in human pathologies, such as cancer, metabolic disorders and neurodegeneration.  In the present mini-review, the authors describe the current understanding of the CoA biosynthetic pathway, provide a detailed overview on expression and subcellular localization of enzymes implicated in CoA biosynthesis, their regulation and the potential to form multi-enzyme complexes for efficient and highly coordinated biosynthetic process.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpYuPC0UHqMr7Vg90H21EOLACvtfcHk0ljwInTb8WtDoA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtlWktLnI&md5=f448cf2e4f54db3275c3262f10dda583</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1042%2FBST20140124&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252FBST20140124%26sid%3Dliteratum%253Aachs%26aulast%3DMartinez%26aufirst%3DD.%2BL.%26aulast%3DTsuchiya%26aufirst%3DY.%26aulast%3DGout%26aufirst%3DI.%26atitle%3DCoenzyme%2520A%2520Biosynthetic%2520Machinery%2520in%2520Mammalian%2520Cells%26jtitle%3DBiochem.%2520Soc.%2520Trans.%26date%3D2014%26volume%3D42%26spage%3D1112%26epage%3D1117%26doi%3D10.1042%2FBST20140124" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Orellana, D. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santambrogio, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rubio, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yekhlef, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cancellieri, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dusi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giannelli, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Venco, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mazzara, P. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cozzi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferrari, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garavaglia, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taverna, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tiranti, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Broccoli, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Levi, S.</span></span> <span> </span><span class="NLM_article-title">Coenzyme A Corrects Pathological Defects in Human Neurons of PANK 2-associated Neurodegeneration</span>. <i>EMBO Mol. Med.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">1197</span>– <span class="NLM_lpage">1211</span>, <span class="refDoi"> DOI: 10.15252/emmm.201606391</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01531&amp;key=10.15252%2Femmm.201606391" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01531&amp;key=27516453" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01531&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtlaitbjF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2016&pages=1197-1211&author=D.+I.+Orellanaauthor=P.+Santambrogioauthor=A.+Rubioauthor=L.+Yekhlefauthor=C.+Cancellieriauthor=S.+Dusiauthor=S.+G.+Giannelliauthor=P.+Vencoauthor=P.+G.+Mazzaraauthor=A.+Cozziauthor=M.+Ferrariauthor=B.+Garavagliaauthor=S.+Tavernaauthor=V.+Tirantiauthor=V.+Broccoliauthor=S.+Levi&title=Coenzyme+A+Corrects+Pathological+Defects+in+Human+Neurons+of+PANK+2-associated+Neurodegeneration&doi=10.15252%2Femmm.201606391"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Coenzyme A corrects pathological defects in human neurons of PANK2-associated neurodegeneration</span></div><div class="casAuthors">Orellana, Daniel I.; Santambrogio, Paolo; Rubio, Alicia; Yekhlef, Latefa; Cancellieri, Cinzia; Dusi, Sabrina; Giannelli, Serena G.; Venco, Paola; Mazzara, Pietro G.; Cozzi, Anna; Ferrari, Maurizio; Garavaglia, Barbara; Taverna, Stefano; Tiranti, Valeria; Broccoli, Vania; Levi, Sonia</div><div class="citationInfo"><span class="NLM_cas:title">EMBO Molecular Medicine</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1197-1211</span>CODEN:
                <span class="NLM_cas:coden">EMMMAM</span>;
        ISSN:<span class="NLM_cas:issn">1757-4684</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Pantothenate kinase-assocd. neurodegeneration (PKAN) is an early onset and severely disabling neurodegenerative disease for which no therapy is available.  PKAN is caused by mutations in PANK2, which encodes for the mitochondrial enzyme pantothenate kinase 2.  Its function is to catalyze the first limiting step of CoA (CoA) biosynthesis.  We generated induced pluripotent stem cells from PKAN patients and showed that their derived neurons exhibited premature death, increased ROS prodn., mitochondrial dysfunctions-including impairment of mitochondrial iron-dependent biosynthesis-and major membrane excitability defects.  CoA supplementation prevented neuronal death and ROS formation by restoring mitochondrial and neuronal functionality.  Our findings provide direct evidence that PANK2 malfunctioning is responsible for abnormal phenotypes in human neuronal cells and indicate CoA treatment as a possible therapeutic intervention.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp1Jz34zLslsrVg90H21EOLACvtfcHk0ljwInTb8WtDoA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtlaitbjF&md5=07cfdaacde87106b2b06a30886c6ea18</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.15252%2Femmm.201606391&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.15252%252Femmm.201606391%26sid%3Dliteratum%253Aachs%26aulast%3DOrellana%26aufirst%3DD.%2BI.%26aulast%3DSantambrogio%26aufirst%3DP.%26aulast%3DRubio%26aufirst%3DA.%26aulast%3DYekhlef%26aufirst%3DL.%26aulast%3DCancellieri%26aufirst%3DC.%26aulast%3DDusi%26aufirst%3DS.%26aulast%3DGiannelli%26aufirst%3DS.%2BG.%26aulast%3DVenco%26aufirst%3DP.%26aulast%3DMazzara%26aufirst%3DP.%2BG.%26aulast%3DCozzi%26aufirst%3DA.%26aulast%3DFerrari%26aufirst%3DM.%26aulast%3DGaravaglia%26aufirst%3DB.%26aulast%3DTaverna%26aufirst%3DS.%26aulast%3DTiranti%26aufirst%3DV.%26aulast%3DBroccoli%26aufirst%3DV.%26aulast%3DLevi%26aufirst%3DS.%26atitle%3DCoenzyme%2520A%2520Corrects%2520Pathological%2520Defects%2520in%2520Human%2520Neurons%2520of%2520PANK%25202-associated%2520Neurodegeneration%26jtitle%3DEMBO%2520Mol.%2520Med.%26date%3D2016%26volume%3D8%26spage%3D1197%26epage%3D1211%26doi%3D10.15252%2Femmm.201606391" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zano, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pate, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frank, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rock, C. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jackowski, S.</span></span> <span> </span><span class="NLM_article-title">Correction of a Genetic Deficiency in Pantothenate Kinase 1 Using Phosphopantothenate Replacement Therapy</span>. <i>Mol. Genet. Metab.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>116</i></span>,  <span class="NLM_fpage">281</span>– <span class="NLM_lpage">288</span>, <span class="refDoi"> DOI: 10.1016/j.ymgme.2015.10.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01531&amp;key=10.1016%2Fj.ymgme.2015.10.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01531&amp;key=26549575" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01531&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsl2gsr7I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=116&publication_year=2015&pages=281-288&author=S.+P.+Zanoauthor=C.+Pateauthor=M.+Frankauthor=C.+O.+Rockauthor=S.+Jackowski&title=Correction+of+a+Genetic+Deficiency+in+Pantothenate+Kinase+1+Using+Phosphopantothenate+Replacement+Therapy&doi=10.1016%2Fj.ymgme.2015.10.011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Correction of a genetic deficiency in pantothenate kinase 1 using phosphopantothenate replacement therapy</span></div><div class="casAuthors">Zano, Stephen P.; Pate, Caroline; Frank, Matthew; Rock, Charles O.; Jackowski, Suzanne</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Genetics and Metabolism</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">116</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">281-288</span>CODEN:
                <span class="NLM_cas:coden">MGMEFF</span>;
        ISSN:<span class="NLM_cas:issn">1096-7192</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">CoA (CoA) is a ubiquitous cofactor involved in numerous essential biochem. transformations, and along with its thioesters is a key regulator of intermediary metab.  Pantothenate (vitamin B5) phosphorylation by pantothenate kinase (PanK) is thought to control the rate of CoA prodn.  Pantothenate kinase assocd. neurodegeneration is a hereditary disease that arises from mutations that inactivate the human PANK2 gene.  Aryl phosphoramidate phosphopantothenate derivs. were prepd. to test the feasibility of using phosphopantothenate replacement therapy to bypass the genetic deficiency in the Pank1-/- mouse model.  The efficacies of candidate compds. were first compared by measuring the ability to increase CoA levels in Pank1-/- mouse embryo fibroblasts.  Administration of selected candidate compds. to Pank1-/- mice cor. their deficiency in hepatic CoA.  The PanK bypass was confirmed by the incorporation of intact phosphopantothenate into CoA using triple-isotopically labeled compd.  These results provide strong support for PanK as a master regulator of intracellular CoA and illustrate the feasibility of employing PanK bypass therapy to restore CoA levels in genetically deficient mice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAw1zJ--PYOrVg90H21EOLACvtfcHk0ljwInTb8WtDoA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsl2gsr7I&md5=f98bdbc9d7ca784c0cc1e9009beda55b</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1016%2Fj.ymgme.2015.10.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ymgme.2015.10.011%26sid%3Dliteratum%253Aachs%26aulast%3DZano%26aufirst%3DS.%2BP.%26aulast%3DPate%26aufirst%3DC.%26aulast%3DFrank%26aufirst%3DM.%26aulast%3DRock%26aufirst%3DC.%2BO.%26aulast%3DJackowski%26aufirst%3DS.%26atitle%3DCorrection%2520of%2520a%2520Genetic%2520Deficiency%2520in%2520Pantothenate%2520Kinase%25201%2520Using%2520Phosphopantothenate%2520Replacement%2520Therapy%26jtitle%3DMol.%2520Genet.%2520Metab.%26date%3D2015%26volume%3D116%26spage%3D281%26epage%3D288%26doi%3D10.1016%2Fj.ymgme.2015.10.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Elbaum, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beconi, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monteagudo, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di Marco, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quinton, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lyons, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vaino, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harper, S.</span></span> <span> </span><span class="NLM_article-title">Fosmetpantotenate (RE-024), a Phosphopantothenate Replacement Therapy for Pantothenate Kinase-Associated Neurodegeneration: Mechanism of Action and Efficacy in Nonclinical Models</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>13</i></span>, <span class="NLM_elocation-id">e0192028</span> <span class="refDoi"> DOI: 10.1371/journal.pone.0192028</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01531&amp;key=10.1371%2Fjournal.pone.0192028" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01531&amp;key=29522513" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01531&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhslWms73E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2018&author=D.+Elbaumauthor=M.+G.+Beconiauthor=E.+Monteagudoauthor=A.+Di+Marcoauthor=M.+S.+Quintonauthor=K.+A.+Lyonsauthor=A.+Vainoauthor=S.+Harper&title=Fosmetpantotenate+%28RE-024%29%2C+a+Phosphopantothenate+Replacement+Therapy+for+Pantothenate+Kinase-Associated+Neurodegeneration%3A+Mechanism+of+Action+and+Efficacy+in+Nonclinical+Models&doi=10.1371%2Fjournal.pone.0192028"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Fosmetpantotenate (RE-024), a phosphopantothenate replacement therapy for pantothenate kinase-associated neurodegeneration: mechanism of action and efficacy in nonclinical models</span></div><div class="casAuthors">Elbaum, Daniel; Beconi, Maria G.; Monteagudo, Edith; Di Marco, Annalise; Quinton, Maria S.; Lyons, Kathryn A.; Vaino, Andrew; Harper, Steven</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">e0192028/1-e0192028/27</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">In cells, phosphorylation of pantothenic acid to generate phosphopantothenic acid by the pantothenate kinase enzymes is the first step in CoA synthesis.  Pantothenate kinase 2, the isoform localized in neuronal cell mitochondria, is dysfunctional in patients with pantothenate kinase-assocd. neurodegeneration.  Fosmetpantotenate is a phosphopantothenic acid prodrug in clin. development for treatment of pantothenate kinase-assocd. neurodegeneration, which aims to replenish phosphopantothenic acid in patients.  Fosmetpantotenate restored CoA in short-hairpin RNA pantothenate kinase 2 gene-silenced neuroblastoma cells and was permeable in a blood-brain barrier model.  The rate of fosmetpantotenate metab. in blood is species-dependent.  Following up to 700 mg/kg orally, blood exposure to fosmetpantotenate was negligible in rat and mouse, but measurable in monkey.  Consistent with the difference in whole blood half-life, fosmetpantotenate dosed orally was found in the brains of the monkey (striatal dialyzate) but was absent in mice.  Following administration of isotopically labeled-fosmetpantotenate to mice, ∼40% of liver CoA (after 500 mg/kg orally) and ∼50% of brain CoA (after 125μg intrastriatally) originated from isotopically labeled-fosmetpantotenate.  Addnl., 10-day dosing of isotopically labeled-fosmetpantotenate, 12.5μg, intracerebroventricularly in mice led to ∼30% of brain CoA contg. the stable isotopic labels.  This work supports the hypothesis that fosmetpantotenate acts to replace reduced phosphopantothenic acid in pantothenate kinase 2-deficient tissues.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpYI2R0GKG5qrVg90H21EOLACvtfcHk0li3KRNqu97Qog"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhslWms73E&md5=1bab5d1617cd78ff1bcffa17ab9d4a52</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0192028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0192028%26sid%3Dliteratum%253Aachs%26aulast%3DElbaum%26aufirst%3DD.%26aulast%3DBeconi%26aufirst%3DM.%2BG.%26aulast%3DMonteagudo%26aufirst%3DE.%26aulast%3DDi%2BMarco%26aufirst%3DA.%26aulast%3DQuinton%26aufirst%3DM.%2BS.%26aulast%3DLyons%26aufirst%3DK.%2BA.%26aulast%3DVaino%26aufirst%3DA.%26aulast%3DHarper%26aufirst%3DS.%26atitle%3DFosmetpantotenate%2520%2528RE-024%2529%252C%2520a%2520Phosphopantothenate%2520Replacement%2520Therapy%2520for%2520Pantothenate%2520Kinase-Associated%2520Neurodegeneration%253A%2520Mechanism%2520of%2520Action%2520and%2520Efficacy%2520in%2520Nonclinical%2520Models%26jtitle%3DPLoS%2520One%26date%3D2018%26volume%3D13%26doi%3D10.1371%2Fjournal.pone.0192028" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Klopstock, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Escolar, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marshall, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perez-Dueñas, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tuller, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Videnovic, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greblikas, F.</span></span> <span> </span><span class="NLM_article-title">The FOsmetpantotenate Replacement Therapy (FORT) Randomized, Double-Blind, Placebo-Controlled Pivotal Trial: Study Design and Development Methodology of a Novel Primary Efficacy Outcome in Patients with Pantothenate Kinase-Associated Neurodegeneration</span>. <i>Clin. Trials</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">410</span>– <span class="NLM_lpage">418</span>, <span class="refDoi"> DOI: 10.1177/1740774519845673</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01531&amp;key=10.1177%2F1740774519845673" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01531&amp;key=31055958" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01531&amp;key=1%3ACAS%3A280%3ADC%252BB3M7isFSlsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2019&pages=410-418&author=T.+Klopstockauthor=M.+L.+Escolarauthor=R.+D.+Marshallauthor=B.+Perez-Due%C3%B1asauthor=S.+Tullerauthor=A.+Videnovicauthor=F.+Greblikas&title=The+FOsmetpantotenate+Replacement+Therapy+%28FORT%29+Randomized%2C+Double-Blind%2C+Placebo-Controlled+Pivotal+Trial%3A+Study+Design+and+Development+Methodology+of+a+Novel+Primary+Efficacy+Outcome+in+Patients+with+Pantothenate+Kinase-Associated+Neurodegeneration&doi=10.1177%2F1740774519845673"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">The FOsmetpantotenate Replacement Therapy (FORT) randomized, double-blind, Placebo-controlled pivotal trial: Study design and development methodology of a novel primary efficacy outcome in patients with pantothenate kinase-associated neurodegeneration</span></div><div class="casAuthors">Klopstock Thomas; Klopstock Thomas; Klopstock Thomas; Escolar Maria L; Marshall Randall D; Tuller Sarah; Perez-Duenas Belen; Videnovic Aleksandar; Greblikas Feriandas</div><div class="citationInfo"><span class="NLM_cas:title">Clinical trials (London, England)</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">410-418</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND/AIMS:  Pantothenate kinase-associated neurodegeneration is a rare neurodegenerative disease with a variable clinical phenotype.  Fosmetpantotenate is in clinical development as a replacement therapy that targets the underlying cause of pantothenate kinase-associated neurodegeneration.  The FOsmetpantotenate Replacement Therapy pivotal trial-an ongoing phase 3, randomized, double-blind, placebo-controlled, multicenter trial-examines the efficacy and safety of fosmetpantotenate in patients with pantothenate kinase-associated neurodegeneration aged 6-65 years.  The FOsmetpantotenate Replacement Therapy trial required the development and validation of a novel patient-reported outcome measure specifically relevant to pantothenate kinase-associated neurodegeneration.  The Pantothenate Kinase-Associated Neurodegeneration-Activities of Daily Living scale was developed to assess activities of daily living related to motor functioning in patients with pantothenate kinase-associated neurodegeneration to evaluate clinically meaningful change as the primary efficacy endpoint in clinical trials.  This article describes the design of the FOsmetpantotenate Replacement Therapy pivotal trial and the development of the Pantothenate Kinase-Associated Neurodegeneration-Activities of Daily Living scale.  METHODS:  A systematic, iterative process consistent with the US Food and Drug Administration guidance and advice from the Committee for Medicinal Products for Human Use at the European Medicines Agency was used to evaluate and adapt or remove scale items of an existing widely used instrument for movement disorders to be pantothenate kinase-associated neurodegeneration-specific, and to create new items.  Modification of scale items was based on input from international experts, patient advocacy leaders, and primary caregivers.  A clinimetric study of the Pantothenate Kinase-Associated Neurodegeneration-Activities of Daily Living scale conducted in patients with pantothenate kinase-associated neurodegeneration or their caregivers (N = 40 at first assessment; N = 39 at second assessment) demonstrated high content and construct validity and excellent test-retest reliability over an approximately 2-week period.  The Pantothenate Kinase-Associated Neurodegeneration-Activities of Daily Living scale was developed to be broadly useful within clinical and research settings in the examination of patient response to pantothenate kinase-associated neurodegeneration therapies.  RESULTS:  Approximately 82 patients will be enrolled in the ongoing FOsmetpantotenate Replacement Therapy pivotal trial.  Change from baseline in Pantothenate Kinase-Associated Neurodegeneration-Activities of Daily Living score over the 24-week double-blind period is the primary efficacy endpoint for the FOsmetpantotenate Replacement Therapy trial.  Treatment effect will be evaluated using a mixed model for repeated measures analysis to assess data from all visits simultaneously.  CONCLUSION:  The development and implementation of the Pantothenate Kinase-Associated Neurodegeneration-Activities of Daily Living scale in the FOsmetpantotenate Replacement Therapy trial illustrates the feasibility and potential patient benefit of putting into practice the current regulatory guidance on the use of patient-reported outcomes in clinical trials.  These processes can be broadly applied to clinical trial methodology that requires newly created or revised patient-reported outcome measures to evaluate outcome change as a primary efficacy endpoint.  The goal of such measures in patients with pantothenate kinase-associated neurodegeneration is to facilitate development of disease-modifying therapeutics in multiple drug development programs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTO8rRZmCc_AijiVMCqkKxVfW6udTcc2eaE_PQjAL2MyLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3M7isFSlsA%253D%253D&md5=08172503820ee6068592bc8669dc131e</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1177%2F1740774519845673&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F1740774519845673%26sid%3Dliteratum%253Aachs%26aulast%3DKlopstock%26aufirst%3DT.%26aulast%3DEscolar%26aufirst%3DM.%2BL.%26aulast%3DMarshall%26aufirst%3DR.%2BD.%26aulast%3DPerez-Due%25C3%25B1as%26aufirst%3DB.%26aulast%3DTuller%26aufirst%3DS.%26aulast%3DVidenovic%26aufirst%3DA.%26aulast%3DGreblikas%26aufirst%3DF.%26atitle%3DThe%2520FOsmetpantotenate%2520Replacement%2520Therapy%2520%2528FORT%2529%2520Randomized%252C%2520Double-Blind%252C%2520Placebo-Controlled%2520Pivotal%2520Trial%253A%2520Study%2520Design%2520and%2520Development%2520Methodology%2520of%2520a%2520Novel%2520Primary%2520Efficacy%2520Outcome%2520in%2520Patients%2520with%2520Pantothenate%2520Kinase-Associated%2520Neurodegeneration%26jtitle%3DClin.%2520Trials%26date%3D2019%26volume%3D16%26spage%3D410%26epage%3D418%26doi%3D10.1177%2F1740774519845673" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jeong, S. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hogarth, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Placzek, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gregory, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fox, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhen, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamada, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van der Zwaag, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lambrechts, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nilsen, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cobb, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pham, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gray, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ralle, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duffy, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwanemann, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rai, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Freed, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wakeman, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woltjer, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sibon, O. C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayflick, S. J.</span></span> <span> </span><span class="NLM_article-title">4′-Phosphopantetheine Corrects CoA, Iron, and Dopamine Metabolic Defects in Mammalian Models of PKAN</span>. <i>EMBO Mol. Med.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>11</i></span>, <span class="NLM_elocation-id">e10489</span> <span class="refDoi"> DOI: 10.15252/emmm.201910489</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01531&amp;key=10.15252%2Femmm.201910489" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01531&amp;key=31660701" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01531&amp;key=1%3ACAS%3A528%3ADC%252BC1MXitVeqsbvJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2019&author=S.+Y.+Jeongauthor=P.+Hogarthauthor=A.+Placzekauthor=A.+M.+Gregoryauthor=R.+Foxauthor=D.+Zhenauthor=J.+Hamadaauthor=M.+van+der+Zwaagauthor=R.+Lambrechtsauthor=H.+Jinauthor=A.+Nilsenauthor=J.+Cobbauthor=T.+Phamauthor=N.+Grayauthor=M.+Ralleauthor=M.+Duffyauthor=L.+Schwanemannauthor=P.+Raiauthor=A.+Freedauthor=K.+Wakemanauthor=R.+L.+Woltjerauthor=O.+C.+M.+Sibonauthor=S.+J.+Hayflick&title=4%E2%80%B2-Phosphopantetheine+Corrects+CoA%2C+Iron%2C+and+Dopamine+Metabolic+Defects+in+Mammalian+Models+of+PKAN&doi=10.15252%2Femmm.201910489"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">4'-Phosphopantetheine corrects CoA, iron, and dopamine metabolic defects in mammalian models of PKAN</span></div><div class="casAuthors">Jeong, Suh Young; Hogarth, Penelope; Placzek, Andrew; Gregory, Allison M.; Fox, Rachel; Zhen, Dolly; Hamada, Jeffrey; van der Zwaag, Marianne; Lambrechts, Roald; Jin, Haihong; Nilsen, Aaron; Cobb, Jared; Pham, Thao; Gray, Nora; Ralle, Martina; Duffy, Megan; Schwanemann, Leila; Rai, Puneet; Freed, Alison; Wakeman, Katrina; Woltjer, Randall L.; Sibon, Ody CM; Hayflick, Susan J.</div><div class="citationInfo"><span class="NLM_cas:title">EMBO Molecular Medicine</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">e10489</span>CODEN:
                <span class="NLM_cas:coden">EMMMAM</span>;
        ISSN:<span class="NLM_cas:issn">1757-4684</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Pantothenate kinase-assocd. neurodegeneration (PKAN) is an inborn error of CoA metab. causing dystonia, parkinsonism, and brain iron accumulation.  Lack of a good mammalian model has impeded studies of pathogenesis and development of rational therapeutics.  We took a new approach to investigating an existing mouse mutant of Pank2 and found that isolating the disease-vulnerable brain revealed regional perturbations in CoA metab., iron homeostasis, and dopamine metab. and functional deffects in complex I and pyruvate dehydrogenase.  Feeding mice a CoA pathway intermediate, 4'-phosphopantetheine, normalized levels of the CoA-, iron-, and dopamine-related biomarkers as well as activities of mitochondrial enzymes.  Human cell changes also were recovered by 4'-phosphopantetheine.  We can mechanistically link a deffect in CoA metab. to these secondary effects via the activation of mitochondrial acyl carrier protein, which is essential to oxidative phosphorylation, iron-sulfur cluster biogenesis, and mitochondrial fatty acid synthesis.  We demonstrate the fidelity of our model in recapitulating features of the human disease.  Moreover, we identify pharmacodynamic biomarkers, provide insights into disease pathogenesis, and offer evidence for 4'-phosphopantetheine as a candidate therapeutic for PKAN.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoXnCouzisj1LVg90H21EOLACvtfcHk0li3KRNqu97Qog"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXitVeqsbvJ&md5=eac9295109744fc7f0e6c04411e902d8</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.15252%2Femmm.201910489&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.15252%252Femmm.201910489%26sid%3Dliteratum%253Aachs%26aulast%3DJeong%26aufirst%3DS.%2BY.%26aulast%3DHogarth%26aufirst%3DP.%26aulast%3DPlaczek%26aufirst%3DA.%26aulast%3DGregory%26aufirst%3DA.%2BM.%26aulast%3DFox%26aufirst%3DR.%26aulast%3DZhen%26aufirst%3DD.%26aulast%3DHamada%26aufirst%3DJ.%26aulast%3Dvan%2Bder%2BZwaag%26aufirst%3DM.%26aulast%3DLambrechts%26aufirst%3DR.%26aulast%3DJin%26aufirst%3DH.%26aulast%3DNilsen%26aufirst%3DA.%26aulast%3DCobb%26aufirst%3DJ.%26aulast%3DPham%26aufirst%3DT.%26aulast%3DGray%26aufirst%3DN.%26aulast%3DRalle%26aufirst%3DM.%26aulast%3DDuffy%26aufirst%3DM.%26aulast%3DSchwanemann%26aufirst%3DL.%26aulast%3DRai%26aufirst%3DP.%26aulast%3DFreed%26aufirst%3DA.%26aulast%3DWakeman%26aufirst%3DK.%26aulast%3DWoltjer%26aufirst%3DR.%2BL.%26aulast%3DSibon%26aufirst%3DO.%2BC.%2BM.%26aulast%3DHayflick%26aufirst%3DS.%2BJ.%26atitle%3D4%25E2%2580%25B2-Phosphopantetheine%2520Corrects%2520CoA%252C%2520Iron%252C%2520and%2520Dopamine%2520Metabolic%2520Defects%2520in%2520Mammalian%2520Models%2520of%2520PKAN%26jtitle%3DEMBO%2520Mol.%2520Med.%26date%3D2019%26volume%3D11%26doi%3D10.15252%2Femmm.201910489" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Srinivasan, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baratashvili, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van der Zwaag, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kanon, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Colombelli, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lambrechts, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schaap, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nollen, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Podgoršek, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kosec, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petkovic, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayflick, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tiranti, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reijngoud, D.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grzeschik, N. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sibon, O. C. M.</span></span> <span> </span><span class="NLM_article-title">Extracellular 4′-Phosphopantetheine Is a Source for Intracellular Coenzyme A Synthesis</span>. <i>Nat. Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">784</span>– <span class="NLM_lpage">792</span>, <span class="refDoi"> DOI: 10.1038/nchembio.1906</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01531&amp;key=10.1038%2Fnchembio.1906" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01531&amp;key=26322826" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01531&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtlylsrnI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2015&pages=784-792&author=B.+Srinivasanauthor=M.+Baratashviliauthor=M.+van+der+Zwaagauthor=B.+Kanonauthor=C.+Colombelliauthor=R.+A.+Lambrechtsauthor=O.+Schaapauthor=E.+A.+Nollenauthor=A.+Podgor%C5%A1ekauthor=G.+Kosecauthor=H.+Petkovicauthor=S.+Hayflickauthor=V.+Tirantiauthor=D.-J.+Reijngoudauthor=N.+A.+Grzeschikauthor=O.+C.+M.+Sibon&title=Extracellular+4%E2%80%B2-Phosphopantetheine+Is+a+Source+for+Intracellular+Coenzyme+A+Synthesis&doi=10.1038%2Fnchembio.1906"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Extracellular 4'-phosphopantetheine is a source for intracellular coenzyme A synthesis</span></div><div class="casAuthors">Srinivasan, Balaji; Baratashvili, Madina; van der Zwaag, Marianne; Kanon, Bart; Colombelli, Cristina; Lambrechts, Roald A.; Schaap, Onno; Nollen, Ellen A.; Podgorsek, Ajda; Kosec, Gregor; Petkovic, Hrvoje; Hayflick, Susan; Tiranti, Valeria; Reijngoud, Dirk-Jan; Grzeschik, Nicola A.; Sibon, Ody C. M.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">784-792</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The metabolic cofactor CoA gained renewed attention because of its roles in neurodegeneration, protein acetylation, autophagy and signal transduction.  The long-standing dogma is that eukaryotic cells obtain CoA exclusively via the uptake of extracellular precursors, esp. vitamin B5, which is intracellularly converted through five conserved enzymic reactions into CoA.  This study demonstrates an alternative mechanism that allows cells and organisms to adjust intracellular CoA levels by using exogenous CoA.  Here CoA was hydrolyzed extracellularly by ectonucleotide pyrophosphatases to 4'-phosphopantetheine, a biol. stable mol. able to translocate through membranes via passive diffusion.  Inside the cell, 4'-phosphopantetheine was enzymically converted back to CoA by the bifunctional enzyme CoA synthase.  Phenotypes induced by intracellular CoA deprivation were reversed when exogenous CoA was provided.  Our findings answer long-standing questions in fundamental cell biol. and have major implications for the understanding of CoA-related diseases and therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqv1LG48W_EhbVg90H21EOLACvtfcHk0lg0Zt0CiqvrIA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtlylsrnI&md5=b8de40f124c4776e56f98c72bb51955c</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.1906&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.1906%26sid%3Dliteratum%253Aachs%26aulast%3DSrinivasan%26aufirst%3DB.%26aulast%3DBaratashvili%26aufirst%3DM.%26aulast%3Dvan%2Bder%2BZwaag%26aufirst%3DM.%26aulast%3DKanon%26aufirst%3DB.%26aulast%3DColombelli%26aufirst%3DC.%26aulast%3DLambrechts%26aufirst%3DR.%2BA.%26aulast%3DSchaap%26aufirst%3DO.%26aulast%3DNollen%26aufirst%3DE.%2BA.%26aulast%3DPodgor%25C5%25A1ek%26aufirst%3DA.%26aulast%3DKosec%26aufirst%3DG.%26aulast%3DPetkovic%26aufirst%3DH.%26aulast%3DHayflick%26aufirst%3DS.%26aulast%3DTiranti%26aufirst%3DV.%26aulast%3DReijngoud%26aufirst%3DD.-J.%26aulast%3DGrzeschik%26aufirst%3DN.%2BA.%26aulast%3DSibon%26aufirst%3DO.%2BC.%2BM.%26atitle%3DExtracellular%25204%25E2%2580%25B2-Phosphopantetheine%2520Is%2520a%2520Source%2520for%2520Intracellular%2520Coenzyme%2520A%2520Synthesis%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2015%26volume%3D11%26spage%3D784%26epage%3D792%26doi%3D10.1038%2Fnchembio.1906" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sharma, L. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Subramanian, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yun, M.-K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frank, M. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">White, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rock, C. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jackowski, S.</span></span> <span> </span><span class="NLM_article-title">A Therapeutic Approach to Pantothenate Kinase Associated Neurodegeneration</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>9</i></span>, <span class="NLM_elocation-id">4399</span> <span class="refDoi"> DOI: 10.1038/s41467-018-06703-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01531&amp;key=10.1038%2Fs41467-018-06703-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01531&amp;key=30352999" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01531&amp;key=1%3ACAS%3A280%3ADC%252BB3cvisFSluw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2018&author=L.+K.+Sharmaauthor=C.+Subramanianauthor=M.-K.+Yunauthor=M.+W.+Frankauthor=S.+W.+Whiteauthor=C.+O.+Rockauthor=R.+E.+Leeauthor=S.+Jackowski&title=A+Therapeutic+Approach+to+Pantothenate+Kinase+Associated+Neurodegeneration&doi=10.1038%2Fs41467-018-06703-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">A therapeutic approach to pantothenate kinase associated neurodegeneration</span></div><div class="casAuthors">Sharma Lalit Kumar; Subramanian Chitra; Frank Matthew W; Rock Charles O; Jackowski Suzanne; Sharma Lalit Kumar; Lee Richard E; Sharma Lalit Kumar; Yun Mi-Kyung; White Stephen W</div><div class="citationInfo"><span class="NLM_cas:title">Nature communications</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">4399</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Pantothenate kinase (PANK) is a metabolic enzyme that regulates cellular coenzyme A (CoA) levels.  There are three human PANK genes, and inactivating mutations in PANK2 lead to pantothenate kinase associated neurodegeneration (PKAN).  Here we performed a library screen followed by chemical optimization to produce PZ-2891, an allosteric PANK activator that crosses the blood brain barrier.  PZ-2891 occupies the pantothenate pocket and engages the dimer interface to form a PANK•ATP•Mg(2+)•PZ-2891 complex.  The binding of PZ-2891 to one protomer locks the opposite protomer in a catalytically active conformation that is refractory to acetyl-CoA inhibition.  Oral administration of PZ-2891 increases CoA levels in mouse liver and brain.  A knockout mouse model of brain CoA deficiency exhibited weight loss, severe locomotor impairment and early death.  Knockout mice on PZ-2891 therapy gain weight, and have improved locomotor activity and life span establishing pantazines as novel therapeutics for the treatment of PKAN.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcScmbQ8u9AhUCsZ1x6zOs0vfW6udTcc2eYyNEFjRyPVabntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3cvisFSluw%253D%253D&md5=ef5c45dc0713731c14e7fd0b5d65778d</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1038%2Fs41467-018-06703-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41467-018-06703-2%26sid%3Dliteratum%253Aachs%26aulast%3DSharma%26aufirst%3DL.%2BK.%26aulast%3DSubramanian%26aufirst%3DC.%26aulast%3DYun%26aufirst%3DM.-K.%26aulast%3DFrank%26aufirst%3DM.%2BW.%26aulast%3DWhite%26aufirst%3DS.%2BW.%26aulast%3DRock%26aufirst%3DC.%2BO.%26aulast%3DLee%26aufirst%3DR.%2BE.%26aulast%3DJackowski%26aufirst%3DS.%26atitle%3DA%2520Therapeutic%2520Approach%2520to%2520Pantothenate%2520Kinase%2520Associated%2520Neurodegeneration%26jtitle%3DNat.%2520Commun.%26date%3D2018%26volume%3D9%26doi%3D10.1038%2Fs41467-018-06703-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Freel
Meyers, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borch, R. F.</span></span> <span> </span><span class="NLM_article-title">Activation Mechanisms of Nucleoside Phosphoramidate Prodrugs</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>43</i></span>,  <span class="NLM_fpage">4319</span>– <span class="NLM_lpage">4327</span>, <span class="refDoi"> DOI: 10.1021/jm000302b</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm000302b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01531&amp;key=1%3ACAS%3A280%3ADC%252BD3M%252FktF2jtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2000&pages=4319-4327&author=C.+L.+Freel%0AMeyersauthor=R.+F.+Borch&title=Activation+Mechanisms+of+Nucleoside+Phosphoramidate+Prodrugs&doi=10.1021%2Fjm000302b"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Activation mechanisms of nucleoside phosphoramidate prodrugs</span></div><div class="casAuthors">Freel Meyers C L; Borch R F</div><div class="citationInfo"><span class="NLM_cas:title">Journal of medicinal chemistry</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">4319-27</span>
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    </div><div class="casAbstract">A series of thymidine and tetrahydrofurfuryl phosphoramidates bearing haloethyl or piperidyl substituents was synthesized and used to investigate the activation mechanisms of nucleoside phosphoramidate prodrugs.  Structure assignments for the tetrahydrofurfuryl reaction products were confirmed by comparison to authentic samples.  Structural assignments for thymidine phosphoramidate reaction products were made by analogy to the tetrahydrofurfuryl products.  Generation of the phosphoramidate anion leads to cyclization and subsequent nucleophilic attack at carbon and phosphorus of the resulting aziridinium ion intermediate to give the observed products.  Nucleophilic attack by water at carbon and phosphorus occurs without selectivity, supporting a mechanism of action of haloethylamine nucleoside prodrugs involving intracellular release of the nucleotide.  Activation of the benzotriazolyl piperidyl phosphoramidates is followed by P-N bond hydrolysis; this reaction is subject to specific acid catalysis and to nucleophilic catalysis by 1-hydroxybenzotriazole.  These results suggest that the mechanism of action of the piperidyl nucleoside phosphoramidates involves the intracellular release of the active nucleotide following P-N bond cleavage, presumably by the action of an endogenous phosphoramidase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRTQx53jINgre-MdeMhXAHkfW6udTcc2eYyNEFjRyPVabntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3M%252FktF2jtA%253D%253D&md5=39bc57b589e439795c8c1a1e1a3f6750</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1021%2Fjm000302b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm000302b%26sid%3Dliteratum%253Aachs%26aulast%3DFreel%2BMeyers%26aufirst%3DC.%2BL.%26aulast%3DBorch%26aufirst%3DR.%2BF.%26atitle%3DActivation%2520Mechanisms%2520of%2520Nucleoside%2520Phosphoramidate%2520Prodrugs%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2000%26volume%3D43%26spage%3D4319%26epage%3D4327%26doi%3D10.1021%2Fjm000302b" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">De
Clercq, E.</span></span> <span> </span><span class="NLM_article-title">The Clinical Potential of the Acyclic (and Cyclic) Nucleoside Phosphonates. The Magic of the Phosphonate Bond</span>. <i>Biochem. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>82</i></span>,  <span class="NLM_fpage">99</span>– <span class="NLM_lpage">109</span>, <span class="refDoi"> DOI: 10.1016/j.bcp.2011.03.027</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01531&amp;key=10.1016%2Fj.bcp.2011.03.027" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01531&amp;key=21501598" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01531&amp;key=1%3ACAS%3A528%3ADC%252BC3MXntVyqsrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=82&publication_year=2011&pages=99-109&author=E.+De%0AClercq&title=The+Clinical+Potential+of+the+Acyclic+%28and+Cyclic%29+Nucleoside+Phosphonates.+The+Magic+of+the+Phosphonate+Bond&doi=10.1016%2Fj.bcp.2011.03.027"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">The clinical potential of the acyclic (and cyclic) nucleoside phosphonates. The magic of the phosphonate bond</span></div><div class="casAuthors">De Clercq, Erik</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Pharmacology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">82</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">99-109</span>CODEN:
                <span class="NLM_cas:coden">BCPCA6</span>;
        ISSN:<span class="NLM_cas:issn">0006-2952</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  The use of the acyclic nucleoside phosphonates, starting with (S)-HPMPA as the prototype, yielded three clin. approved antiviral drugs, cidofovir for the treatment of CMV retinitis in AIDS patients, adefovir dipivoxil for the treatment of chronic hepatitis B and tenofovir disoproxil fumarate for the treatment of HIV infections (AIDS) and HBV infections.  This era has now grown to many more acyclic (and cyclic) nucleoside phosphonates (such as the "open ring" DAPy and Fd4A phosphonates) and alkoxyalkyl and phosphonoamidate prodrugs thereof, as well as new clin. applications, including new drug combination regimens for the treatment of AIDS, the chemoprophylaxis of HIV infections, and the anticancer potential against some malignant disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpIOtQhoT42-rVg90H21EOLACvtfcHk0li3dmd_H3Y8XQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXntVyqsrg%253D&md5=70d42eb223d9039fc420113fe75f2310</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1016%2Fj.bcp.2011.03.027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bcp.2011.03.027%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BClercq%26aufirst%3DE.%26atitle%3DThe%2520Clinical%2520Potential%2520of%2520the%2520Acyclic%2520%2528and%2520Cyclic%2529%2520Nucleoside%2520Phosphonates.%2520The%2520Magic%2520of%2520the%2520Phosphonate%2520Bond%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2011%26volume%3D82%26spage%3D99%26epage%3D109%26doi%3D10.1016%2Fj.bcp.2011.03.027" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Meier, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balzarini, J.</span></span> <span> </span><span class="NLM_article-title">Application of the CycloSal-Prodrug Approach for Improving the Biological Potential of Phosphorylated Biomolecules</span>. <i>Antiviral Res.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>71</i></span>,  <span class="NLM_fpage">282</span>– <span class="NLM_lpage">292</span>, <span class="refDoi"> DOI: 10.1016/j.antiviral.2006.04.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01531&amp;key=10.1016%2Fj.antiviral.2006.04.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01531&amp;key=16735066" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01531&amp;key=1%3ACAS%3A528%3ADC%252BD28XotlGktLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=2006&pages=282-292&author=C.+Meierauthor=J.+Balzarini&title=Application+of+the+CycloSal-Prodrug+Approach+for+Improving+the+Biological+Potential+of+Phosphorylated+Biomolecules&doi=10.1016%2Fj.antiviral.2006.04.011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Application of the cycloSal-prodrug approach for improving the biological potential of phosphorylated biomolecules</span></div><div class="casAuthors">Meier, C.; Balzarini, J.</div><div class="citationInfo"><span class="NLM_cas:title">Antiviral Research</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">71</span>
        (<span class="NLM_cas:issue">2-3</span>),
    <span class="NLM_cas:pages">282-292</span>CODEN:
                <span class="NLM_cas:coden">ARSRDR</span>;
        ISSN:<span class="NLM_cas:issn">0166-3542</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Pronucleotides represent a promising tool to improve the biol. activity of nucleoside analogs in antiviral and cancer chemotherapy.  The cycloSal-approach is one of several conceptually different pronucleotide systems.  This approach can be applied to various nucleoside analogs.  A salicyl alc. as a cyclic bifunctional masking unit is used, and shown to afford a chem. driven release of the particular nucleotide from the lipophilic phosphate triester precursor mol.  A conceptual extension of the cycloSal-approach results in the design of "lock-in"-cycloSal-derivs.  The cycloSal-approach is not restricted to the delivery of bioactive nucleotides but also useful for the intracellular delivery of hexose-1-phosphates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqf1uTGjRu7KLVg90H21EOLACvtfcHk0li3dmd_H3Y8XQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XotlGktLc%253D&md5=19f9f8927db18911f71debd985dbff51</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1016%2Fj.antiviral.2006.04.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.antiviral.2006.04.011%26sid%3Dliteratum%253Aachs%26aulast%3DMeier%26aufirst%3DC.%26aulast%3DBalzarini%26aufirst%3DJ.%26atitle%3DApplication%2520of%2520the%2520CycloSal-Prodrug%2520Approach%2520for%2520Improving%2520the%2520Biological%2520Potential%2520of%2520Phosphorylated%2520Biomolecules%26jtitle%3DAntiviral%2520Res.%26date%3D2006%26volume%3D71%26spage%3D282%26epage%3D292%26doi%3D10.1016%2Fj.antiviral.2006.04.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gunic, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Girardet, J.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramasamy, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stoisavljevic-Petkov, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chow, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yeh, L.-T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamatake, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raney, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hong, Z.</span></span> <span> </span><span class="NLM_article-title">Cyclic Monophosphate Prodrugs of Base-Modified 2′-C-Methyl Ribonucleosides as Potent Inhibitors of Hepatitis C Virus RNA Replication</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">2452</span>– <span class="NLM_lpage">2455</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2007.02.030</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01531&amp;key=10.1016%2Fj.bmcl.2007.02.030" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01531&amp;key=17331721" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01531&amp;key=1%3ACAS%3A528%3ADC%252BD2sXktVentrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=2452-2455&author=E.+Gunicauthor=J.-L.+Girardetauthor=K.+Ramasamyauthor=V.+Stoisavljevic-Petkovauthor=S.+Chowauthor=L.-T.+Yehauthor=R.+K.+Hamatakeauthor=A.+Raneyauthor=Z.+Hong&title=Cyclic+Monophosphate+Prodrugs+of+Base-Modified+2%E2%80%B2-C-Methyl+Ribonucleosides+as+Potent+Inhibitors+of+Hepatitis+C+Virus+RNA+Replication&doi=10.1016%2Fj.bmcl.2007.02.030"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Cyclic monophosphate prodrugs of base-modified 2'-C-methyl ribonucleosides as potent inhibitors of hepatitis C virus RNA replication</span></div><div class="casAuthors">Gunic, Esmir; Girardet, Jean-Luc; Ramasamy, Kanda; Stoisavljevic-Petkov, Vesna; Chow, Suetying; Yeh, Li-Tain; Hamatake, Robert K.; Raney, Anneke; Hong, Zhi</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2452-2455</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A new series of hetero-base-modified 2'-C-Me ribonucleosides was synthesized and tested as inhibitors of hepatitis C virus (HCV) RNA replication.  The nucleosides showed a weak inhibitory activity in a HCV replicon system (EC50 = 92 μM) and did not exhibit any cytotoxicity (CC50 > 300 μM).  Cyclic monophosphate (cMP) prodrugs of the same nucleosides were synthesized and also tested in the HCV replicon system.  Prodrugs exhibited strong potency (EC50 = 0.008 μM) without significant cytotoxicity (CC50 > 50 μM).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp4DkSvrNtlr7Vg90H21EOLACvtfcHk0li3dmd_H3Y8XQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXktVentrc%253D&md5=a3e608835c20a504bc5753724dc09e5b</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2007.02.030&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2007.02.030%26sid%3Dliteratum%253Aachs%26aulast%3DGunic%26aufirst%3DE.%26aulast%3DGirardet%26aufirst%3DJ.-L.%26aulast%3DRamasamy%26aufirst%3DK.%26aulast%3DStoisavljevic-Petkov%26aufirst%3DV.%26aulast%3DChow%26aufirst%3DS.%26aulast%3DYeh%26aufirst%3DL.-T.%26aulast%3DHamatake%26aufirst%3DR.%2BK.%26aulast%3DRaney%26aufirst%3DA.%26aulast%3DHong%26aufirst%3DZ.%26atitle%3DCyclic%2520Monophosphate%2520Prodrugs%2520of%2520Base-Modified%25202%25E2%2580%25B2-C-Methyl%2520Ribonucleosides%2520as%2520Potent%2520Inhibitors%2520of%2520Hepatitis%2520C%2520Virus%2520RNA%2520Replication%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2007%26volume%3D17%26spage%3D2452%26epage%3D2455%26doi%3D10.1016%2Fj.bmcl.2007.02.030" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pradere, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garnier-Amblard, E. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coats, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amblard, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schinazi, R. F.</span></span> <span> </span><span class="NLM_article-title">Synthesis of Nucleoside Phosphate and Phosphonate Prodrugs</span>. <i>Chem. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>114</i></span>,  <span class="NLM_fpage">9154</span>– <span class="NLM_lpage">9218</span>, <span class="refDoi"> DOI: 10.1021/cr5002035</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cr5002035" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01531&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsVSnsL7J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=114&publication_year=2014&pages=9154-9218&author=U.+Pradereauthor=E.+C.+Garnier-Amblardauthor=S.+J.+Coatsauthor=F.+Amblardauthor=R.+F.+Schinazi&title=Synthesis+of+Nucleoside+Phosphate+and+Phosphonate+Prodrugs&doi=10.1021%2Fcr5002035"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of Nucleoside Phosphate and Phosphonate Prodrugs</span></div><div class="casAuthors">Pradere, Ugo; Garnier-Amblard, Ethel C.; Coats, Steven J.; Amblard, Franck; Schinazi, Raymond F.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">114</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">9154-9218</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Herein, we review the most important mono-, di-, and triphosphate and phosphonate prodrug approaches applied to nucleoside analogs from a chem. point of view, detailing the strengths and limitations of each approach.  We will focus on the various synthetic pathways discussing: (1) the chem. variation of the biolabile phosphonate masking groups; (2) the reliability of using P(III) and/or P(V) chem. for both phosphate and phosphonate prodrug synthesis; (3) the influence of the masking group(s) introduction conditions (solvent, temp., stoichiometry) on the overall outcome for each method; (4) the various protection/deprotection strategies used to impart improved yield and regioselectivity relative to the nature of the nucleobase and the sugar; and (5) the influence of reaction conditions or protective groups on the stereoselectivity (Rp/Sp) obsd. at the phosphorus center as well as the methods employed to sep. both Rp and Sp isomers along with the asym. strategies for the synthesis of predominantly single diastereoisomers at the phosphorus center.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo2UgEs4_SnUrVg90H21EOLACvtfcHk0lgsuXMFJbOwAg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsVSnsL7J&md5=115175a0c31890dd5b7b9f4ae9a9191f</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Fcr5002035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr5002035%26sid%3Dliteratum%253Aachs%26aulast%3DPradere%26aufirst%3DU.%26aulast%3DGarnier-Amblard%26aufirst%3DE.%2BC.%26aulast%3DCoats%26aufirst%3DS.%2BJ.%26aulast%3DAmblard%26aufirst%3DF.%26aulast%3DSchinazi%26aufirst%3DR.%2BF.%26atitle%3DSynthesis%2520of%2520Nucleoside%2520Phosphate%2520and%2520Phosphonate%2520Prodrugs%26jtitle%3DChem.%2520Rev.%26date%3D2014%26volume%3D114%26spage%3D9154%26epage%3D9218%26doi%3D10.1021%2Fcr5002035" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pradère, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roy, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Montagu, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sari, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamada, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balzarini, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Snoeck, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andrei, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Agrofoglio, L. A.</span></span> <span> </span><span class="NLM_article-title">Synthesis and Antiviral Evaluation of Bis(POM) Prodrugs of (E)-[4′-Phosphono-but-2′-En-1′-Yl]Purine Nucleosides</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">126</span>– <span class="NLM_lpage">133</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2012.08.042</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01531&amp;key=10.1016%2Fj.ejmech.2012.08.042" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01531&amp;key=23047229" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01531&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhsleisr7N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2012&pages=126-133&author=U.+Prad%C3%A8reauthor=V.+Royauthor=A.+Montaguauthor=O.+Sariauthor=M.+Hamadaauthor=J.+Balzariniauthor=R.+Snoeckauthor=G.+Andreiauthor=L.+A.+Agrofoglio&title=Synthesis+and+Antiviral+Evaluation+of+Bis%28POM%29+Prodrugs+of+%28E%29-%5B4%E2%80%B2-Phosphono-but-2%E2%80%B2-En-1%E2%80%B2-Yl%5DPurine+Nucleosides&doi=10.1016%2Fj.ejmech.2012.08.042"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and antiviral evaluation of bis(POM) prodrugs of (E)-[4'-phosphono-but-2'-en-1'-yl]purine nucleosides</span></div><div class="casAuthors">Pradere, Ugo; Roy, Vincent; Montagu, Aurelien; Sari, Ozkan; Hamada, Manabu; Balzarini, Jan; Snoeck, Robert; Andrei, Graciela; Agrofoglio, Luigi A.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">126-133</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Seventeen hitherto unknown bis(POM) (POM = CH2OCOCMe3) prodrugs of novel (E)-[4'-phosphono-but-2'-en-1'-yl]purine nucleosides were prepd. in a straight approach and at good yields.  Those compds. were synthesized by the reaction of purine nucleobases directly with the phosphonate synthon 3 bearing POM biolabile groups under Mitsunobu conditions.  All obtained compds. were evaluated for their antiviral activities against a large no. of DNA and RNA viruses including herpes simplex viruses 1 and 2, varicella zoster virus, feline herpes virus, human cytomegalovirus, HIV-1 and HIV-2.  Among these mols., some of them exhibit anti-VZV and anti-HIV activity at submicromolar concns.  This class of compd. will be of further interest for lead optimization as anti-infectious agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqxVPiJ_V4O9rVg90H21EOLACvtfcHk0lgsuXMFJbOwAg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhsleisr7N&md5=f35f9503d66add5e5258919f92fcaab0</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2012.08.042&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2012.08.042%26sid%3Dliteratum%253Aachs%26aulast%3DPrad%25C3%25A8re%26aufirst%3DU.%26aulast%3DRoy%26aufirst%3DV.%26aulast%3DMontagu%26aufirst%3DA.%26aulast%3DSari%26aufirst%3DO.%26aulast%3DHamada%26aufirst%3DM.%26aulast%3DBalzarini%26aufirst%3DJ.%26aulast%3DSnoeck%26aufirst%3DR.%26aulast%3DAndrei%26aufirst%3DG.%26aulast%3DAgrofoglio%26aufirst%3DL.%2BA.%26atitle%3DSynthesis%2520and%2520Antiviral%2520Evaluation%2520of%2520Bis%2528POM%2529%2520Prodrugs%2520of%2520%2528E%2529-%255B4%25E2%2580%25B2-Phosphono-but-2%25E2%2580%25B2-En-1%25E2%2580%25B2-Yl%255DPurine%2520Nucleosides%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2012%26volume%3D57%26spage%3D126%26epage%3D133%26doi%3D10.1016%2Fj.ejmech.2012.08.042" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sugiyama, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eastgate, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fritz, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murugesan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conlon, D. A.</span></span> <span> </span><span class="NLM_article-title">Development of a Process for the Preparation of Chloromethyl Chlorosulfate</span>. <i>Org. Process Res. Dev.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">1827</span>– <span class="NLM_lpage">1831</span>, <span class="refDoi"> DOI: 10.1021/op300246d</span> </span><div class="citationLinks">[<a href="/doi/10.1021/op300246d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01531&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsFOlsbnM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2012&pages=1827-1831&author=B.+Zhengauthor=M.+Sugiyamaauthor=M.+D.+Eastgateauthor=A.+Fritzauthor=S.+Murugesanauthor=D.+A.+Conlon&title=Development+of+a+Process+for+the+Preparation+of+Chloromethyl+Chlorosulfate&doi=10.1021%2Fop300246d"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Development of a Process for the Preparation of Chloromethyl Chlorosulfate</span></div><div class="casAuthors">Zheng, Bin; Sugiyama, Masano; Eastgate, Martin; Fritz, Alan; Murugesan, Saravanababu; Conlon, David A.</div><div class="citationInfo"><span class="NLM_cas:title">Organic Process Research & Development</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1827-1831</span>CODEN:
                <span class="NLM_cas:coden">OPRDFK</span>;
        ISSN:<span class="NLM_cas:issn">1083-6160</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A process for the prepn. of chloromethyl chlorosulfate ClCH2OSO2Cl (I) from chloroiodomethane and chlorosulfonic acid was developed.  The substitution reaction of chloroiodomethane with chlorosulfonic acid yielded I and iodine (generated by oxidn. of iodide by chlorosulfonic acid); the yield was improved by oxidizing the reaction mixt. with bleach to convert iodine to iodate (to prevent iodide-mediated decompn. of I) and by scavenging water with thionyl chloride [to prevent the formation of bis(chloromethyl) sulfate as a byproduct].  The process provided I in 92% soln. yield and high purity (>99 GC area %) on 160 g scale.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrGAQ5GFMKzgrVg90H21EOLACvtfcHk0lgsuXMFJbOwAg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsFOlsbnM&md5=4d09cacbe655ea9843e07e3d971567e0</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1021%2Fop300246d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fop300246d%26sid%3Dliteratum%253Aachs%26aulast%3DZheng%26aufirst%3DB.%26aulast%3DSugiyama%26aufirst%3DM.%26aulast%3DEastgate%26aufirst%3DM.%2BD.%26aulast%3DFritz%26aufirst%3DA.%26aulast%3DMurugesan%26aufirst%3DS.%26aulast%3DConlon%26aufirst%3DD.%2BA.%26atitle%3DDevelopment%2520of%2520a%2520Process%2520for%2520the%2520Preparation%2520of%2520Chloromethyl%2520Chlorosulfate%26jtitle%3DOrg.%2520Process%2520Res.%2520Dev.%26date%3D2012%26volume%3D16%26spage%3D1827%26epage%3D1831%26doi%3D10.1021%2Fop300246d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Meier, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mercer, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rivera, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burkart, M. D.</span></span> <span> </span><span class="NLM_article-title">Synthesis and Evaluation of Bioorthogonal Pantetheine Analogues for in Vivo Protein Modification</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>128</i></span>,  <span class="NLM_fpage">12174</span>– <span class="NLM_lpage">12184</span>, <span class="refDoi"> DOI: 10.1021/ja063217n</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja063217n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01531&amp;key=1%3ACAS%3A528%3ADC%252BD28Xos1Sgt7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=128&publication_year=2006&pages=12174-12184&author=J.+L.+Meierauthor=A.+C.+Mercerauthor=H.+Riveraauthor=M.+D.+Burkart&title=Synthesis+and+Evaluation+of+Bioorthogonal+Pantetheine+Analogues+for+in+Vivo+Protein+Modification&doi=10.1021%2Fja063217n"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and Evaluation of Bioorthogonal Pantetheine Analogues for in Vivo Protein Modification</span></div><div class="casAuthors">Meier, Jordan L.; Mercer, Andrew C.; Rivera, Heriberto, Jr.; Burkart, Michael D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">128</span>
        (<span class="NLM_cas:issue">37</span>),
    <span class="NLM_cas:pages">12174-12184</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">In vivo carrier protein tagging has recently become an attractive target for the site-specific modification of fusion systems and new approaches to natural product proteomics.  A detailed study of pantetheine analogs was performed to identify suitable partners for covalent protein labeling inside living cells.  A rapid synthesis of pantothenamide analogs was developed and used to produce a panel which was evaluated for in vitro and in vivo protein labeling.  Kinetic comparisons allowed the construction of a structure-activity relation to pinpoint the linker, dye, and bioorthogonal reporter of choice for carrier protein labeling.  Finally bioorthogonal pantetheine analogs were shown to target carrier proteins with high specificity in vivo and undergo chemoselective ligation to reporters in crude cell lysate.  The methods demonstrated here allow carrier proteins to be visualized and isolated for the first time without the need for antibody techniques and set the stage for the future use of carrier protein fusions in chem. biol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpEmOTLofNIwbVg90H21EOLACvtfcHk0lg1RQWqOLwZ2g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xos1Sgt7o%253D&md5=b580ba45e1a936d1795e4331109370cd</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1021%2Fja063217n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja063217n%26sid%3Dliteratum%253Aachs%26aulast%3DMeier%26aufirst%3DJ.%2BL.%26aulast%3DMercer%26aufirst%3DA.%2BC.%26aulast%3DRivera%26aufirst%3DH.%26aulast%3DBurkart%26aufirst%3DM.%2BD.%26atitle%3DSynthesis%2520and%2520Evaluation%2520of%2520Bioorthogonal%2520Pantetheine%2520Analogues%2520for%2520in%2520Vivo%2520Protein%2520Modification%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2006%26volume%3D128%26spage%3D12174%26epage%3D12184%26doi%3D10.1021%2Fja063217n" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cullis, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Snip, E.</span></span> <span> </span><span class="NLM_article-title">Stereochemical Course of Cerium(IV)-Catalyzed Hydrolysis of Cyclic Nucleotides</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>121</i></span>,  <span class="NLM_fpage">6125</span>– <span class="NLM_lpage">6130</span>, <span class="refDoi"> DOI: 10.1021/ja990686z</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja990686z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01531&amp;key=1%3ACAS%3A528%3ADyaK1MXjslOjt7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=121&publication_year=1999&pages=6125-6130&author=P.+M.+Cullisauthor=E.+Snip&title=Stereochemical+Course+of+Cerium%28IV%29-Catalyzed+Hydrolysis+of+Cyclic+Nucleotides&doi=10.1021%2Fja990686z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Stereochemical Course of Cerium(IV)-Catalyzed Hydrolysis of Cyclic Nucleotides</span></div><div class="casAuthors">Cullis, Paul M.; Snip, Erwin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">121</span>
        (<span class="NLM_cas:issue">26</span>),
    <span class="NLM_cas:pages">6125-6130</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">CeIV has been shown to catalyze the hydrolysis of thymidine 3',5'-cyclic thiophosphate (cTMPS) to give a mixt. of 3'-TMPS and 5'-TMPS with rates comparable to those previously reported for cAMP and cTMP.  The ratio of the 3'-TMPS and 5'-TMPS products was dependent on the abs. configuration of the cTMPS; starting from Rp cTMPS, with the sulfur equatorial, the 3'-TMPS:5'-TMPS ratio was ca. 7:1 whereas for the corresponding Sp cTMPS the ratio was 3:2.  Both diastereoisomers of thymidine 3',5'-cyclic [18O]thiophosphate have been synthesized, and the stereochem. course of the hydrolysis reaction catalyzed by CeIV has been detd.  In each case, the reaction proceeds with clean inversion of configuration, consistent with coordination of the metal ion to the exocyclic oxygen substituent and delivery of the hydroxide nucleophile from one of the remaining metal coordination sites with in-line geometry.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGraYfd5cpFbeLVg90H21EOLACvtfcHk0lg1RQWqOLwZ2g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXjslOjt7o%253D&md5=9d82bcbec6bcf898ce5626a1154a7b3b</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1021%2Fja990686z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja990686z%26sid%3Dliteratum%253Aachs%26aulast%3DCullis%26aufirst%3DP.%2BM.%26aulast%3DSnip%26aufirst%3DE.%26atitle%3DStereochemical%2520Course%2520of%2520Cerium%2528IV%2529-Catalyzed%2520Hydrolysis%2520of%2520Cyclic%2520Nucleotides%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1999%26volume%3D121%26spage%3D6125%26epage%3D6130%26doi%3D10.1021%2Fja990686z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Buchwald, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knowles, J. R.</span></span> <span> </span><span class="NLM_article-title">Determination of the Absolute Configuration of [16O,17O,18O]Phosphate Monoesters by Using Phosphorus-31 NMR</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">1980</span>,  <span class="NLM_volume"><i>102</i></span>,  <span class="NLM_fpage">6601</span>– <span class="NLM_lpage">6602</span>, <span class="refDoi"> DOI: 10.1021/ja00541a056</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja00541a056" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01531&amp;key=1%3ACAS%3A528%3ADyaL3cXmtFaktL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=1980&pages=6601-6602&author=S.+L.+Buchwaldauthor=J.+R.+Knowles&title=Determination+of+the+Absolute+Configuration+of+%5B16O%2C17O%2C18O%5DPhosphate+Monoesters+by+Using+Phosphorus-31+NMR&doi=10.1021%2Fja00541a056"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Determination of the absolute configuration of [16O,17O,18O]phosphate monoesters by using phosphorus-31 NMR</span></div><div class="casAuthors">Buchwald, Stephen L.; Knowles, Jeremy R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">1980</span>),
    <span class="NLM_cas:volume">102</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">6601-2</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    </div><div class="casAbstract">The abs. configuration of chiral [16O,17O,18O]phosphate monoesters can be detd. by high resoln. 31P NMR.  When 1-[16O,17O,18O]phospho-(S)-propane-1,2-diol is cyclized, and then methylated with diazomethane, anal. of the resulting mixt. of diastereoisomeric cyclic triesters by 31P NMR gives an 8-line spectrum.  Species contg. 17O are not obsd. because of quadrupolar broadening of the 31P resonance.  The dependence of the 18O isotopic shift on the nature of the 31P-O bond, allows an unambiguous assignment of the abs. configuration at P.  This method, while less quant. than the mass spectrometric technique developed previously, has the advantages of both conceptual and practical simplicity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrTJ5csUTXSfLVg90H21EOLACvtfcHk0lg1RQWqOLwZ2g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL3cXmtFaktL4%253D&md5=53da8c33f2860d733974603ac59b24dc</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1021%2Fja00541a056&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja00541a056%26sid%3Dliteratum%253Aachs%26aulast%3DBuchwald%26aufirst%3DS.%2BL.%26aulast%3DKnowles%26aufirst%3DJ.%2BR.%26atitle%3DDetermination%2520of%2520the%2520Absolute%2520Configuration%2520of%2520%255B16O%252C17O%252C18O%255DPhosphate%2520Monoesters%2520by%2520Using%2520Phosphorus-31%2520NMR%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1980%26volume%3D102%26spage%3D6601%26epage%3D6602%26doi%3D10.1021%2Fja00541a056" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Balibar, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hollis-Symynkywicz, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tao, J.</span></span> <span> </span><span class="NLM_article-title">Pantethine Rescues Phosphopantothenoylcysteine Synthetase and Phosphopantothenoylcysteine Decarboxylase Deficiency in <i>Escherichia coli</i> but Not in <i>Pseudomonas aeruginosa</i></span>. <i>J. Bacteriol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>193</i></span>,  <span class="NLM_fpage">3304</span>– <span class="NLM_lpage">3312</span>, <span class="refDoi"> DOI: 10.1128/JB.00334-11</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01531&amp;key=10.1128%2FJB.00334-11" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01531&amp;key=21551303" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01531&amp;key=1%3ACAS%3A528%3ADC%252BC3MXosVSmsLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=193&publication_year=2011&pages=3304-3312&author=C.+J.+Balibarauthor=M.+F.+Hollis-Symynkywiczauthor=J.+Tao&title=Pantethine+Rescues+Phosphopantothenoylcysteine+Synthetase+and+Phosphopantothenoylcysteine+Decarboxylase+Deficiency+in+Escherichia+coli+but+Not+in+Pseudomonas+aeruginosa&doi=10.1128%2FJB.00334-11"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Pantethine rescues phosphopantothenoylcysteine synthetase and phosphopantothenoylcysteine decarboxylase deficiency in Escherichia coli but not in Pseudomonas aeruginosa</span></div><div class="casAuthors">Balibar, Carl J.; Hollis-Symynkywicz, Micah F.; Tao, Jianshi</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Bacteriology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">193</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">3304-3312</span>CODEN:
                <span class="NLM_cas:coden">JOBAAY</span>;
        ISSN:<span class="NLM_cas:issn">0021-9193</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">CoA plays a central and essential role in all living organisms.  The pathway leading to CoA biosynthesis has been considered an attractive target for developing new antimicrobial agents with novel mechanisms of action.  By using an arabinose-regulated expression system, the essentiality of coaBC, a single gene encoding a bifunctional protein catalyzing two consecutive steps in the CoA pathway converting 4'-phosphopantothenate to 4'-phosphopantetheine, was confirmed in Escherichia coli.  Using this regulated coaBC strain, further E. coli can effectively metabolize pantethine to bypass the requirement for coaBC.  Pantethine cannot be used by Pseudomonas aeruginosa to obviate coaBC.  Through reciprocal complementation studies in combination with biochem. characterization, it was demonstrated that the differential characteristics of pantethine use in these two microorganisms are due to the different substrate specificities assocd. with endogenous pantothenate kinase, the first enzyme in the CoA biosynthetic pathway encoded by coaA in E. coli and coaX in P. aeruginosa.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpyEk83lTpVsbVg90H21EOLACvtfcHk0lg1RQWqOLwZ2g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXosVSmsLc%253D&md5=7a1eef41544e6ef5612094d228500f9f</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1128%2FJB.00334-11&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FJB.00334-11%26sid%3Dliteratum%253Aachs%26aulast%3DBalibar%26aufirst%3DC.%2BJ.%26aulast%3DHollis-Symynkywicz%26aufirst%3DM.%2BF.%26aulast%3DTao%26aufirst%3DJ.%26atitle%3DPantethine%2520Rescues%2520Phosphopantothenoylcysteine%2520Synthetase%2520and%2520Phosphopantothenoylcysteine%2520Decarboxylase%2520Deficiency%2520in%2520Escherichia%2520coli%2520but%2520Not%2520in%2520Pseudomonas%2520aeruginosa%26jtitle%3DJ.%2520Bacteriol.%26date%3D2011%26volume%3D193%26spage%3D3304%26epage%3D3312%26doi%3D10.1128%2FJB.00334-11" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brunetti, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dusi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morbin, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uggetti, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moda, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">D’Amato, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giordano, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">D’Amati, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cozzi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Levi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayflick, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tiranti, V.</span></span> <span> </span><span class="NLM_article-title">Pantothenate Kinase-Associated Neurodegeneration: Altered Mitochondria Membrane Potential and Defective Respiration in Pank2 Knock-out Mouse Model</span>. <i>Hum. Mol. Genet.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">5294</span>– <span class="NLM_lpage">5305</span>, <span class="refDoi"> DOI: 10.1093/hmg/dds380</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01531&amp;key=10.1093%2Fhmg%2Fdds380" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01531&amp;key=22983956" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01531&amp;key=1%3ACAS%3A528%3ADC%252BC38XhslKnsLfI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2012&pages=5294-5305&author=D.+Brunettiauthor=S.+Dusiauthor=M.+Morbinauthor=A.+Uggettiauthor=F.+Modaauthor=I.+D%E2%80%99Amatoauthor=C.+Giordanoauthor=G.+D%E2%80%99Amatiauthor=A.+Cozziauthor=S.+Leviauthor=S.+Hayflickauthor=V.+Tiranti&title=Pantothenate+Kinase-Associated+Neurodegeneration%3A+Altered+Mitochondria+Membrane+Potential+and+Defective+Respiration+in+Pank2+Knock-out+Mouse+Model&doi=10.1093%2Fhmg%2Fdds380"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Pantothenate kinase-associated neurodegeneration: altered mitochondria membrane potential and defective respiration in Pank2 knock-out mouse model</span></div><div class="casAuthors">Brunetti, Dario; Dusi, Sabrina; Morbin, Michela; Uggetti, Andrea; Moda, Fabio; D'Amato, Ilaria; Giordano, Carla; d'Amati, Giulia; Cozzi, Anna; Levi, Sonia; Hayflick, Susan; Tiranti, Valeria</div><div class="citationInfo"><span class="NLM_cas:title">Human Molecular Genetics</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">5294-5305</span>CODEN:
                <span class="NLM_cas:coden">HMGEE5</span>;
        ISSN:<span class="NLM_cas:issn">0964-6906</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Neurodegeneration with brain iron accumulation (NBIA) comprises a group of neurodegenerative disorders characterized by high brain content of iron and presence of axonal spheroids.  Mutations in the PANK2 gene, which encodes pantothenate kinase 2, underlie an autosomal recessive inborn error of CoA metab., called pantothenate kinase-assocd. neurodegeneration (PKAN).  PKAN is characterized by dystonia, dysarthria, rigidity and pigmentary retinal degeneration.  The pathogenesis of this disorder is poorly understood and, although PANK2 is a mitochondrial protein, perturbations in mitochondrial bioenergetics have not been reported.  A knock-out (KO) mouse model of PKAN exhibits retinal degeneration and azoospermia, but lacks any neurol. phenotype.  The absence of a clin. phenotype has partially been explained by the different cellular localization of the human and murine PANK2 proteins.  Here we demonstrate that the mouse Pank2 protein localizes to mitochondria, similar to its human orthologue.  Moreover, we show that Pank2-defective neurons derived from KO mice have an altered mitochondrial membrane potential, a defect further corroborated by the observations of swollen mitochondria at the ultra-structural level and by the presence of defective respiration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpj-jrm27dzq7Vg90H21EOLACvtfcHk0liL_u4zQqAomg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhslKnsLfI&md5=65f0eeb667d36c4da04b612a233a6ca7</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1093%2Fhmg%2Fdds380&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fhmg%252Fdds380%26sid%3Dliteratum%253Aachs%26aulast%3DBrunetti%26aufirst%3DD.%26aulast%3DDusi%26aufirst%3DS.%26aulast%3DMorbin%26aufirst%3DM.%26aulast%3DUggetti%26aufirst%3DA.%26aulast%3DModa%26aufirst%3DF.%26aulast%3DD%25E2%2580%2599Amato%26aufirst%3DI.%26aulast%3DGiordano%26aufirst%3DC.%26aulast%3DD%25E2%2580%2599Amati%26aufirst%3DG.%26aulast%3DCozzi%26aufirst%3DA.%26aulast%3DLevi%26aufirst%3DS.%26aulast%3DHayflick%26aufirst%3DS.%26aulast%3DTiranti%26aufirst%3DV.%26atitle%3DPantothenate%2520Kinase-Associated%2520Neurodegeneration%253A%2520Altered%2520Mitochondria%2520Membrane%2520Potential%2520and%2520Defective%2520Respiration%2520in%2520Pank2%2520Knock-out%2520Mouse%2520Model%26jtitle%3DHum.%2520Mol.%2520Genet.%26date%3D2012%26volume%3D21%26spage%3D5294%26epage%3D5305%26doi%3D10.1093%2Fhmg%2Fdds380" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tian, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wysocki, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arnold, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ravichandran, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sternson, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Looger, L. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lavis, L. D.</span></span> <span> </span><span class="NLM_article-title">Selective Esterase-Ester Pair for Targeting Small Molecules with Cellular Specificity</span>. <i>Proc. Natl. Acad. Sci. U.S.A.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>109</i></span>,  <span class="NLM_fpage">4756</span>– <span class="NLM_lpage">4761</span>, <span class="refDoi"> DOI: 10.1073/pnas.1111943109</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01531&amp;key=10.1073%2Fpnas.1111943109" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01531&amp;key=22411832" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01531&amp;key=1%3ACAS%3A528%3ADC%252BC38XltF2msbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=109&publication_year=2012&pages=4756-4761&author=L.+Tianauthor=Y.+Yangauthor=L.+M.+Wysockiauthor=A.+C.+Arnoldauthor=A.+Huauthor=B.+Ravichandranauthor=S.+M.+Sternsonauthor=L.+L.+Loogerauthor=L.+D.+Lavis&title=Selective+Esterase-Ester+Pair+for+Targeting+Small+Molecules+with+Cellular+Specificity&doi=10.1073%2Fpnas.1111943109"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Selective esterase-ester pair for targeting small molecules with cellular specificity</span></div><div class="casAuthors">Tian, Lin; Yang, Yunlei; Wysocki, Laura M.; Arnold, Alma C.; Hu, Amy; Ravichandran, Balaji; Sternson, Scott M.; Looger, Loren L.; Lavis, Luke D.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">109</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">4756-4761, S4756/1-S4756/12</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Small mols. are important tools to measure and modulate intracellular signaling pathways.  A longstanding limitation for using chem. compds. in complex tissues has been the inability to target bioactive small mols. to a specific cell class.  Here, we describe a generalizable esterase-ester pair capable of targeted delivery of small mols. to living cells and tissue with cellular specificity.  We used fluorogenic mols. to rapidly identify a small ester masking motif that is stable to endogenous esterases, but is efficiently removed by an exogenous esterase.  This strategy allows facile targeting of dyes and drugs in complex biol. environments to label specific cell types, illuminate gap junction connectivity, and pharmacol. perturb distinct subsets of cells.  We expect this approach to have general utility for the specific delivery of many small mols. to defined cellular populations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqFjIH1CDwPTrVg90H21EOLACvtfcHk0liL_u4zQqAomg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XltF2msbo%253D&md5=739853ea85d7e1591d9ca6caa282c341</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1111943109&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1111943109%26sid%3Dliteratum%253Aachs%26aulast%3DTian%26aufirst%3DL.%26aulast%3DYang%26aufirst%3DY.%26aulast%3DWysocki%26aufirst%3DL.%2BM.%26aulast%3DArnold%26aufirst%3DA.%2BC.%26aulast%3DHu%26aufirst%3DA.%26aulast%3DRavichandran%26aufirst%3DB.%26aulast%3DSternson%26aufirst%3DS.%2BM.%26aulast%3DLooger%26aufirst%3DL.%2BL.%26aulast%3DLavis%26aufirst%3DL.%2BD.%26atitle%3DSelective%2520Esterase-Ester%2520Pair%2520for%2520Targeting%2520Small%2520Molecules%2520with%2520Cellular%2520Specificity%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2012%26volume%3D109%26spage%3D4756%26epage%3D4761%26doi%3D10.1073%2Fpnas.1111943109" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Montagu, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pradére, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roy, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nolan, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Agrofoglio, L. A.</span></span> <span> </span><span class="NLM_article-title">Expeditious Convergent Procedure for the Preparation of Bis(POC) Prodrugs of New (E)-4-Phosphono-but-2-En-1-Yl Nucleosides</span>. <i>Tetrahedron</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>67</i></span>,  <span class="NLM_fpage">5319</span>– <span class="NLM_lpage">5328</span>, <span class="refDoi"> DOI: 10.1016/j.tet.2011.05.017</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01531&amp;key=10.1016%2Fj.tet.2011.05.017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01531&amp;key=1%3ACAS%3A528%3ADC%252BC3MXnsVCku7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2011&pages=5319-5328&author=A.+Montaguauthor=U.+Prad%C3%A9reauthor=V.+Royauthor=S.+P.+Nolanauthor=L.+A.+Agrofoglio&title=Expeditious+Convergent+Procedure+for+the+Preparation+of+Bis%28POC%29+Prodrugs+of+New+%28E%29-4-Phosphono-but-2-En-1-Yl+Nucleosides&doi=10.1016%2Fj.tet.2011.05.017"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Expeditious convergent procedure for the preparation of bis(POC) prodrugs of new (E)-4-phosphono-but-2-en-1-yl nucleosides</span></div><div class="casAuthors">Montagu, Aurelien; Pradere, Ugo; Roy, Vincent; Nolan, Steven P.; Agrofoglio, Luigi A.</div><div class="citationInfo"><span class="NLM_cas:title">Tetrahedron</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">29</span>),
    <span class="NLM_cas:pages">5319-5328</span>CODEN:
                <span class="NLM_cas:coden">TETRAB</span>;
        ISSN:<span class="NLM_cas:issn">0040-4020</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A series of unsatd. acyclonucleoside bis(POC) prodrugs of E configuration were synthesized through an expeditious, highly efficient and stereoselective one-step procedure from corresponding bis(POC)allyl-phosphonate through Ru catalyzed cross-coupling metathesis reaction.  The [RuCl2(PCy3)(SIPr)(Indenylidene)] and [RuCl2(PCy3)(IMes)(benzylidene)] catalysts were employed; the unsatd. ANP were used bore C5-halovinyl uracil, C5-dihalovinyl-uracil or furano-pyrimidine motifs.  The chem. cleavage of bio-labile (POC) group is a useful pathway to acid phosphonate derivs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp5Og5ECKbRhrVg90H21EOLACvtfcHk0liL_u4zQqAomg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXnsVCku7k%253D&md5=d8a31f7868961a908b18a72d53a88954</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1016%2Fj.tet.2011.05.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tet.2011.05.017%26sid%3Dliteratum%253Aachs%26aulast%3DMontagu%26aufirst%3DA.%26aulast%3DPrad%25C3%25A9re%26aufirst%3DU.%26aulast%3DRoy%26aufirst%3DV.%26aulast%3DNolan%26aufirst%3DS.%2BP.%26aulast%3DAgrofoglio%26aufirst%3DL.%2BA.%26atitle%3DExpeditious%2520Convergent%2520Procedure%2520for%2520the%2520Preparation%2520of%2520Bis%2528POC%2529%2520Prodrugs%2520of%2520New%2520%2528E%2529-4-Phosphono-but-2-En-1-Yl%2520Nucleosides%26jtitle%3DTetrahedron%26date%3D2011%26volume%3D67%26spage%3D5319%26epage%3D5328%26doi%3D10.1016%2Fj.tet.2011.05.017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fung, H. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stone, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piacenti, F. J.</span></span> <span> </span><span class="NLM_article-title">Tenofovir Disoproxil Fumarate: A Nucleotide Reverse Transcriptase Inhibitor for the Treatment of HIV Infection</span>. <i>Clin. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">1515</span>– <span class="NLM_lpage">1548</span>, <span class="refDoi"> DOI: 10.1016/S0149-2918(02)80058-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01531&amp;key=10.1016%2FS0149-2918%2802%2980058-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01531&amp;key=12462284" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01531&amp;key=1%3ACAS%3A528%3ADC%252BD38XpsVSqsbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2002&pages=1515-1548&author=H.+B.+Fungauthor=E.+A.+Stoneauthor=F.+J.+Piacenti&title=Tenofovir+Disoproxil+Fumarate%3A+A+Nucleotide+Reverse+Transcriptase+Inhibitor+for+the+Treatment+of+HIV+Infection&doi=10.1016%2FS0149-2918%2802%2980058-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Tenofovir disoproxil fumarate: a nucleotide reverse transcriptase inhibitor for the treatment of HIV infection</span></div><div class="casAuthors">Fung, Horatio B.; Stone, Elizabeth A.; Piacenti, Frank J.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Therapeutics</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1515-1548</span>CODEN:
                <span class="NLM_cas:coden">CLTHDG</span>;
        ISSN:<span class="NLM_cas:issn">0149-2918</span>.
    
            (<span class="NLM_cas:orgname">Excerpta Medica, Inc.</span>)
        </div><div class="casAbstract">A review.  Tenofovir disoproxil fumarate (DF) is the first nucleotide reverse transcriptase inhibitor approved for use in combination with other antiretroviral agents in the treatment of HIV-1 infection in the United States.  Unlike the nucleoside reverse transcriptase inhibitors, which must undergo 3 intracellular phosphorylation steps for activation, nucleotide analogs such as tenofovir require only 2 such steps.  This redn. in the phosphorylation requirement has the potential to produce more rapid and complete conversion of the drug to its pharmacol. active metabolite.  This article describes the pharmacol. properties and potential clin. usefulness of tenofovir DF.  Relevant information was identified through searches of MEDLINE (1996-Apr. 2002), Iowa Drug Information Service (1996-Apr. 2002), and International Pharmaceutical Abstrs. (1970-Apr. 2002), as well as from meeting abstrs. of major HIV/AIDS conferences (1996-2002), using the search terms tenofovir, tenofovir disoproxil fumarate, PMPA, bis(POC)PMPA, GS-4331-05, acyclic nucleoside phosphonate, and nucleotide reverse transcriptase inhibitor.  Addnl. information was obtained from material submitted to the US Food and Drug Administration by the manufacturer of tenofovir DF in support of its New Drug Application.  In vitro, tenofovir DF has exhibited anti-HIV activity in various HIV-infected cell lines and has produced a synergistic or additive effect against HIV when combined with other antiretroviral agents.  In adult humans, tenofovir has a vol. of distribution of 0.813 L/kg, is minimally bound to plasma protein (7.2%), has a plasma elimination half-life of 12.0 to 14.4 h, and is mainly excreted unchanged in urine (70%-80%).  Dose adjustment based on sex or body wt. does not appear to be necessary, although dose redn. may be necessary in the elderly; there are currently no data on tenofovir DF in renal or hepatic insufficiency.  The results of clin. trials suggest the efficacy of tenofovir DF in reducing plasma levels of HIV-1 RNA when used as an add-on to a stable antiretroviral regimen.  The most commonly (>3%) reported adverse events in clin. trials have included nausea, diarrhea, asthenia, headache, vomiting, flatulence, abdominal pain, and anorexia.  The most commonly (>2%) reported lab. abnormalities (grade III or IV) included increases in creatine kinase, triglycerides, amylase, aspartate aminotransferase, and alanine aminotransferase, as well as hyperglycemia and glucosuria.  Serious adverse events leading to discontinuation of tenofovir DF were infrequent (5%), occurring with an incidence similar to that with placebo (8%).  The recommended dosage of tenofovir DF in adults is 300 mg/d PO; pharmacokinetic and efficacy studies in children are ongoing.  Although addnl. studies are needed, tenofovir DF appears to be a promising agent for the treatment of HIV infection.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp_At-9GMM12LVg90H21EOLACvtfcHk0li33laaQAWmmw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XpsVSqsbc%253D&md5=716b9b05811ed7a100bfc50280094e25</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1016%2FS0149-2918%2802%2980058-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0149-2918%252802%252980058-3%26sid%3Dliteratum%253Aachs%26aulast%3DFung%26aufirst%3DH.%2BB.%26aulast%3DStone%26aufirst%3DE.%2BA.%26aulast%3DPiacenti%26aufirst%3DF.%2BJ.%26atitle%3DTenofovir%2520Disoproxil%2520Fumarate%253A%2520A%2520Nucleotide%2520Reverse%2520Transcriptase%2520Inhibitor%2520for%2520the%2520Treatment%2520of%2520HIV%2520Infection%26jtitle%3DClin.%2520Ther.%26date%3D2002%26volume%3D24%26spage%3D1515%26epage%3D1548%26doi%3D10.1016%2FS0149-2918%2802%2980058-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cederbaum, A. I.</span></span> <span> </span><span class="NLM_article-title">Alcohol Metabolism</span>. <i>Clin. Liver Dis.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">667</span>– <span class="NLM_lpage">685</span>, <span class="refDoi"> DOI: 10.1016/j.cld.2012.08.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01531&amp;key=10.1016%2Fj.cld.2012.08.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01531&amp;key=23101976" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01531&amp;key=1%3ACAS%3A280%3ADC%252BC3s%252FosVyjsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2012&pages=667-685&author=A.+I.+Cederbaum&title=Alcohol+Metabolism&doi=10.1016%2Fj.cld.2012.08.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Alcohol metabolism</span></div><div class="casAuthors">Cederbaum Arthur I</div><div class="citationInfo"><span class="NLM_cas:title">Clinics in liver disease</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">667-85</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">This article describes the pathways and factors that modulate blood alcohol levels and metabolism and describes how the body disposes of alcohol.  The various factors that play a role in the distribution of alcohol in the body, influence the absorption of alcohol, and contribute to first-pass metabolism of alcohol are described.  Most alcohol is oxidized in the liver, and general principles and overall mechanisms for alcohol oxidation are summarized.  The kinetics of alcohol elimination in-vivo and the various genetic and environmental factors that can modify the rate of alcohol metabolism are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT137Qxyuzmxk2yPDyEFiigfW6udTcc2eZbvRRg2XaTx7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3s%252FosVyjsQ%253D%253D&md5=f95cf0d488509d8c5ab3ad5345e50c2f</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1016%2Fj.cld.2012.08.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cld.2012.08.002%26sid%3Dliteratum%253Aachs%26aulast%3DCederbaum%26aufirst%3DA.%2BI.%26atitle%3DAlcohol%2520Metabolism%26jtitle%3DClin.%2520Liver%2520Dis.%26date%3D2012%26volume%3D16%26spage%3D667%26epage%3D685%26doi%3D10.1016%2Fj.cld.2012.08.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hansch, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rockwell, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jow, P. Y. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leo, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steller, E. E.</span></span> <span> </span><span class="NLM_article-title">Substituent Constants for Correlation Analysis</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1977</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">304</span>– <span class="NLM_lpage">306</span>, <span class="refDoi"> DOI: 10.1021/jm00212a024</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm00212a024" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01531&amp;key=1%3ACAS%3A528%3ADyaE2sXltVOqsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=1977&pages=304-306&author=C.+Hanschauthor=S.+D.+Rockwellauthor=P.+Y.+C.+Jowauthor=A.+Leoauthor=E.+E.+Steller&title=Substituent+Constants+for+Correlation+Analysis&doi=10.1021%2Fjm00212a024"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Substituent constants for correlation analysis</span></div><div class="casAuthors">Hansch, Corwin; Rockwell, Sharon D.; Jow, Priscilla Y. C.; Leo, Albert; Steller, Edward E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1977</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">304-6</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    </div><div class="casAbstract">Consts. for π and σ were measured for 48 misc. arom. substituents of interest to medicinal chemists.  Swain and Lupton's ℱ and ℘ values were calcd. from the σ consts.  Values for molar refractivity are given for each of the substituents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpAn5OlCZr0DLVg90H21EOLACvtfcHk0li33laaQAWmmw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE2sXltVOqsw%253D%253D&md5=9b7aaf958d1387060416b9fe9a6adad1</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1021%2Fjm00212a024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00212a024%26sid%3Dliteratum%253Aachs%26aulast%3DHansch%26aufirst%3DC.%26aulast%3DRockwell%26aufirst%3DS.%2BD.%26aulast%3DJow%26aufirst%3DP.%2BY.%2BC.%26aulast%3DLeo%26aufirst%3DA.%26aulast%3DSteller%26aufirst%3DE.%2BE.%26atitle%3DSubstituent%2520Constants%2520for%2520Correlation%2520Analysis%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1977%26volume%3D20%26spage%3D304%26epage%3D306%26doi%3D10.1021%2Fjm00212a024" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref100"><div class="reference"><strong class="refLabel"><a href="#ref100" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit100"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vaino, A.</span>; <span class="NLM_string-name">Biestek, M.</span>; <span class="NLM_string-name">Shkreli, M.</span></span><span> </span><span class="NLM_article-title">Pantothenate derivatives for the treatment of neuroligic disorders</span>. <span class="NLM_patent">WO2013163576</span>, Published 31 Oct <span class="NLM_year">2013</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&author=A.+Vaino&author=M.+Biestek&author=M.+Shkreli&title=Pantothenate+derivatives+for+the+treatment+of+neuroligic+disorders"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit100&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DVaino%26aufirst%3DA.%26atitle%3DPantothenate%2520derivatives%2520for%2520the%2520treatment%2520of%2520neuroligic%2520disorders%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-5"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i62"><a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c01531">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_36001"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acs.jmedchem.0c01531?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c01531</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Procedure for the PBEC BBB assay, assessment of the effect of compound <b>2a</b> on tubulin and histone acetylation, ROESY spectra of compound <b>1</b>, ROESY spectra of compound <b>2a</b>, X-ray crystal structure of compound <b>2a</b>, <sup>1</sup>H and <sup>31</sup>P NMR spectra of key compounds, and UPLC chromatograms of key compounds (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c01531/suppl_file/jm0c01531_si_002.pdf">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c01531/suppl_file/jm0c01531_si_001.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c01531/suppl_file/jm0c01531_si_001.csv">jm0c01531_si_001.csv (3.14 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c01531/suppl_file/jm0c01531_si_002.pdf">jm0c01531_si_002.pdf (15.08 MB)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.0c01531&amp;pbContext=%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2020.63.issue-24%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.0c01531%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.0c01531" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                3MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"6799c8192a05d1cb","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
